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ABSTRACT 
 
Mast cells affect brain physiology and behavior. 
Katherine M. Nautiyal 
 
 Mast cells are immune cells that are found in the brain.  Behavioral and endocrine 
states increase the number and activation of brain mast cells, independent of the animal’s 
immune status.  Activation causes the release of many neuro-active mediators into the 
brain parenchyma.  However, the function or impact of mast cells in the brain has not 
been studied.  The recruitment of mast cells to the brain, and their subsequent activation 
following a stressor suggests that they may have a role in regulating the stress response 
through interactions with neural systems.  The goal of this thesis is to examine the 
functional role of brain mast cells using a mouse model.   
 Mast cells are present in the mouse brain parenchyma, meninges and choroid 
plexus from birth throughout adulthood.   A mast cell deficient (KitW-sh /W-sh) mouse is a 
strong model to study the effects of mast cells on brain physiology and behavior.  The 
homozygote mutant lacks all brain mast cells resulting in reductions of mast cell-derived 
mediators.  Interestingly, mast cell deficient mice have increased levels of anxiety-like 
behavior and stress-induced defecation compared to heterozygote (mast cell competent) 
littermate controls.  Since mast cells are activated by stressors via corticotrophin 
releasing factor, it is surprising that no differences in the hypothalamic-pituitary-adrenal 
axis reactivity are seen between mast cell deficient mice and littermate controls.  
 Instead, the effects of mast cells on anxiety behavior and physiology may be 
mediated through mast cell contribution of serotonin to the hippocampus, a brain region 
where many mast cells reside. In vitro, application of a mast cell activator to hippocampal 
slices causes a rise in serotonin levels in the hippocampus of control, but not mast cell 
deficient mice.  Given the known effects of hippocampal serotonin as a trophic factor and 
transmitter, hippocampal function is likely affected by the absence of mast cells.  There 
are deficits in hippocampal neurogenesis, but not subventricular zone neurogenesis (a 
brain region with no mast cells), in mast cell deficient mice.  This deficit can be reversed 
by increasing serotonin signaling with SSRI treatment or by enriched housing conditions.  
Mast cell deficient mice also have deficits in hippocampal dependent spatial learning and 
memory which can be reversed by enriched housing.   
 Overall these results show that mast cells affect neural systems and behavior in 
the absence of an immune stimulus. These studies link an immune cell to the brain and 
behavior, and suggest a beneficial role for the recruitment of mast cells and subsequent 
neuroimmune interactions. 
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While the immune and central nervous systems were initially thought to function 
independently to mediate survival, there is bidirectional communication between these two 
systems (Steinman, 2004).  Psychoneuroimmunology (PNI) is a rapidly advancing field which 
aims to study the mechanisms of the interactions between brain, behavior and immunity.  Robert 
Ader is considered the father of PNI for his contributions in the 1970s showing that the immune 
system could be conditioned by the taste of saccharin (Ader and Cohen, 1975).  Other seminal 
studies showed that stress can affect immunity and chronic stress causes immune system 
dysfunction (Monjan and Collector, 1977; Glaser et al., 1985).  Most of this early work focused 
on how the brain and behavioral states could affect immunity, and the mechanisms underlying 
this direction of neuroimmune communication have been delineated (Sternberg, 2001; 
Schedlowski and Pacheco-Lopez, 2010).  Currently, there is more focus on immune to brain 
communication given evidence that immune system dysfunction may play a role in the etiology 
or pathogenesis of psychiatric and neurological disorders (Raison et al., 2006; Irwin and Miller, 
2007; Theoharides et al., 2008a). 
 There are multiple known mechanisms for immune to brain communication (Solomon, 
1987).  Many studies have focused on brain effects of cytokines released by peripheral immune 
cells (Maier and Watkins, 1998).  As messengers or transmitters of the immune system, 
cytokines communicate immune status to other cells and systems, including the central nervous 
system.  These actions are mediated by both blood-borne and neural routes.  In the former, 
cytokines can cross into the brain at sites lacking the blood brain barrier (BBB) or by active 
transport across the BBB to act directly on cytokine receptors located on neurons throughout the 
brain (Watkins et al., 1995).  In the latter, cytokines in the periphery activate ascending vagal 
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fibers which terminate at caudal brainstem nuclei such as the nucleus of the solitary tract which 
then connects to many homeostatic neural regulatory systems (Watkins et al., 1995).  While 
cytokines can be released from peripheral immune cells and have actions on the brain, there are 
also immune cells resident in the brain, including lymphocytes, brain macrophages (microglia), 
dendritic cells and mast cells (Hough, 1988; Hickey, 2001; Hanisch and Kettenmann, 2007; 
Bulloch et al., 2008).  Given that these cells release cytokines and other immune molecules 
within the brain, they are poised to be powerful players in immune to brain communication in 
disease, as well as healthy baseline states. 
 It is becoming increasingly clear that immune cells in the brain in the healthy baseline 
state are necessary for normal brain functioning and play a positive role in brain-immune system 
interaction and the regulation of cognition and emotionality (Yirmiya and Goshen, 2011).  
Immune activation, namely the initiation of an immune response to an antigen, during 
development is required for the normal development of the organism.  A lack of these immune 
responses can have detrimental effects on both autoimmune and mental health disorders (Raison 
et al., 2010).  The idea that immune activation is necessary for correct programming of immune 
regulatory responses has been termed the ‘hygiene’ or ‘old friends’ hypothesis (Rook and 
Brunet, 2005).  It suggests that a lack of immune activation prevents the necessary development 
of immunoregulatory mechanisms that are required to regulate activated immune system 
components following immune activation in the healthy adult individual.  It also suggests that a 
basal level of harmless microorganism or ‘old friends’ keeps the immune system otherwise 
occupied thereby decreasing the chance for an immune response to innocuous, for example a 
self-protein which would lead to an auto-immune disorder.  The hypothesis overall presents a 
possible explanation for the increase in autoimmune and mental health disorders in developed 
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countries in which people are more shielded from bacteria and other pathogens due to societal 
norms of hygiene and cleanliness (Rook and Lowry, 2008).  One recent study in rodents provides 
compelling data to support this view.  Bilbo and her colleagues show that a bacterial immune 
challenge early in life is protective against stress-induced depression in adulthood (Bilbo et al., 
2008).  In a larger sense, these examples represent the current trend in thinking that immune-
brain interactions are beneficial.  Psychoneuroimmunology today has progressed from studies 
looking at the detrimental roles of immune cells in neuroinflammation and their surveillance 
roles in the steady state to exploring the complex and intricate balance of neuroimmune 
interactions and resulting effects on brain and behavior.   
It is clear that the immune system is an integral part of mammalian physiology and has 
roles beyond supporting host defense.  Immune cells and cytokines are involved in normal brain 
development, neural signaling as well as behavioral outputs.  Peripheral immune cells release 
cytokines that activate vagal afferents or gain access to the brain through the blood-brain barrier 
or circumventricular organs.  In the latter case, cytokine receptors on neurons and glia are the 
bridge between the immune system and the brain.  More recently, studies have begun to identify 
and study immune cells that are resident in the brain.  Microglia, T cells, dendritic cells and mast 
cells are all immune cells that reside in the brain under normal physiological conditions.  In this 
dissertation the physiological and behavioral functions of brain mast cells are investigated.   
Given that mast cells are immune cells found in the brain, I propose that they can function as a 
direct link between the immune and central nervous systems and are prime candidates to mediate 




Mast cells are immune cells 
 Mast cells are hematopoietic immune cells best known for their role in allergy and other 
Type I hypersensitive responses (Metcalfe et al., 1997).  They are located in vascularized tissues 
of the body.  Mast cells are best known for their response to innocuous agents causing irritating 
responses associated with seasonal allergies, asthma and mosquito bites.  In the most severe case 
of a hypersensitive reaction, mast cells are involved in anaphylaxis which can cause death.   
 Nearly a century after their discovery, Kitamura and colleagues showed that mast cells 
are progeny of hematopoietic tissues (Kitamura et al., 1977; Kitamura et al., 1978).  However 
these studies did not identify the mast cell precursor or where in the hematopoietic lineage that a 
cell becomes committed to the mast cell lineage.  Given that mast cells were morphologically 
similar to basophils, it was believed that mast cells, like basophils were also derived from 
myeloid progenitors with an unknown intermediate precursor (Janeway et al., 2008).  Some also 
hypothesized that mature blood-borne basophils were the precursor of tissue-resident mast cells 
since basophils, but not mast cells are found in the blood (Kitamura and Ito, 2005). In 2005, 
Chen and colleagues described the mast cell lineage from the hematopoietic stem cells that was 
independent from basophils (Chen et al., 2005).  It is now known that mast cells are born in the 
bone marrow from hematopoietic stem cells and derive directly from multipotent progenitors 
(Fig 1).  Although unlikely, this study did not definitively show that mast cells can’t also be 
derived from common myeloid progenitors.  Mast cell progenitors circulate in the blood as 
differentiated mast cell precursors and then enter tissue before maturing into tissue specific 
phenotypes according to their local microenvironment (Chen et al., 2005).  They used 
fluorescence activated cell sorting to indentify a committed mast cell precursor circulating in the 
blood characterized as Lin(-)c-Kit(+)Sca-1(-)-Ly6c(-)-FcepsilonRIalpha(-)CD27(-)beta7(+) 
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T1/ST2+.  In vitro these precursors give rise to only mast cells.  Mast cell precursors lack 
granules, IgE receptors and other mature mast cell morphology like philopodia.  
 From the blood, mast cell precursors enter nearly all tissues of the body before maturing 
into mast cells.  In the rat, mast cells are first seen in tissues at embryonic day 17 (Gamble and 
Stempak, 1961).  Mast cells are not mitotic, and therefore must maintain their population by 
differentiation from continuously generated progenitors, throughout the organisms life (Padawer, 
1961; Selye, 1965).  Once tissue-resident, mature mast cells maintain the ability to migrate 
within the tissue via philopodia.  Mature mast cells have vesicle-like cytoplasmic granules, in 
which they store preformed chemical agents known as mediators.   
Figure 1.  Relationship of mast cell precursors to other hematopoietic progenitors.
This figure shows that mast cells (MC) are derived from mast cell precursors (MCP) that 
differentiate directly from multipotential progenitors (MPP).  MCPs may also arise from 
common myeloid progenitors (CMP).   Adapted from Chen et al., PNAS 2005.  
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Mast cell mediators  
 A single mast cell may contain up to 1000 granules (Blank and Rivera, 2004).  There is a 
large set of mediators that can be synthesized, stored and ready for immediate release by mast 
cell granules (Marshall, 2004).  These granule-associated preformed mediators are considered 
“primary mediators”.  Histamine, serotonin, nerve growth factor and heparin are the most notable 
of these (Oliver et al., 1947; Hough, 1988; Lambracht-Hall et al., 1990b; Levi-Montalcini et al., 
1996).  However, mast cells vary in their granule content based on the tissue in which they reside 
(Metcalfe, 1984).  This renders mast cells found in different tissues to be distinct populations 
containing different quantities and proportions of mediators, and unique to their local 
microenvironment.  Upon activation, mast cells degranulate and release primary mediators from 
their granules into the surrounding tissue (Metcalfe, 1983).  Release of granules from mast cells 
can occur all at once or in a piecemeal fashion (Ruoss et al., 1991).  The case in which a potent 
stimulus causes a mast cell to release all of its granules is considered anaphylactic degranulation 
(Thiernesse et al., 1978).   
Another subset of “secondary” mediators can be synthesized by mast cells subsequent to 
their activation (Marshall, 2004).  In contrast to the short latency effects that occur from release 
of the primary preformed mediators, these secondary mediators are only synthesized upon 
activation of specific receptor-activated cell signaling cascades.  The secondary mediators 
include many cytokines like tumor necrosis factor-α, interferons and interleukins, as well as 
peptides like corticotrophin releasing hormone and Substance P, and growth factors like nerve 
growth factor (Levi-Montalcini et al., 1996; Marshall, 2004).  Additionally, other pro-
inflammatory lipid derived mediators like prostaglandins and leukotrienes are secondary 
mediators as well as some growth factors like nerve growth factor.  Overall, the mast cell has the 
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potential to release over 50 mediators [see Table 1] (Marshall, 2004), making it one of the most 
diverse cells in the body. However all mast cells do not release all of these mediators because 
mast cells mature phenotypically depending on the local microenvironment (Galli, 1990), even 
within a single tissue (Zhuang et al., 1999).   
 




The role of mast cells in host defense 
Mast cells undergo degranulation following activation by a variety of immune and other 
stimuli.  Toll-like receptors on mast cells recognize pathogen-associated molecular patterns 
(PAMPs) on gram-negative bacteria like lipopolysaccharide and the peptidoglycan of gram-
positive bacteria (Supajatura et al., 2001).  Mast cells also respond to the complement system 
through their receptors for complement fragments like C3a, C3b and C5a (Morrison, 1978).  
Additionally mast cells respond to other non-immunological stimuli via activation of their G 
protein-coupled receptors (Kuehn and Gilfillan, 2007). 
Given the large number of pluripotential mediators, it is surprising that for decades the 
only known beneficial role of mast cells in host defense was in the response to parasites (Galli 
and Wershil, 1996), redundant to the closely related basophil and eosinophil cell types 
(Askenase, 1977; Gleich and Loegering, 1984).  Furthermore, the evolutionary conservation of 
mast cells in species suggests that there is an undiscovered, but potentially important role for 
mast cells in mammalian biology (Maurer et al., 2003).  In the past decade, novel and beneficial 
functional roles of mast cells have been identified proving that these cells are an important 
element of the immune system.      
First, due to their location in high numbers at host-environment interfaces, they act as 
sentinels (Galli et al., 1999).  Generally one of the first cell types to detect an invasion or injury, 
mast cells also have the capability to very quickly release pro-inflammatory signals as they are 
already synthesized and ready for immediate release.  Mast cells signal many different tissues 
(see Fig 1).  For example, histamine released from granules produces vasodilation of nearby 
blood vessels to increase blood flow to recruit immune cells to the location (Dacey and Bassett, 
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1987).  In addition, other vasoactive mediators act on smooth muscles cells and endothelial cells 
to increase vascular permeability and allow immune cells to enter the tissue (Goldsby, 2003).  
 Secondly, mast cells also enhance survival in certain models of bacterial infection.  In an 
extreme case of septic peritonitis induced by cecal ligation and puncture, mast cells are 
beneficial in the immune response (Echtenacher et al., 1996).  Mice that lack mast cells show 
increased mortality which is reversed by repopulation of mast cells into these mice.  
Furthermore, other studies implicate mast cell derived tumor necrosis factor alpha (TNF-α) in the 
beneficial response of mast cells during sepsis.  TNF-α from mast cells promotes neutrophil 
influx (Malaviya et al., 1996) and complement mediated immunity, particularly by binding C3 
and C4 proteins (Prodeus et al., 1997).   
 Mast cells are also necessary in the 
defense against venomous reptiles and other 
stinging insects (Metz et al., 2006).  Mice 
without mast cells become hypothermic and die 
following injection with the venom from 
rattlesnakes or honeybees at doses that cause no 
mortality in normal mice.  It is known that these 
venoms induce mast cell degranulation and that 
released mast cell proteases can degrade 
venomous toxins (Maurer et al., 2004).  
Specifically, carboxylpeptidase A (an 
exopeptidase) is a protease released from mast 
cell granules and is required for mast cell 
Figure 2. Peripheral targets of mast cell products
Adapted from Goldsby et al, Immunology 5th ed
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mediated survival following venom administration (Metsarinne et al., 2002).  More generally, it 
is thought this protease could be a common mechanism by which mast cells contribute to 
enhancing survival in a model of bacterial infection by degrading the endogenous vasoconstrictor 
peptide endothelin-1, a peptide which induces vasoconstriction and is detrimental in severe 
bacterial infections (Maurer et al., 2004).   
 Finally, another recently discovered role of mast cells in host defense is as an antigen 
presenting cell.   Mast cells can express major histocompatibility molecule II (MHC II) and 
costimulatory molecule CD86 upon priming with INF-γ and IL-4 (Raposo et al., 1997).  The 
expression of these cell surface markers allows the interaction with T cells.  Mast cells can 
promote the migration of T cells to inflammatory sites by secreting chemotactic factors like IL-
16 and can encourage T cell differentiation to T helper (Th) cells by secretion of IL-4 (Huels et 
al., 1995; Rumsaeng et al., 1997) .  Primed mast cells can induce activation of effector T cells, 
but unlike dendritic cells can not activate naïve T cells (Kambayashi et al., 2009).  New research 
shows that CD4+ T cells form immunological synapses with mast cells by reshaping their 
cytoskeleton, which indicates functional T cell receptor activation (Gaudenzio et al., 2009).   
 
Mast cells are located in the brain 
 Mast cells are found in the brains of mammalian and avian species (for review see Silver 
et al., 1996).  Mast cells are located predominantly in the midbrains of mammals, but the 
distribution varies among species (Hough, 1988).  Mast cells begin to migrate to the CNS during 
late embryonic and early postnatal development, as shown in the rat (Lambracht-Hall et al., 
1990a).  The lifespan of a mast cell depends on its resident location as well as the age of the 
animal and there are no reports on the lifespan of a brain mast cell.  In the periphery, reports vary 
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widely from 8 days in the skin of young rats, to 10 months in the peritoneal cavity of adult rats 
(Padawer, 1974; Kiernan, 1979).  During adulthood, mast cells continue to repopulate the brain, 
purportedly through entry of mast cell precursors circulating in the blood.  Although mature mast 
cells are not normally found in the blood, the ability for mature mast cells to enter the brain was 
demonstrated by injecting labeled mast cells into the blood and locating them within the 
parenchyma on the brain side of the blood brain barrier within an hour (Silverman et al., 2000).   
 In the adult healthy rodent brain parenchyma, mast cells are found preferentially near 
blood vessels on the brain side of the blood-brain barrier, frequently in apposition to astroglial 
processes (Hough, 1988; Khalil et al., 2007).  In addition to their location near blood vessels, 
brain mast cells are also found adjacent to neuronal processes, even with mast cell granules 
captured in pre-synaptic terminals (Wilhelm et al., 2005).  In addition to their location in brain 
parenchyma, mast cells are also found in large numbers in the meninges and the choroid plexus 
within ventricles.  Considerable variation among species occurs in both the number and 
distribution of mast cells in the brain (Persinger, 1979).  In the mouse and rat, two species in 
which brain mast cells have been extensively studied, mast cells are commonly found in the 
midbrain and diencephalic parenchyma – particularly thalamic nuclei, as well as in the 
hippocampal formation and surrounding leptomeninges.  Additionally, mast cells are found in 
large numbers in meningeal spaces surrounding the olfactory bulb and circumventricular organs 
(Selye, 1965; Hough, 1988; Silver et al., 1996; Asarian et al., 2002; Taiwo et al., 2005; Hendrix 
et al., 2006; Kovacs and Larson, 2006; Khalil et al., 2007).   
 At baseline states in the brain, the majority of mast cells are active and releasing some 
number of granules into the surrounding tissue (Florenzano and Bentivoglio, 2000).  By pinching 
off from the cell, the granules release their contents into the extracellular space by exocytosis.  
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Granule remnants, in the form of proteoglycans can bind the mediators and allow the mediators 
to avoid degradation and diffuse far with the granule remnants (Ruoss et al., 1991).  Within the 
mast cell, mediators are resynthesized and repackaged into new granules for subsequent 
additional release (Levi-Schaffer and Riesel, 1989).  The contribution of this basal activity is 
substantial for the overall neurochemistry of the brain.  For example, up to 90% of histamine in 
the rat thalamus is derived from mast cells rather than neuronal systems (Goldschmidt et al., 
1985).  Given that histamine is a potent neurotransmitter (Brown et al., 2001), this suggests that 
mast cells can have a profound impact on neural signaling. 
In fact, the contents of mast cell granules applied to a brain slice in vitro cause changes in 
the firing of thalamic neurons.  This indicates a potential for direct and immediate effects of mast 
cell activation on the brain (Kovacs et al., 2006).  Using the patch clamp technique, other studies 
show that mast cell mediators, specifically histamine and serotonin act on brain receptors (H2 
and 5-HT7, respectively) to contribute to neuronal excitation by reducing potassium conductance 
and enhancing the hyperpolarization-activated cation current (Khalil, 2006).   
 
Brain mast cells are affected by behavioral and physiological state 
In addition to the basal activity of the resident population of brain mast cells, the 
activation of mast cells can be further increased resulting in the release of more granules from a 
single mast cell and the subsequent synthesis of additional mediators.   Furthermore, the total 
number of mast cells in the brain can also be increased (Silver et al., 1996). Interestingly, 
behavioral and hormonal states, unrelated to immune signals, cause the migration of mast cells 
into the brain.  An early reports of this shows that social defeat stress and stroking rat pups 
before weaning also cause increases of mast cell number and/or activation in the brain 
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(Persinger, 1980).  This may also explain the large variation in the number of mast cells in the 
brain found even within species (Persinger, 1979).     
Brain mast cell numbers and activational state are affected by stimuli such as mating and 
stressors (Zhuang et al., 1993; Bugajski et al., 1994; Cirulli et al., 1998; Asarian et al., 2002).  
The former was demonstrated by Silver and her colleagues who reported that following mating 
in ring doves, mast cell number increases around 4 fold in the habenula (Zhuang et al., 1993).  
This phenomenon has also been reported following sex behavior in rodents.  Mast cells increase 
in the male rat brain following a period of cohabitation with a female rat (Asarian et al., 2002).  
This effect is dependent on the hormonal status of the female.  The increases in mast cell number 
arise by way of migration of additional mast cells into the CNS, rather than from mitosis 
(Zhuang et al., 1997).  Both the brain chemoattractant signal and physiological relevance of the 
migration of mast cells into the brain are still largely unknown.   
In addition to sex, stress also causes changes in mast cell number, however stressors vary 
in how they affect brain mast cells.  Acute stressors have been shown to change both activational 
state and numbers of brain mast cells.   For example, non-traumatic immobilization stress 
induces mast cell degranulation above baseline levels (Esposito et al., 2001).  Additionally 
chronic social isolation of mice, which induces a stress response as a component of the resulting 
“isolation syndrome”, reduces the number of brain mast cells (Bugajski et al., 1994).  This could, 
however, be due to an increased activational state of the mast cells coupled with their method of 
detection which may not always localize fully degranulated mast cells.  This hypothesis that the 
differences arise from a lack of detection is further supported by data illustrating increases in 
mast cell derived histamine indicating mast cell activation and degranulation following social 
isolation (Bugajski et al., 1994).  Furthermore, initiation of psychosocial stress in mice increases 
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the number of brain mast cells localized to the habenula, thalamus, and hypothalamus (Cirulli et 
al., 1998).  Previous chronic subordination stress induced by exposure to an aggressive male 
causes increased numbers of mast cells following a subsequent exposure to an aggressor 
compared to mice with no history of subordination stress (Cirulli et al., 1998).  This study 
suggests that a stress-related “programming” of mast cell migration to the brain is possible. 
The unknown physiological relevance of mast cells in the brain makes for an interesting 
problem. Furthermore the fact that behavior increases the number of mast cells in the brain 
suggests a potential solution to this problem.   The behaviorally responsive brain mast cell 
population suggests that there may be a behavioral response-relevant function of mast cells in the 
brain (Silver et al., 1996).   
 
Models to study mast cell function 
Mast cell deficient KitW-sh/W-sh (sash-/-) mice provide an excellent model to study mast cell 
function in vivo.  Sash-/- mice carry a naturally occurring inversion mutation upstream from the 
white spotting (W) locus in the promoter for the c-kit receptor (Duttlinger et al., 1993).  This 
causes reduced c-kit receptor expression in the bone marrow and therefore an inability of 
hematopoietic stem cells to bind stem cell factor, a signal which causes the differentiation from 
myeloid progenitors to mast cell precursors.  Therefore the progenitors do not differentiate into 
mast cell precursors resulting in a complete lack of mast cells (Kitamura and Fujita, 1989).  
These mice are available for purchase (B6.Cg-KitW-sh/HNihrJaeBsmJ).  Sash-/- mice have no other 
known abnormalities in immune cell number or function (Grimbaldeston et al., 2005).  However 
given that the c-kit receptor is required for the maturation of melanocytes, the homozygote 
mutants have white hair, and the heterozygote mutants have a white stripe or “sash” around the 
mid-torso (Besmer et al., 1993).  Abnormalities that have been noted are a lack of interstitial 
16 
cells of Cajal in the gut as well as bile reflux (Grimbaldeston et al., 2005).  Other pleiotropic 
effects of this mutation have been determined.  There are abnormalities in angiogenesis which 
affects the vascularization of solid state tumors and adipose tissue resulting in smaller tumors 
and the prevention of diet-induced obesity (Soucek et al., 2007; Liu et al., 2009).  The mutation 
also results in an altered response to sepsis (Metz et al., 2006; Nautiyal et al., 2009). 
The sash-/- mouse model has been validated in a number of studies and has proven to be a 
reliable genetic mast cell loss-of-function model (Maurer et al., 2004; Metz et al., 2006; Soucek 
et al., 2007; Liu et al., 2009).  This model sharply contrasts with a previously used model of 
genetic mast cell deficiency, the Wv/Wv mouse (Kitamura et al., 1978; Echtenacher et al., 1996; 
Grimbaldeston et al., 2005).  This mouse has a complete lack of c-kit receptor expression in all 
tissues including the testes causing dysfunctions like sterility and anemia.  Therefore the use of 
the sash mouse is beneficial for both practical (in laboratory breeding) and logical (few non-mast 
cell mediated abnormalities) reasons. These mice can be compared to heterozygote and wild-type 
(WT) littermates to provide optimal control groups.   
Given that mast cells injected into the periphery can enter the brain (Silverman et al., 
2000), reconstitution of mast cells into sash-/- mice has been proposed as a way to recover 
phenotype and function.  Local and peripheral reconstitution of mast cells can be achieved 
through injection of genetically compatible bone marrow-derived cultured mast cells (BMCMCs) 
from WT animals (Grimbaldeston et al., 2005).  Specifically, intradermal or intraperitoneal 
injection of BMCMCs into sash mice repopulates the tissues surrounding the injection site.  
Intravenous injection of BMCMCs causes mast cells to populate the skin, gut, lung and spleen of 
sash-/- mice.  However, the distribution and numbers of mast cells do not match those found in 
WT mice.  The numbers of mast cells found in skin were lower than normal levels in WT mice, 
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and the numbers of mast cells found in lung and spleen were inconsistent with the lack of mast 
cell populations in these tissues in WT animals.  Importantly, in this study, no mast cells were 
found in the brain.  Overall, it is possible to successfully reconstitute mast cells into peripheral 
tissues of sash-/- mice by irradiation followed by intravenous injection of either BMCMCs or 
whole bone marrow cells. Irradiation removes the host immune system and presumably allows 
for donor cells to remain in the host rather than being removed as a target of an autoimmune 
response, like that during a host rejection response following tissue transplantation.  However, 
the ability to repopulate brain mast cells following irradiation is unknown.    
 
Pharmacological model of mast cell deficiency 
To localize the spatial and temporal impact of mast cells on brain and behavior, 
pharmacological blockade of mast cell activation with disodium cromolgycate (cromolyn) can be 
used in WT animals (Theoharides et al., 1980; Norris, 1996).  It is commonly used as a treatment 
for asthmatic patients via nasal spray (Theoharides, 1990).  Cromolyn acts by stabilizing the 
mast cell membrane to prevent degranulation by preventing calcium influx into the cell (Norris, 
1996).  There are additional effects of cromolyn on other immune cell types including 
macrogphages, monocytes, neutrophils and eosinophils (Kay et al., 1987; Norris, 1996). 
Cromolyn does not cross the blood-brain barrier (Simons, 1996; Blaiss, 2004) and can 
therefore be injected centrally (intracerebroventricular) or peripherally (intraperitoneal) to 
dissociate brain versus peripheral mast cell effects.   Additionally, these injections can be done in 
adulthood, thereby eliminating the effects of mast cells on development.  Lastly, cromolyn can 
be injected acutely (Soucek et al., 2007; Nautiyal et al., 2008; Liu et al., 2009), thus allowing 
assessment of the short term effects of mast cells.   
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Potential physiological functions of brain mast cells 
 Mast cell function in the periphery is now becoming clear and is helpful in informing the 
potential roles of brain mast cells.  Three unrelated roles are explored for their potential 
relevance in the function of brain mast cells.  First, known mast cell effects on angiogenesis 
suggest a potential function of brain mast cell impact on development.  Additionally, mast cell 
interactions with the hypothalamic pituitary adrenal axis suggests the possibility of mast cell 
mediation of stress behavior.  Lastly, mast cell release of serotonin suggests a role for mast cells 
in mediating emotionality.  The supporting literature for each of these hypotheses are discussed 
here.  
 Mast cell effects on angiogenesis Not only do mast cells contain mediators that change 
vascular tone, but they also release mediators that aid in the formation of blood vessels 
themselves.  It is possible, therefore, that a lack of mast cell derived mediators causes 
deficiencies in angiogenesis resulting in inadequate blood flow to sustain the development or 
maintenance of neural systems mediating behavior.  There is a known association between the 
migration of mast cells and the development of blood vessels in the brain (Lambracht-Hall et al., 
1990a).  In the rat brain, almost 90% of mast cells are seen contacting a blood vessel during early 
postnatal development (Khalil et al., 2007).  More specifically, they are located predominantly 
on large blood vessels and preferentially at branch points.  Since the development of 
microvasculature in the brain is accomplished by the sprouting of branches off of large blood 
vessels, the hypothesis was pursued that mast cells may contribute to this process by correlating 
the branching of blood vessels and the location and number of mast cells in the brain during 
development.  There were increased mast cell numbers at branch points during the 
developmental period characterized by large expansion of vasculature.  Overall this 
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characterization of the distribution of mast cells in the developing brain suggests that mast cells 
are positioned to have a role in the development of brain blood vessels.   
Mast cell effects on angiogenesis has been investigated in solid state tumors, specifically 
looking at the vascularization of pancreatic tumors (Soucek et al., 2007).  Induction of a 
pancreatic tumor in genetic and pharmacological models of mast cell deficiency resulted in 
reduced vascularization of the tumor.  Of clinical relevance, this resulted in smaller tumors via 
both decreased cell proliferation and increased apoptosis.  The blockade of mast cell migration to 
the tumor site also decreased tumor growth.  Lastly, blockade of mast cells in an already 
enlarged tumor caused recession of blood vessels and a shrinkage of the tumor due to hypoxia-
induced cell death.  This study overall suggests a necessary role for peripheral mast cells in de 
novo tumor angiogenesis and blood vessel maintenance.   
Mast cells affect the hypothalamic pituitary adrenal axis  Mast cell interactions with the 
neural system underlying stress behaviors is bidirectional.  While it is clear that brain mast cells 
are affected by stressors, the mechanisms of stress effects on mast cells have only been 
investigated in peripheral tissues.  This work has mainly concerned direct effects of 
corticotrophin releasing hormone (CRH) on mast cells.  CRH is an important mediator in the 
stress response, initiating the activation of the hypothalamic-pituitary-adrenal (HPA) axis.  CRH 
effects on mast cells in vivo in the gut, skin and dura as well as in vitro preparations have been 
described and may be generalized to brain mast cells.  
Mast cells express both CRH receptors 1 (R1) and 2 (R2), and CRH binding of these 
receptors induces mast cell activation (Cao et al., 2005).  In the gut, CRH binding by mast cells 
has been studied in the context of finding the mechanism for stress-induced abnormalities in 
colonic function.  Stressful situations cause worsening of symptoms associated with irritable 
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bowel syndrome and ulcerative colitis.  Both animal models and human biopsies implicate CRH 
and mast cells in the link between stress and gut inflammation.  CRH binding to R1 on intestinal 
mast cells causes the release of nerve growth factor (Barreau et al., 2007) inducing increases in 
gut permeability and thus gut inflammation (Tache et al., 2002; Wallon et al., 2008). 
In the skin, Arck and colleagues describe mast cells as 'central cellular switchboards of 
pruritogenic inflammation’ in that they consider them key regulators in the itch induced by stress 
promoted inflammatory skin diseases (Arck and Paus, 2006).  The primary mechanism 
implicated in stress-induced mast cell activation in the skin is CRH.  An acute stressor causes 
increases in skin CRH and the activation of skin mast cells resulting in increased skin vascular 
permeability (Lytinas et al., 2003).  This response was mimicked by direct intradermal injection 
of CRH and also by activation of skin mast cells directly with Compound 48/80 (C 48/80), a 
mast cell secretagogue.   
Most closely related to possible direct actions of CRH on brain mast cells, are studies on 
mast cells located in the dura.  Acute and chronic stress conditions cause disruptions in the 
blood-brain barrier (BBB) that are especially cause for clinical concern in conditions like 
multiple sclerosis and metastases of tumors to the brain (Esposito et al., 2001; Theoharides et al., 
2008b).  It is thought that activation of dura mast cells during stress mediates the breakdown of 
the BBB.  Stress-induced increases in BBB permeability are reduced following administration of 
the mast cell stabilizer cromolyn, which blocks degranulation  (Esposito et al., 2001).  A role for 
CRH in the mast cell-dependent increase in BBB permeability has been described (Esposito et 
al., 2002).  Although the mast cell mediators directly responsible for the break down of the BBB 
are not described, the researchers have shown that dura mast cells can release histamine, 
21 
cytokines and vascular endothelial growth factor (VEGF) following CRH R stimulation 
(Theoharides et al., 2008b).   
While CRH activates mast cells, mast cells also have the capability to release CRH.  
Human mast cells in vitro, derived from umbilical cord blood, release both CRH and urocortin 
(Ucn), an endogenous ligand of CRH Rs that is structurally and functionally similar to CRH 
(Kempuraj et al., 2004).  These cells contain both the protein and also mRNA of both CRH and 
Ucn.  Furthermore, stimulation of mast cells with immunoglobulin E (IgE) antibodies causes the 
release of CRH and Ucn from the majority of these cells in vitro.  Studies in vivo illustrate that 
mast cell-derived CRH has a functional effect on the HPA axis.  Intracerebral injection of C 
48/80, causes dose dependent increases in ACTH and cortisol in dogs (Bugajski et al., 1997 ; 
Matsumoto et al., 2004).  C 48/80-induced increases in ACTH and cortisol are blocked with prior 
administration of an anti-CRH antibody (Matsumoto et al., 2004).  Taken together, these results 
show that when stimulated by immune agents, mast cells can release CRH causing subsequent 
activation of the HPA axis.  Given that the HPA axis mediates anxiety and fear, this is one of the 
most direct mechanisms by which brain mast cells could influence behavior.   
 Mast cell derived serotonin  Mast cells synthesize, store and secrete serotonin 
(Lambracht-Hall et al., 1990b; Kushnir-Sukhov et al., 2007).  Given that mast cells release and 
resynthesize mediators, this leaves open the possibility for one mast cell to contribute a large 
amount of serotonin to the tissue in which it resides.  Although the function of mast cell derived 
serotonin has not been investigated in the brain, it has been studied extensively in the gut 
(Metcalfe, 1984). Mast cell degranulation induces increases in intestinal motility through 
activation of serotonin receptors (Bueno et al., 1991).  Mast cell derived serotonin also plays a 
large role in the pathophysiology of irritable bowl syndrome.   
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In the brain, the most commonly attributed source of serotonin is from neurons located in 
the caudal raphe nuclei (Zhou and Azmitia, 1983), however given the presence of mast cells in 
the brain, their contribution to brain serotonin should be considered.  Murine mast cells in culture 
can each store up to 0.2 pg of serotonin at a given time point (Kushnir-Sukhov et al., 2007).  The 
role of serotonin in the brain is broad, as it is a multipotential amine- acting as a transmitter, a 
neurotrophic factor, a chemotactic factor and as a target for the treatment of various psychiatric 
conditions.  Given this, there are multiple hypotheses for the mechanism by which mast cell 
derived serotonin may impact the brain, which can be explored from both development and adult 
perspectives.   
At the most basic level, it was suggested in the 1960s that serotonin should be considered 
as a major neurotransmitter involved in emotional behavior (Sudak and Maas, 1964).  Since then, 
decades of research show that manipulation of serotonergic transmission alters emotional 
reactivity specifically including indices of anxiety and depressive behavior (reviewed in Griebel, 
1995).  The treatments for depressive disorders now center primarily around increasing serotonin 
transmission in the brain.  However, most of the work implicating serotonin in the regulation of 
emotionality only considers neuronal sources of the transmitter.  A recent study provides 
evidence which suggests that mast cell-derived serotonin plays a role in regulating emotionality 
(Kushnir-Sukhov et al., 2008).  Patients diagnosed with mastocytosis, a disease characterized by 
a profound abnormality and/or increase in mast cells in the body, underwent clinical assessment 
and blood collection for measurement of serotonin.  The clinical assessment included a screen 
for psychiatric symptoms including depression, anxiety, emotional instability, and memory loss.   
Blood serotonin levels in mastocytosis patients had a bimodal distribution, and those with low 
23 
serotonin levels, indicating a lack of mast cell-derived serotonin had significantly more clinical 
psychiatric symptoms.   
 
Thesis Goal 
 Their presence in the brain, response to behavioral and endocrine states and release of 
neuroactive mediators, suggests that brain mast cells are likely candidates for immune system 
effects brain and behavior.  However, their physiological function in the brain is unknown.  The 
goal of this thesis is to investigate the ways in which mast cells may affect brain and behavior in 
the healthy steady state animal.  First the baseline characterization of mast cells in the mouse 
brain is explored with a focus on distribution throughout development and in adulthood and mast 
cell deficient models are validated for their subsequent use in determining the effects of a lack of 
mast cells (Chapter 2).  Mast cell number, histamine levels and vasculature (Appendix) are 
reported for the genetic mast cell loss-of-function mice and their controls.  Next, the results of 
broad baseline behavioral screens are reported from genetic and pharmacological models of mast 
cell deficiency (Chapter 3).  Given that differences in emotionality behavior were found, the 
remainder of the dissertation focuses on delineating the mechanisms by which mast cells may 
affect the neural systems underlying emotional behavior.  One avenue of research examines mast 
cell effects on the HPA axis (Chapter 4).  Another, more promising line of research focuses on 
the impact of mast cells on the hippocampus (Chapter 5).   Studies explore mast cell contribution 
of serotonin to the hippocampal milieu, as well as effects of mast cell deficiency on hippocampal 
neurogenesis and hippocampus-dependent cognition.  Overall, this research in this dissertation 
investigates the physiological function of mast cells in the brain, and the mechanisms by which 
mast cells may impact brain and behavior.   
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 Mast cells are immune cells that are found in the brains of mammals during development 
and in adulthood, however their function is unknown.  Given the availability of mast cell 
deficient KitW-sh/W-sh (on a C57BL/6 background), investigations into the physiological role of 
brain mast cells is possible.  Although the distribution of mast cells in the rat brain has been 
extensively studied, the location and number of mast cells are known to vary among species and 
even strains.  Therefore, analyses of the location of mast cells in the C57BL/6 adult and 
developing mouse brain are presented here as an exploratory study, and to inform potential 
function.  While KitW-sh/W-sh mice have been validated for use to study peripheral mast cell 
function, these are the first studies to focus on brain physiology.  Lastly, donor mast cells were 
injected into C57BL/6 or KitW-sh/W-sh mice in order to determine the conditions required to 
increase or reconstitute brain mast cells and suggest that mast cells are recruited to regions which 
contain host mast cells populations. 
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Introduction 
 Mast cells are found within the cranium - distributed in parenchyma, leptomeninges, 
dura, choroid plexus and perivascular spaces throughout development and adulthood in a variety 
of mammalian species (Lambracht-Hall et al., 1990; Dimitriadou et al., 1996; Michaloudi et al., 
2007).  Mast cell distribution is known to vary among species (Selye, 1965), strains (Hendrix et 
al., 2006), and individuals within a strain (Persinger, 1979).  The relevance of these differences 
in distribution and number as well as the functional role of mast cells in the adult and developing 
brain are still largely unknown (Johnson and Krenger, 1992; Maurer et al., 2003).  Experiments 
here are aimed at developing a model to study brain mast cell function by – (1) describing the 
developmental and adult brain mast cells in the C57BL/6 mouse, (2) exploring the brain of a 
mast cell deficient C57BL/6- KitW-sh/W-sh mouse for its potential use as a genetic loss-of-CNS 
mast cell- function model, and (3) investigating gain-of-CNS mast cell-function models by 
artificial population of the mouse brain with donor mast cells or their precursors.   
 Mast cell deficient C57BL/6- KitW-sh/W-sh (sash-/-) mice have provided a powerful tool to 
study peripheral mast cell function (Kitamura and Fujita, 1989; Duttlinger et al., 1993).  Sash-/- 
mice lack mast cells completely and their immune profile has been well characterized (Maurer et 
al., 2004; Grimbaldeston et al., 2005).  Although sash-/- mice have been used as a model to 
determine peripheral mast cell function (Echtenacher et al., 1996; Grimbaldeston et al., 2005; 
Nautiyal et al., 2009), their brain and behavior have not been studied.  In order to validate the use 
of the mast cell deficient sash-/- mouse as a potential model to study the function of brain mast 
cells, we examined their brain physiology with respect to mast cells, mast cell mediators and c-
kit receptor expression. First, the distribution of brain mast cells in the different genotypes (-/-, 
+/-, +/+) is assessed.  Next the amount of histamine, a primary mediator of mast cells, is 
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measured in the brains of sash+/+, sash+/- and sash-/- mice.  Lastly, the expression of the c-kit 
receptor protein in the brain is considered given that the c-kit receptor promoter is the site of the 
mutation in sash-/- mice and brain c-kit signaling is known to have non-mast cell mediated effects 
on brain and behavior.   
 The ability to artificially populate the brain with mast cells provides an opportunity to 
study the role of the immune cells in the context of age and location-specific brain function.  
Previous research in rat shows that donor peritoneal mature mast cells (PMCs) injected 
intravenously, cross the blood-brain barrier to reside within brain parenchyma within 1 h 
following injection (Silverman et al., 2000).  The introduction of a large number of mast cells 
into a WT or mast cell deficient mouse brain may provide valuable gain-of-function model.  
Additionally, chronic reconstitution of brain mast cells would allow for assessment long-term 
effects of brain mast cells.  The time course, location and required conditions of mast cell 
migration to the brain are unknown.   
 The repopulation of mast cell deficient KitW-sh/W-sh mice has been used extensively in 
studies of peripheral mast cell function.  Peripheral mast cell populations in KitW-sh/W-sh mice can 
be partially restored by intravenous or intraperitoneal injections of wild-type bone marrow-
derived mast cells (BMMCs) (Grimbaldeston et al., 2005; Wolters et al., 2005).  The method has 
been used in many studies as a mast cell knock-in model to study the role of peripheral mast cells 
(Mallen-St Clair et al., 2004; Soucek et al., 2007; Liu et al., 2009). However the resulting 
distribution of donor mast cells in peripheral organs does not match that of normal mast cells in a 
WT mouse and removal of the spleen allows for more reconstitution in mast resident locations 
(Grimbaldeston et al., 2005; Wolters et al., 2005).  Repopulation with bone marrow cells results 
in a donor peripheral mast cell population only following irradiation (Grimbaldeston et al., 
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2005).  While mast cell reconstitution may serve as a powerful tool for examining some aspects 
of mast cell biology in the periphery, there has been little attention paid to the efficacy of mast 
cell reconstitution in the brain of KitW-sh/W-sh mice. Overall, the population of brain mast cells has 
not been comprehensively studied, although Grimbaldeston and collegues report that no mast 
cells are found in their sampling on brain tissue following intravenous injection with BMMCs.  
 Previous studies have not attempted to analyze the fate of BMMCs injected into WT 
animals.  The partial repopulation and abnormal distribution may be unique to mice that lack 
host mast cells.  It is possible that mast cells hone to regions of other mast cells, and that the lack 
of mast cells in the KitW-sh/W-sh mice cause a distribution of mast cells that is different than that 
found in WT mice.  Additionally most prior research has attempted to reconstitute mast cells by 
way of mature mast cells from in vitro preparations.  Physiologically, mast cells do not enter 
tissue in this mature state.  Therefore these results leave open the potential for differences in 
migration and distribution of these mature mast cells compared to immature, but differentiated, 
mast cells that normally circulate in the blood and enter tissue.   
 Overall the goal of this chapter is to describe the location of C57BL/6 mouse brain mast 
cells in development and adulthood and to validate a model to study their function in vivo.  
Additionally, the effect of different sources of mast cells for reconstitution, the time it takes for 
donor cells to invade the brain, and their distribution in comparison to host mast cells are 
questions explored in these studies.   
 
Methods 
Animals and housing 
 Three lines of mice were used in these studies: (1) Offspring of C57BL/6 wild-type (WT) 
mice (purchased from Jackson Laboratories, Bar Harbor, ME), bred in the Barnard College  
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animal facilities were used to study the localization of brain mast cells.  These WT mice were 
also used as donor and recipient mice for the mast cell reconstitution studies. (2) Mast cell 
deficient C57BL/6-KitW-sh/W-sh (sash-/-) mice were obtained from Jackson Laboratories (B6.Cg-
KitW-sh/HNihrJaeBsmJ) and bred to establish a colony at the Columbia University animal 
facilities. Sash-/- mice lack mast cells due to an inversion mutation upstream from the c-kit 
receptor promoter, causing a reduced expression of c-kit on the bone marrow cells and therefore 
an inability for mast cells to differentiate from their myeloid progenitors (Kitamura and Fujita, 
1989; Chen et al., 2005).  All other immune cells in sash-/- mice are normally expressed 
(Grimbaldeston et al., 2005).  Sash-/- mice were crossed with C57BL/6 WT mice (Jackson 
Laboratories) to generate heterozygous KitW-sh/+ (sash+/-) mice.  Studies reported here used either 
sash+/- littermate mice (from sash+/- × sash-/- crosses) or sash+/+ and sash+/- littermates (from 
sash+/- × sash+/- crosses) as controls.  (3) Transgenic Okabe mice (Jackson Laboratories 
(C57BL/6-Tg(CAG-EGFP)1Osb/J) were used as donor mice for mast cell reconstitution studies, 
when indicated.  In these mice, green fluorescent protein (GFP) cDNA is under the control of a 
chicken beta-actin promoter and cytomegalovirus enhancer using the expression of GFP in all 
tissues except erythrocytes and hair (Okabe et al., 1997).   
Animals were housed in standard lab cages with corn-cob bedding with ad libitum food 
and water in a 12:12 light-dark cycle at 22±1 °C.  All housing and experimental procedures were 
approved by the Institutional Animal Care and Use Committee at Columbia University.   
Distribution of brain mast cells during development 
For quantification and localization of brain mast cells throughout development, male and 
female WT pups (n=5/age) were sacrificed at postnatal age (PN) 1, 5, 9, 12, 18, 21 and 38 (adult) 
by rapid decapitation (at PN 1,5,9) or perfusion (at PN 12, 18, 21, 38). For all animals, crania 
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were cleaned of skin, muscles and lower jaw structure and post-fixed in 4% paraformaldehyde 
overnight.  Crania were placed in a mild formic acid bone decalcifier (Immunocal, Tallman, NY) 
for 24h, then washed in water and phosphate buffer (PB).  Tissue was then gelatin embedded 
(Fisher Scientific, Waltham, MA) and cut into 50 μm sagittal sections on a cryostat (Microm HM 
500M, Walldorf). Sections were thaw-mounted onto slides (Probe-on-plus slides, FisherBrand), 
and stored at -80 °C until stained with toludine blue (TB) for mast cell localization.   
 
Analysis of the KitW-sh/W-wh mutant brain 
For assessment of mast cell number in mutant KitW-sh mouse strain, male sash+/+ (n=5), 
sash+/- (n=5), and sash-/- (n=5) mice were used. Mice were rapidly decapitated and the brain was 
removed from the crania and blocked in half sagitally.  The right hemisphere was then cut into 
coronal blocks post-fixed in 4% paraformaldehyde for 7 days before cryoprotected in 20% 
sucrose in phosphate buffer (PB). 50 μm slide-mounted coronal sections were stained with TB 
for mast cell localization.   
To assess the contribution of mast cells to histamine content, levels of whole brain 
histamine was measured in two runs, first in male sash-/- mice (n=8) and their male age matched 
WT controls, and then again in male sash-/- (n=7) and sash+/- littermate mice (n=7).  Mice were 
sacrificed by rapid decapitation and brains were snap frozen in crushed dry ice and stored at -80 
°C until an enzyme-linked immmunoadsorbent assay (ELISA) was performed.  
To assess brain c-kit receptor expression, perfused brains from male sash+/- (n=2) and 
sash-/- (n=2) were cut into 50 μm thick coronal sections on a cryostat and IHC for the c-kit 
receptor was performed on free-floating sections, as previously described (Shanas et al., 1998).    
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Reconstitution of brain mast cells   
 Peritoneal mast cells  Peritoneal mast cells harvested from WT mice were labeled with 
Cell Tracker orange (CTO) and were injected into recipient WT male mice (n=2). Approximately 
1 × 106 cell-tracker orange (CTO)-labeled mast cells were injected intravenously through the 
carotid artery into each recipient mouse. One hour following injection, recipient mice were 
perfused and immunohistochemistry (IHC) for avidin was performed on 50 μm thick coronal 
sections to label mast cells for visualization concurrently with CTO. 
Whole blood transfusion from Okabe mice to WT and sash-/- mice Whole blood was 
transfused from Okabe mice (n=5) to WT (n=5) or sash-/- (n=4) mice.  Okabe mice were deeply 
anesthetized with sodium pentobarbital (200 mg/kg) and blood was collected in a heparin-coated 
syringe by cardiac puncture.  Whole blood (0. 2ml) was immediately injected intravenously into 
the carotid artery of recipient WT or sash-/- mice.  WT mice were perfused 2 (n=2), 4 (n=1), 8 
(n=1) or 12 (n=1) weeks following transfusion. Sash-/- mice were perfused either 2 (n=2) or 12 
(n=2) weeks following transfusion.  Fixed brain tissue was cut on a cryostat in 50 μm thick 
coronal sections and IHC for avidin (to label mast cells) and GFP (to localize donor cells) was 
performed.   
 
Histochemistry  
Perfusion Mice that were sacrificed by perfusion were deeply anesthetized with sodium 
pentobarbital (200 mg/kg) and transcardially perfused with 0.9% saline followed by 4% 
paraformaldehdye.  Brains were removed from crania, post-fixed overnight in 4% 
paraformaldehyde and then transferred for 20% sucrose in PB) for 48 h before being cut on a 
cryostat (Microm HM 500). 
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Toludine blue staining Slide mounted sections were stained with the metachromatic 
acidic TB (Sigma, St. Louis, MO) to localize mast cells, as previously described (Asarian et al., 
2002).  Briefly, slides were washed in 60% EtOH for 2 min, stained with TB for 10 min (4 
mg/ml TB in 60% EtOH, pH=2.0), washed briefly in distilled water, then dehydrated through a 
series of ethanols (50% for 15 s, 70% for 45 s, 2 x 95% for 1 min, 2 x 100% for 1 min) then 
cleared in Citrasolv (3 x 5 min) and coverslipped with Permount.  
IHC for c-kit receptor, avidin and GFP  Free-floating sections were washed in PB, 
blocked in normal donkey serum (NDS) in PB with 0.1% triton-X (PBT), and incubated in 
primary antibody [rabbit anti-human c-kit receptor at 1:500 (#PC34, Ab-1, Oncogene Research 
Products, MA) or rabbit anti-GFP at 1:10,000 (#A6455, Molecular Probes, Carlsbad, CA)] in 
PBT for 48 h.  Sections were then washed in PBT and incubated with CY3 conjugated donkey 
anti-rabbit (for c-kit receptor) or CY2 conjugated donkey anti-rabbit (for GFP) secondary 
antibodies and CY3 egg white avidin (for mast cells) for 2 h (Jackson Immunoresearch, West 
Grove, PA).  Subsequently, sections were washed in PB and mounted on subbed glass slides, air 
dried, dehydrated through a series of ethanols, cleared in Xylenes and coverslipped with 
Krystalon.   
 ELISA for histamine. Brain tissue was allowed to thaw and then homogenized in a 1% 
sodium dodecyl sulfate (SDS) solution in d2H2O with protease inhibitor (Roche Diagnostics, 
Basel, Switzerland).  The homogenate was spun down at 7500 g for 30 min at 4 °C.  The 
supernatant was removed and assayed using a commercially available mouse histamine ELISA 
kit according to manufacturer direction (Cayman Chemicals, Ann Arbor, MI).   
 
Peritoneal mast cell harvest   
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Mast cells were harvested from the peritoneal cavity of WT mice as previously described 
(Silverman et al., 2000).  Briefly, WT mice were anesthetized with sodium pentobarbital (200 
mg/kg) and injected intraperitoneally with 7 ml of Tyrode’s salt buffer (Sigma, St. Louis, MO).  
The abdomen was massaged for 5min and the peritoneal fluid was collected and centrifuged at 
200 g for 7 min. The cell pellet was resuspended in 10 ml red blood cell lysis buffer (Roche, 
Mannhein, Germany) for 5 min, centrifuged (300 g, 10 min), washed twice with Tyrode’s salt 
buffer and centrifuged (200 g, 7 min). The final cell pellet was resuspended in a 70% isotonic 
Percoll cell solution [70% Percoll, 10% Tyrodes salt buffer, 1% fetal bovine serum, 19% dH20], 
overlaid with 2 ml of media [85% RPMI, 15% Fetal Bovine Serum] and centrifuged (580 g, 15 
min) with gradual slow-down.  The mast cell pellet at the bottom of the tube was retrieved, 
counted and resuspended in media containing 1 nM Cell Tracker orange (CTO; Molecular 
Probes, Eugene, OR) and incubated for 45 min at 37 °C.  Cells were centrifuged and resuspended 
in Tyrodes salt buffer for injection. 
 
Data analysis  
Mast cell localization in development. Intracranial mast cells were mapped throughout 
development from TB stained sagittal sections focusing on the location with regard to gross brain 
anatomy.  Every fourth sagittal section through the brain was analyzed by two observers for the 
number and location of mast cells using a light microscope (BH-2, Olympus America Inc. Center 
Valley, PA).  A TB-stained cell was considered a mast cell if it was deep purple against the light 
blue background and had a visibly lighter nucleus and deeply stained granules.  Localized mast 
cells were plotted on figures from a mouse brain atlas (Paxinos and Franklin, 2004).  Mast cells 
from each of the five mice per age were mapped onto four representative atlas figures 
representing the entire rostral-caudal extent of the hippocampus.  Each mast cell was indicated 
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on a brain atlas map with a colored dot.  Each mouse is represented by dots of a different color 
allowing dissociation of individual differences. Our analysis did not distinguish the compartment 
(e.g. parenchyma vs. meninges) in which the cell was located, only the approximate coordinates 
on the atlas maps in relation to nearby brain regions visible with the TB Nissl stain.  Additionally 
each mast cell noted was labeled as being within or closest to one of seven predetermined brain 
regions including olfactory bulb, cortex, hippocampus, amygdala, thalamus, hypothalamus, and 
cerebellum.  Assignment to a particular brain area included mast cells located within the 
parenchyma as well as those within the perivascular spaces, meningeal layers or ventricular 
compartments within and surrounding the brain area itself.   
Mast cells in KitW-sh mutant mice.  The total number of TB stained mast cells were 
counted in every other section throughout the diencephalon and hippocampus, including 
surrounding meninges and choroid plexus (from bregma -1.06 mm to bregma-3.64 mm). 
IHC staining Immunoreactivity was visualized using a fluorescent microscope (Nikon 
Eclipse E800) equipped with a GFP filter cube (480±20 nm excitation spectrum) to detect CY2 
and a Texas Red filter cube (560±40 nm excitation spectrum) to detect CY3 and CTO 
fluorophores. Images were captured with a Q-Imaging Retiga EXi, fast 1394 camera 
(Quantitative Imaging) and QCapture software (version 2.95.0, Quantitative Imaging, Surrey, 
BC, Canada).  Every fourth section through the hippocampus and cerebellum was analyzed for 
immunoreactivity to c-kit receptor.  Every other section throughout the diencephalon was 










Figure 1. Mast cells in the mouse brain. Representative 
photomicrographs of toludine stained mast cells located within 
the (i, ii) parenchyma and (iii, iv) choroid plexus. scale bar, 
30μm (i,iii); 5 μm (ii,iv). 
Results 
Intracranial mast cell location throughout 
development 
Mast cells are resident in the mouse 
CNS, located in the parenchyma as well as 
meninges and choroid plexus within the 
ventricles (Fig 1).   
 Mast cells are found in the brain of 
mice from PN1 through adulthood (Fig 2-8). 
Mapping the location of mast cells onto brain atlas maps from five mice per time point, revealed 
that mast cells are located within intracranial and parenchymal spaces with different distributions 
throughout development.  At PN1, mast cells are localized predominantly in the meninges and 
ventricles (Fig 2).  At this age, the majority of mast cells found in the parenchyma are located 
within the hippocampus or olfactory bulb.  At PN5, mast cells have a similar distribution 
compared to PN1, however more are now found in hippocampal parenchyma as well as forebrain 
parenchyma (Fig 3).  Subsequently, by PN9, more mast cells enter the olfactory bulb and many 
more mast cells appear in the brain’s ventral meninges (Fig 4). The distribution of mast cells is 
largely unchanged from PN9 to PN12 (Fig 5).  By PN18, many more mast cells appear in the 
dorsal meninges, which results in a decrease in the percentage of mast cells found in the 
parenchyma in relation to the total number (Fig 6).  A very similar pattern is seen at PN21, with 
no large changes in distribution occurring from PN19 (Fig 7).  By adulthood, the mast cells in 
the connective tissue and choroid plexus in the ventricles surrounding the hippocampus have 
migrated more rostrally towards the caudal lateral ventricles to reside within the tissue of the 
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cisterna magna and hippocampal fissures (Fig 8).  Mast cells also appear in both dorsal and 
ventral meninges of the adult brain.  The majority of the ventral population is resident in the 
meninges and ventricular spaces next to the ventral hippocampus. The largest parenchymal 
population in adulthood occurs within the hippocampus and caudal-lateral thalamic nuclei 
surrounding the cisterna magna.   
 A summary of the distribution of CNS mast cells over age is shown in Figure 9.  Overall, 
mast cells are located near cortical areas most predominantly.  This is due to mast cells located 
within the meninges, and not representative of parenchymal mast cells.  The large peak in mast 
cells located within and nearby the cerebellum at PN 21 is due to a large migration of mast cells 
to the dorsal meninges surrounding the cerebellum.  In most other brain regions, the number of 
mast cells increases slightly from PN1 through adulthood representing an increase of both 
parenchymal and meningeal mast cells.   
Figure 2. Intracranial mast cells in the C57BL/6 mouse brain at post-natal day 1. Each dot 
represents a mast cell localized with toludine blue.  Mast cells from five mice were plotted on four 
representative sagittal brain atlas maps. The colors represent mast cells from individual animals.  
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Figure 3. Intracranial mast cells in the C57BL/6 mouse brain at post-natal day 5. Each dot 
represents a mast cell localized with toludine blue.  Mast cells from five mice were plotted on four 
representative sagittal brain atlas maps. The colors represent mast cells from individual animals.  
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Figure 4. Intracranial mast cells in the C57BL/6 mouse brain at post-natal day 9. Each dot 
represents a mast cell localized with toludine blue.  Mast cells from five mice were plotted on 
four representative sagittal brain atlas maps. The colors represent mast cells from individual 
animals.
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Figure 5. Intracranial mast cells in the C57BL/6 mouse brain at post-natal day 12. Each dot 
represents a mast cell localized with toludine blue.  Mast cells from five mice were plotted on 
four representative sagittal brain atlas maps. The colors represent mast cells from individual 
animals.
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Figure 6. Intracranial mast cells in the C57BL/6 mouse brain at post-natal day 18. 
Each dot represents a mast cell localized with toludine blue.  Mast cells from five mice 
were plotted on four representative sagittal brain atlas maps. The colors represent mast 
cells from individual animals.
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Figure 7. Intracranial mast cells in the C57BL/6 mouse brain at post-natal day 21.
Each dot represents a mast cell localized with toludine blue.  Mast cells from five mice 
were plotted on four representative sagittal brain atlas maps. The colors represent mast 






























Figure 9. Age effects on the distribution of CNS mast cells. The distribution of the 
number of mast cells found within and nearby brain regions is shown in C57BL/6 WT mice 
















Figure 8. Intracranial mast cells in the adult C57BL/6 mouse brain. Each dot represents a 
mast cell localized with toludine blue.  Mast cells from five mice were plotted on four representative 
sagittal brain atlas maps. The colors represent mast cells from individual animals.
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Comparison of brain mast cells in sash+/+ and sash+/- littermates of sash-/- mice. 
Mast cells occur in the brain of sash+/+ and sash+/- mice, but not sash-/- mice (Fig 10).   No mast 
cells were found in any of the sash-/- mice examined (n=5). Parenchymal mast cells were 
quantified in every other section through one hemisphere of the diencephalon of sash+/- (n=5) 
and sash+/+ (n=5) littermates of sash-/- mice.  Large individual variability is seen in the number of 
mast cells found in the parenchyma.  However, the spatial distributions did not vary among 
individuals and were similar to that previously seen (in Fig 8).  Sash+/- littermates had an average 
24±6 mast cells counted in every other section throughout the parenchyma surrounding the 
hippocampus.  Sash+/+ littermates had 44±12 mast cells in the equivalent region. While sash+/- 
littermates do not have a level of brain mast cells equivalent to wild-type (sash+/+) mice, they do 
have mast cells in the brain, and also carry the mutation on one allele, making these mice 
suitable controls for experiments assessing the role of mast cells in the brain.   
 
Brain histamine levels 
It is well established that brain mast cells contribute to the neural pool of histamine in the brain 
(Grzanna and Shultz, 1982; Oishi et al., 1988; Bugajski et al., 1995). In order to confirm mast 
cell contribution to this brain amine level, we measured histamine in whole brain homogenates 
of sash+/+, sash+/- and sash-/- mice.  Sash-/- mice had 31.6% of WT control levels and 41.9% of 
sash+/- littermate levels of brain histamine (3.6 nM in sash-/- compared to 11.4 and 8.6 nM in WT 
[t11=15.0, p<0.01] and sash+/- controls [t11=8.5, p<0.01] respectively; Fig 11).  The results 
confirm that mast cell deficiency causes a reduction in brain histamine in a graded manner by 



















Figure 10. Comparison of the number of brain mast cells in mast cell deficient 
(KitW-sh/W-sh; sash-/-) mice and their sash+/- and sash+/+ littermates. Mast cells 
were localized in every other coronal sections of the right hemisphere through out 
the dencephalon (from bregma -1.06mm to bregma-3.64mm). Each of five animals 
per genotype is represented with a black dot.  Grey lines denote group average ±








Figure 11.  Histamine measures of whole brain homogenates of 
sash+/- and sash-/- mice. (A) Sash-/- mice (white bars) have 68.4% 
less brain histamine than WT controls (black bars).  (B) Sash-/- mice 
(white bars) have 58.1% less brain histamine compared to their 
sash+/- littermate controls.  Histamine levels (pg/g of brain weight) are 
represented as mean ± SEM; *, p<0.01.  
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Normal c-kit receptor expression in the brain of sash-/- mice 
IHC for c-kit receptor revealed that sash-/- mice have normal c-kit receptor expression in the 
brain (Fig 12).  Compared to sash+/- mice, sash-/- mice show the same pattern and level of 
expression in the cerebellum and hippocampus.  Both sash+/- and sash-/- mice express c-kit 
receptor in the in the molecular layer of the cerebellum, and in the axons of basket cells in the 
Purkinje cell layer which form nests around the Purkinje cell bodies, consistent with previous 
reports (Zhang and Fedoroff, 1997).  Additionally, c-kit receptor expression was also analyzed in 
the hippocampus given its documented expression there and its functional role in hippocampal 
physiology (Zhang and Fedoroff, 1997; Jin et al., 2002).  Expression was normal in the dentate 
gyrus of the hippocampus of the sash-/- mice compared to sash+/- littermates.   
 
Figure 12.  C-kit receptor in the brains of sash+/- and sash-/- mice. C-kit 
receptor staining is seen in the basket cells surrounding Purkinje cells of the 
cerebellum (left) and the dentate gyrus of the hippocampus (right) of both Wsh/+
(top) and Wsh/Wsh (bottom) mice. scale bars: Cerebellum and hippocampus low 







Peritoneal mast cells traffic to WT mouse brain within an hour 
Donor mast cells isolated from the peritoneal cavity of C57BL/6 WT mice were located in the 
brain of C57BL/6 WT mice 1 h after injection.  Mast cells were located by avidin staining and 
donor cells were visualized by CTO (Fig 13).  Donor mast cells, marked by co-localization of 
avidin and CTO, are observed in areas near where host mast cells were located, as previously 




Figure 13. Peritoneal derived mast cells traffic to the C57BL/6 WT mouse 
brain within one hour. Avidin labeling shows mast cells localized near a blood 
vessel (bv) and in the cisterna magna and the hippocampal (hipp) and thalamic 
(thal) parenchyma adjacent to it.  CTO flourescence indicates the donor peritoneal 
cells.  The merged image shows that some of the avidin labeled mast cells are from 







Blood transfusion results in donor mast cells in the brain of WT, but not sash-/- mice 
Host mast cells, identified by their single label with avidin, were localized in the diencephalic 
and hippocampal parenchyma as well as choroid plexus and meninges of WT mice (Fig 14a).  
Donor cells were identified by their expression of GFP and were found throughout the brain of 
WT mice following whole blood reconstitution, but not in WT control mice that did not undergo 
blood transfusion (data not shown).  Donor mast cells were those double-labeled with avidin and 
GFP.  Donor mast cells were found in the brains of WT mice as early as two weeks following 
transfusion.  Donor mast cells were also found in the brains of WT animals 4, 8, and 12 weeks 
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following transfusion. There were no differences in number or distribution of donor cells or 
donor mast cells between time points following transfusion, therefore the data from all time 
points were combined for the remainder of analysis.   
 The distribution of donor non-mast cells, donor mast cells and host mast cells 
demonstrates that donor mast cells are only seen in brain areas that contain large populations of 
host mast cells (Fig 14b).  The specificity of mast cells honing to these regions is suggested by 
the fact that donor non-mast cells (GFP+, avidin-) were seen spread throughout the brain 
including in regions where mast cell occur infrequently, like the cortex (Fig 14c).   
 In sash-/- mice, GFP+ donor cells were found in the brain at both 2 (n=2) and 20 (n=2) 
weeks following blood transfusion.  However, none of these GFP+ cells were mast cells (Fig 
14a).  There was no difference in the distribution of GFP+ cells at 2 or 20 weeks following 
transfusion, so data from the two time points were combined for the remainder of the analysis.  
GFP+ cells were found in the cortex, thalamus, hypothalamus and meninges and choroid plexus 
(Fig 14d).  The distribution of donor (GFP+) cells in sash-/- mice was similar to the distribution 





Figure 14.  Mast cell precursors in whole blood traffic to the C57BL/6 
WT, but not sash-/- mouse brain.  (A) Avidin and GFP staining is shown for 
representative WT (top) and sash-/- (bottom) mice following whole blood 
transfusion.  A non-reconstituted WT control mouse (middle) is also shown.  
Both reconstitued and non-reconstituted WT mice have avidin+ mast cells.  
Reconstituted WT mice also show GFP+ cells in the brain indicating their 
origin from the Okabe donor.  The merged picture shows that some of these 
donor cells are mast cells.  WT control mice have no GFP+ cells. Sash-/-












































































(C) The distribution of avidin+ (red), GFP+ (green) and double labeled (blue) cells are quantified by nucleus.  
Cells localized in 5 WT mice following blood transfusion from Okabe mice are combined and presented here.
























(B) The distribution of avidin+ (red), GFP+ (green) and double labeled (blue) cells is shown on 
6 representative atlas sections.  Cells localized in 5 WT mice following blood transfusion from 











 Overall these data confirm that mast cells are located in the mouse brain throughout 
development and in adulthood and provide a comprehensive analysis including distribution 
throughout multiple developmental ages.  Furthermore, these data suggest a genetic model to 
study the functional role of brain mast cells in vivo. Sash-/- mice have no brain mast cells which 
results in a substantial reduction of a known mast cell mediator, histamine.  Importantly, 
although sash-/- mice carry a mutation which affects the c-kit receptor promoter, these mice have 
normal levels of c-kit receptor expression in the brain.  This is important because stem cell factor 
–c-kit receptor signaling is known to affect some brain functions (Kondo et al., 2002).  Lastly, 
(D) The distribution of GFP+ (green) cells is shown here on 6 representative atlas sections.  
Cells localized in 3 sash-/- mice following blood transfusion from Okabe mice are combined 
and presented here.  There were no avidin+ cells found in the brains of these mice.  
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brain blood vessels were assessed in sash-/- mice because mast cells are known to affect 
angiogenesis, but no major abnormalities were seen (see Appendix).  There were small 
differences in thalamic blood vessels in adult sash-/- mice, and limited delays in the development 
of cortical blood vessels in sash-/- mice.  These developmental deficits did not persist in 
adulthood.   The results also confirm that mature mast cells injected intravenously can cross the 
blood-brain barrier and gain access to the brain in mice, a result previously shown in rat 
(Silverman et al., 2000). Additionally, whole blood transfusion results in a brain population of 
donor mast cells with normal mast cell distributions in WT, but not mast cell deficient KitW-
sh/W-sh mice. This study is the first report using whole blood transfusions to introduce donor 
mast cells into brain tissue which may be useful in studies of brain mast cells. 
 Data here show the C57BL/6, have mast cells in the CNS throughout development and in 
adulthood which suggests that mast cells may have a role in the development and maturation of 
the brain.  Additionally, there is a similar distribution of mast cells among animals at a given age 
suggesting there is a signal for migration to these brain regions specifically.  These locations may 
inform potential function of mast cells during development as has been considered in the rat 
brain (Michaloudi et al., 2003; Khalil et al., 2007).  This is supported by recent studies showing 
that mast cell deficient mice have profound abnormalities in emotionality behavior and cognition 
which have known sensitive periods in early postnatal development (Nautiyal et al., 2008).   
 Results from the reconstitution studies presented here show that donor mast cells isolated 
from the peritoneal cavity (PMCs) of WT mice can enter the brain of recipient WT mice within 1 
h, confirming results shown previously in the rat (Silverman et al., 2000).  This is the first 
demonstration of migration of mature mast cells into the mouse brain and suggests that the lack 
of mast cells found in the brains of KitW-sh/W-sh mice following injection of BMCMCs 
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(Grimbaldeston et al., 2005) is not due to species differences.  Additionally, given that BMCMCs 
and PMCs are both mature mast cells, it is unlikely that cell source mediates the difference.  The 
likely source of the difference in mast cell localization in the mouse brain between our results 
and those presented by Grimbaldeston and colleagues is the recipient animal (WT vs KitW-sh/W-sh) 
and the latencies following intravenous injection of mast cells (1 h vs 12 weeks). The variables 
of latency and recipient animals are explored in our results here from studies of whole blood 
transfusion from Okabe mice to either WT or KitW-sh/W-sh mice.   
 This is the first demonstration that precursors in mast cell competent donor blood can 
result in mature mast cells in the adult WT mouse.  Compared to other hematopoietic derived 
immune cells, mast cells leave the bone marrow and circulate in the blood in an immature state, 
then enter tissue where they mature (Kitamura and Fujita, 1989). The blood-borne mast cell 
precursors were only recently identified, characterized as Lin-c-Kit+Sca-1--Ly6c-FcεRIα-CD27-
β7+T1/ST2+ (Chen et al., 2005).  This discovery leaves open the potential to introduce donor 
mast cells into tissue through whole blood transfusion.  Our results here show that mast cells 
from Okabe mice appear in the brain of WT mice as early as 2 weeks, and as late as 12 weeks 
following transfusion.     
 Whole blood transfusion does not result in a population of mast cells within the brain of 
KitW-sh/W-sh mice. The lack of donor mast cells found in the brain of KitW-sh/W-sh mice is consistent 
with results from other studies following intravenous injection of BMMCs (Grimbaldeston et al., 
2005).  Additionally, Bennet and colleagues found very few mast cells restricted to the meninges 
of KitW-sh/W-sh mice with experimental autoimmune encephalomyelitis (EAE) following 
intravenous injection of BMMCs (Bennett et al., 2009).  In comparison, EAE causes the 
recruitment of a large number of donor and host mast cells to the brain in WT mice following 
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intravenous injection of BMMCs.  In our studies, the use of blood, which contains mast cell 
precusors, differentiated from multipotent hematopoietic cells in the bone marrow, but immature 
mast cells, also did not result in brain mast cells in mice devoid of host mast cells.  Taken 
together these data suggest that mast cells may migrate to the brain based on the presence of host 
mast cells there which play a role in recruitment of additional mast cells.  This hypothesis is 
further supported by evidence that the distribution of donor mast cells in peripheral tissues 
following intravenous injection of BMMCs into KitW-sh/W-sh mice does not match the distribution 
found in WT mice.  
  Donor mast cells were found preferentially in brain regions containing host mast 
cell populations.  Other types of donor cells were found distributed more widely throughout the 
brain – found in additional areas with no mast cells nearby.  The locations that contain donor 
cells represent a specific subset of brain regions that maybe more penetrable to blood-born cells.  
However, our data suggests that there is a more specific subset of brain areas within these 
regions that mast cells hone to.  It is possible that mast cells are being recruited by other mast 
cells or the chemical milieu in these regions promote mast cells migration there.  Of the large 
number of chemokines and other immune molecules that promote the recruitment of mast cells, 
many are major mast cell mediators and known as very potent mast cell chemoattractants.  These 
include TGF-b, TNF-a, NGF, IL-8, histamine and serotonin (Gruber et al., 1994; Nilsson et al., 
1999; Sawada et al., 2000; Hofstra et al., 2003; Kushnir-Sukhov et al., 2006; Brzezinska-
Blaszczyk et al., 2007).   Mast cells in turn have a number of cell surface molecules, like CD34 
and CXCR2, involved in cell-cell adhesion and that have been implicated in mast cell mobility 
and trafficking (Nilsson et al., 1999; Drew et al., 2002; Blanchet et al., 2007).   
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 Overall, these results point to a model with which to study brain mast cell function in the 
mouse, and begin to characterize the mast cell contribution to brain neurochemistry and 
development.  Mast cells in the brain hone to specific areas suggesting a role in regulating non-
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Brain mast cells link the immune system to anxiety-like behavior 
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Abstract 
 Mast cells are resident in the brain and contain numerous mediators, including 
neurotransmitters, cytokines and chemokines, that are released in response to a variety of natural 
and pharmacological triggers. The number of mast cells in the brain fluctuates with stress, and 
various behavioral and endocrine states. These properties suggest that mast cells are poised to 
influence neural systems underlying behavior. Using genetic and pharmacological loss-of-
function models we performed a behavioral screen for emotionality and baseline behaviors 
including the assessment of locomotor and sensory functions. We found that mast cell deficient 
KitW-sh/W-sh (sash-/-) mice have a greater anxiety-like phenotype than wild-type and  heterozygote 
littermate control animals in the open field arena and elevated plus maze.  Secondly, we show 
that inactivation of brain, but not peripheral, mast cell activation increased anxiety-like behavior.  
Taken together, the data implicate brain mast cells in the modulation of anxiety-like behavior, 




 The immune and central nervous systems are traditionally thought to meet different types 
of requirements for survival.  Importantly, there is evidence for dynamic interactions between the 
two (Capuron et al., 2003; Rosenkranz et al., 2003; Steinman, 2004).  These interactions can be 
mediated by immune signaling molecules or immune cells located in the brain.  While it is 
known that some immune cells, such as microglia are resident in the brain for surveillance and 
clearance (Nimmerjahn et al., 2005; Hanisch and Kettenmann, 2007; Kettenmann, 2007), the 
roles of other immune cells are under-explored. We focus here on mast cells, which are localized 
not only in the periphery but are also resident in the brain of all mammalian species studied 
(Dropp, 1976; Hough, 1988; Silver et al., 1996).  
 Mast cells are a heterogeneous population of granulocytic cells of the immune system. 
They contain numerous mediators including neurotransmitters, cytokines, chemokines and lipid-
derived factors (Marshall, 2004).  Mast cells in the brain are constitutively active (Florenzano 
and Bentivoglio, 2000) releasing their contents by means of piecemeal or anaphylactic 
degranulation (Dvorak et al., 1992). Additionally, their activity is increased by a wide range of 
stimuli including immune and non-immune signals such as hormones, like corticotrophin 
releasing hormone, and various neuropeptides like Substance P and neurotensin (Paus et al., 
2006). Of their over 50 mediators, some are synthesized upon activation (e.g. substance P, 
somatostatin, cytokines) while others are preformed and stored in granules, allowing for very fast 
release (e.g. serotonin, histamine) (Penner and Neher, 1989; Johnson and Krenger, 1992; 
Marshall, 2004).  Due to their ability to migrate, they can serve as “single cell glands” delivering 
mediators “on demand” and influencing neuronal activity (Silverman et al., 2000; Khalil et al., 
2004). Mast cell can act via autocrine and paracrine mechanisms (Boyce, 2007), and their 
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secretions can reach a large spatial volume.   Their granule remnants can even be acquired by 
neurons through endocytosis (Wilhelm et al., 2005).   
 The residence of mast cells in meninges and perivascular locations on the brain side of 
the blood-brain barrier (Hough, 1988; Khalil et al., 2007), primarily in thalamic and hippocampal 
regions (Taiwo et al., 2005; Hendrix et al., 2006), indicate that they are strategically situated to 
affect neural and vascular responses. However, the function of mast cells in the brain is 
unknown. A role in normal physiology and behavior is suggested as the brain population of mast 
cells fluctuates with endocrine status, and changes following stress and handling (Persinger, 
1980; Cirulli et al., 1998; Asarian et al., 2002; Kovacs and Larson, 2006).  Not surprisingly, 
there are individual differences in the number of brain mast cells within species (Persinger, 
1979),  perhaps associated with behavioral and/or experiential differences.   
 We explored the possibility that mast cells in the brain might contribute to the modulation 
of behavior. The analysis entailed a behavioral screen assessing three components of generalized 
arousal (Pfaff, 2005), including anxiety-like behavior, locomotor activity and sensory 
responsiveness and using high-throughput automated assays (Arrieta-Cruz et al., 2007).  The 
availability of the KitW-sh/W-sh (sash-/-) mouse mutant provided a powerful genetic tool for the in 
vivo analysis the role of mast cells (Duttlinger et al., 1993; Grimbaldeston et al., 2005).  While 
lacking mast cells, these mice have normal levels of all other hematopoietic and lymphoid cells 
(Grimbaldeston et al., 2005).  Additional pharmacological manipulation of mast cells permitted 
confirmation of the function(s) suggested in the mast cell deficient adult mouse, ruling out 
developmental effects of a lack of mast cells. The present work describes genetic and 
pharmacological loss-of-function studies which examined the relationship of brain mast cells 




Mast cell deficient KitW-sh/W-sh (sash-/-) mice were obtained from Jackson Laboratory 
(B6.Cg-KitW-sh/HNihrJaeBsmJ; strain 5051, Bar Harbor, ME).  Sash-/- mice carry a mutation 
upstream from the white spotting (W) locus causing disruption of the 5’ regulatory sequences 
and therefore reduced signaling through c-kit tyrosine kinase (Duttlinger et al., 1993).  This 
reduced c-kit expression in the bone marrow causes an inability of hematopoietic stem cells to 
differentiate into mast cell precursors resulting in a complete lack of mast cells (Kitamura and 
Fujita, 1989; Grimbaldeston et al., 2005).  No other known disruptions in the development of 
hematopoietic stem cell derivatives or any other irregularities in c-kit receptor mRNA or protein 
expression, with the exception of melanocytes (causing irregular fur pigmentation) have been 
found (Duttlinger et al., 1993). 
Studies assessing anxiety-like behavior were first completed with male sash-/- (n=8) and 
unrelated age-matched C57/BL6 wild-type (WT) control mice (n=8).  A second cohort, run with 
heterozygote (sash+/-) littermates (n=7) serving as controls for sash-/- mice (n=6) allowed us to 
control for other genetic variability and epigenetic factors that might affect behavior.  This 
allowed the assessment of the effects of a lack of mast cells independent of the mutation.  These 
same sash-/- and sash+/- littermates were also used in tests of fear behavior, assays of responses to 
sensory stimuli including pain, and startle and pre-pulse inhibition. Separate cohorts of animals 
were used to test depressive-like behaviors and circadian rhythmicity.  All animals were male, 
and housed in a 12:12 light-dark cycle and food and water were available ad libitum.  All 
experimental procedures were in accordance with the protocols of the Institutional Animal Care 
and Use Committees at The Rockefeller University and Columbia University. 
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Cromolyn blockade of mast cell degranulation 
In a separate experiment, the response to disodium cromoglycate (cromolyn, Sigma 
Aldrich, St. Louis, MO) was examined in male C57/BL6 WT animals (n=14, Jackson 
Laboratory, Bar Harbor, ME).  Mice were anesthetized with a Ketamine (100 mg/kg) - Xylazine 
(13 mg/kg) mixture and implanted stereotaxically (David Kopf Intruments, Tujunga, CA) with 
chronic indwelling cannulas (Plastics One, Roanoke, VA).  Tips of the cannula were directed 0.2 
mm dorsal to the right lateral ventricle (bregma-0.5mm, mid-1.2mm, skull-2.5) for use with an 
injector cannula 0.2 mm longer than the guide cannula. Following recovery, animals were 
subject to a 2x2 study design receiving either saline or cromolyn via intraperitoneal (i.p.) or 
intracerebroventricular (i.c.v.) injections.  Cromolyn doses were 10 mg/kg (i.p.) and 50 μg/3μl 
(i.c.v.).  Cromolyn or saline was injected for 3 days, and behavioral testing was completed on the 
third day following injection.   
 
Behavioral Testing 
 Open Field Arena For assessment of open field behavior, mice were placed individually 
into a 40 x 40 cm brightly lit, plexiglass open field (OF) arena.  The bottom was demarcated into 
a 5x5 grid making 25 equal-sized (8x8 cm) squares.  Mice were allowed to explore the arena 
undisturbed for 5 minutes.  Video tapes were scored by 2 experimenters blind to the study for 
latency to enter and number of entries into the center square (8x8 cm). 
Elevated Plus Maze The elevated plus maze was elevated 30 cm from the ground with a 5 
cm x 5 cm center platform and 4 arms (5 cm wide by 30 cm long) with two opposing “closed” 
arms encased by 15 cm high opaque black walls (Rockefeller University Instrument Shop, New 
York, NY).  Mice were placed in the center of the maze oriented towards an open arm and 
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allowed to explore undisturbed and videotaped for 10 minutes.  Video tapes were scored by 
experimenters that were blind to the study latency to enter an open arm, number of entries into 
open arms and instances of investigations into open arms.   
 Defecation The number of boli was counted for each animal following behavioral testing. 
For measures of baseline defecation animals were placed individually in bins with a grid 
bottomed floor without bedding for 24 h.  Dry weight and number of boli were recorded.  
Defecation data are represented as average rates (number of boli/minute). 
 Baseline homecage behavior  Mice were placed individually into behavioral testing 
chambers.  Activity was assessed using the behavior monitoring equipment which collects 
movements as number of beam breaks.  The infra-red photobeams cover the cage volume in a 
three dimensional lattice with 1 cm spatial resolution (AccuScan Instruments, Columbus, OH). 
Disruption of a beam results in an activity count, which is recorded in a PC using Versamax 
software (AccuScan Instruments). Movement measurements include vertical activity (VACT), 
horizontal activity (HACT), and total distance (TD).  
 Cued Fear Conditioning The fear conditioning paradigm took place over three days.  
Shocks were administered through Habitest Operant Cage shock floors (Coulbourn Instruments, 
Allentown, PA) integrated into standard Plexiglass cages and were produced by Precision 
Programmable Animal Shocker (Coulbourn Instruments, Allentown, PA) within an isolation 
chamber.  Graphic State software controlled tone and shock stimuli delivery and also collected 
activity data.  Contextual cues including lights (on or off), background noise (white noise or no 
noise) and smell (ethanol or isopropyl alcohol) were altered for testing to preclude measuring a 
contextual fear response.  All mice were exposed to an initial habituation session in which mice 
were placed into the chamber but no stimuli were delivered.  Training and testing occurred on 
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the following 2 days respectively.  On the training day, mice were again placed in the chamber 
and a tone (30 s, 2KHz, 120dB) was paired with a shock (0.5 mA) three times.  Each pairing was 
separated by at least one min.  On the testing day, animals were again placed in the apparatus and 
presented 3 tones (30 s) separated by an inter-trial interval of 90-110 s.  Freezing behavior was 
recorded during all sessions and used as an index of fear as described previously (LeDoux, 
2003).  
 Sucrose Preference Test The sucrose preference test was used as a measure of anhedonia 
(Willner et al., 1987).  Mice were habituated to presentation of water and 1% sucrose in water in 
addition to their normal ad lib feed for 3 days before testing began.  Following the third 
habituation day, animals were deprived of food and water for 24 h, and then presented with both 
water and sucrose water for 1 h.  Consumption of both water and sucrose water was recorded, 
and the percent sucrose consumption of the total liquid consumption was calculated for each 
animal. 
 Tail Suspension Mice were suspended by their tails to measure learned helplessness as a 
measure of depressive-like behavior (Steru et al., 1985).  Their tails were taped, 1cm from the tip 
with lab tape, to a horizontal bar of a ringstand elevated 40 cm from the ground.  Animals were 
videotaped for 7 min and their behavior was scored for time spent immobile. 
 Forced Swim Test Mice were tested in the forced swim test as a secondary measurement 
of depressive-like behavior, behavioral despair (Porsolt et al., 1977).  Mice were placed in a clear 
3 L beaker of room temperature water for 7 minutes.  Activity is videotaped and scored for 
amount of time spent floating.   
 Circadian Rhythmicity Circadian rhythmicity was also assessed as a measure of baseline 
homecage behavior.  It was determined by monitoring running wheel activity in constant 
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darkness (DD).  Animals were housed individually with a running wheel (11cm diameter) with 
ad lib access to food and water.  Cages were placed in a light-tight and air ventilated wood 
chamber and left undisturbed for 1 week.  The number of wheel revolutions was monitored using 
MiniMitter data collection hardware and VitalView software (MiniMitter-Respironics, Bend, 
OR) and analyzed using ClockLab (Actimetrix, Wilmette, IL). 
 Sensory Responsiveness Sensory responsiveness was measured via activity data collected 
in the behavioral testing chambers described above (for Homecage activity measures).  Hardware 
(LabLinc V; Coulbourn Instruments, Allentown, PA) controlled stimulus delivery directed by 
Graphic State software (Coulbourn Instruments).  This allowed for stimulus delivery and data 
collection without any experimenter interruption.  Sensory testing commenced 1h after lights on.  
The automated stimulus delivery program required 5 minutes of resting state defined as no 
horizontal movement before delivering any stimulus to establish a low baseline with which to 
compare the sensory response.  Tactile, vestibular and olfactory stimuli were used to test the 
three senses not assessed in other behavioral assays (Pfaff, 2005).  The tactile stimulus was 
delivered first.  A 10 s puff of air at 16 psi was delivered through nozzles positioned at the top 
corners of the cage.  An obligatory waiting period of at least 10 minutes was required of each 
animal before the vestibular stimulus was delivered.  The vestibular stimulus was delivered by 
activation of the orbital shakers placed underneath each behavioral testing chamber for 15 s at 90 
RPM.  After the animal returned to a resting state and at least 10 minutes passed, the olfactory 
stimulus was delivered last.  This consisted of a 10 s stream of air passing through a jar filled 
with benzaldehyde (an almond smell, Sigma, St. Louis, MO) and into the cage through 2 jets 
placed near the floor.   
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 Startle and Pre-pulse inhibition Testing was conducted in an SR-Lab System (San Diego, 
CA) enclosed in an isolation chamber (15 x 16 x 23 inches).  Animals were placed in a clear 
plexiglass cylinder (5.1 cm OD, 12 cm long) on a piezoelectric vibration sensor.  The sensor was 
connected to a PC for stimulus delivery and data acquisition.  A speaker placed 28 cm above the 
cylinder emitted sound levels calibrated by a sound level meter.  Animals were run in the startle 
and pre-pulse inhibition (PPI) tests on separate days between ZT 14 and ZT 18.  Before each test 
commenced, a 5 minute acclimation period allowed the animals to adjust to the environment and 
the 86 dB background white noise.  In the startle test, each subject was presented a total of 90 
auditory stimuli of white noise, each lasting 40 ms over a 25 minute period.  Nine different 
sound levels (82, 88, 92, 96, 100, 105, 110, 115, 120 dB) were presented in a pseudorandom 
order in 10 blocks. Specifically, the stimuli were randomized within each block with each 
stimulus level presented once per block.  The inter-trial interval was randomized between 9 and 
23 seconds to prevent habituation.  Movement was recorded by the sensor every 1 ms for 100 ms 
following the onset of the each sound stimulus.  The maximum startle amplitude, latency to the 
maximum startle amplitude and the amplitude of the starting movement were all recorded.  In the 
PPI test each trial consisted of a pre-pulse (20 ms) followed by a 115 dB stimulus (40 ms) 
separated by 100 ms.  The pre-pulses were white noise stimuli that were 4, 6, 8, 10, and 12 dB 
louder than baseline white noise.  The startle amplitude to the 115 dB pulse was recorded every 1 
ms for 100 ms.   
 Tail Flick  Pain threshold was measured using a Tail Flick Monitor (Model TF, 
Omnitech).  Briefly, the mice were held stationary on the platform and the tail inserted into the 
groove before the heating device was turned on.  The latency to the tail flick off of the heating 
apparatus was determined by the lack of interruption of a photo-beam across the groove.   
77 
Statistical Analysis 
 Sash-/- mice were compared to WT mice or sash+/- littermates in two separate 
comparisons using one-way ANOVAs.  Results from the pharmacological loss-of-function 
experiment were compared using two-way ANOVA (treatment x injection route).  Pairwise 
multiple comparisons were performed with Tukey’s HSD test when appropriate.   
 
Results  
Anxiety phenotype of sash-/- mice 
Anxiety-like behavior was assessed using two tests.  In the open field test, sash-/- mice 
displayed more anxiety-like behavior (Fig 1).  The latency of the sash-/- mice to enter the center 
square was 83 s longer than that of WT mice [sash-/-(n=8): 141 s; WT (n=8): 58 s; p<0.05], and 
nearly three times as long as their sash+/- littermates [sash-/-(n=6): 268 s; sash+/-(n=7): 93 s, 
p<0.01].  Sash-/- mice also entered the center square slightly, but not significantly, fewer times 
than WT mice (3.6 vs. 4.7 times respectively, p>0.05).   Similarly, sash-/- mice entered the center 
square fewer times than sash+/- littermates (0.5 vs. 3.7 times, p<0.01).   
Figure 1. Mast cell effects on 
open field behavior. (A) Sash-/-
mice (white bars) had a longer 
latency to enter the center square 
in the open field test compared to 
WT mice (black bars).  Differences 
in number of entries into the center 
square between sash-/- and WT 
mice were suggestive but not 
significant (p>0.05).  (B) Sash-/-
mice (white bars) also had less 
exploratory behavior compared to 
the littermate sash+/- mice 
(hatched bars).  Sash-/- mice took 
longer to enter the center square 
and had fewer entries into the 
center square.  Data are 




 The sash-/- mice also displayed more anxiety-like behavior than WT and sash+/- littermate 
controls in the elevated plus maze (Fig. 2).  Sash-/- mice (n=8) entered open arms about 3-4 times 
less than WT (n=8) and sash+/- littermate (n=7) controls (p<0.05).  Additionally sash-/- mice 
investigated the entrances to the open arms less than WT mice (p<0.01).  There was no 
difference between the sash+/- and sash-/- littermate groups in the number of their investigations 
into the open arms.  In the measure of latency to enter an open arm, there was a trend, but no 
significant difference, between the sash-/- and WT animals.  However, sash-/- mice displayed a 
longer latency to enter the open arm compared to their sash+/- littermates (p<0.05).   
 Differences in the behavior of sash-/- mice seen in the open field arena and elevated plus 
maze between the two cohorts (i.e. Fig 1A vs. 1B and 2A vs. 2B) are likely due to the differences 
in previous experience relating to location of rearing and housing and stress induced by shipment 
from Jackson Laboratories (see methods).  Given that conditions were different between cohorts, 
only comparisons between groups of animals run with the same conditions should be considered. 
Figure 2. Mast cell effects on 
elevated plus maze behavior.
(A) Sash-/- mice (white bars) had 
fewer entries and investigations 
into open arms compared to WT 
control mice (black bars).  The 
latency to enter an open arm was 
not significantly different between 
sash-/- and WT mice.  (B) Sash-/-
mice (white bars) had fewer 
entries into open arms compared 
to littermate sash+/- mice 
(hatched bars).  While there was 
no difference in the number of 
investigations into open arms, 
sash-/- mice had significantly 
longer latency to enter an open 
arm. Data are presented as 




  Stress-induced defecation served as a measure of anxiety-like behavior.  
Defecation during behavioral testing in the open field and elevated plus maze was greater in 
sash-/- mice (n=8) compared to WT (n=8) and sash+/- controls (n=7; Fig. 3).  Sash-/- mice 
produced more boli than did WT mice and sash+/- during the open field (p<0.01 for age matched; 
p<0.05 for littermates) and elevated plus maze tests (p<0.01 for age-matched; p<0.05 for 
littermates). Importantly there were no differences in baseline defecation, measured by average 
rate or weight of defecation over 24 hour periods in their home cage.  There were also no 
differences in metabolism between sash-/- and WT or sash+/- controls as measured by body 
weight at the time of sacrifice. 
Figure 3. Mast cell deficiency effects on defecation.
(A) The excretion rate was higher in sash-/- mice (white 
bars) compared to WT mice (black bars) during 
behavioral testing in the open field arena and elevated 
plus maze.  Baseline homecage defecation in sash-/- and 
WT mice was not significantly different.  (B)  Sash-/- mice 
(white bars) had higher defecation rates compared to 
littermate sash+/- mice (hatched bars) in all behavioral 
tests.  Baseline homecage defecation was not different 
between genotypes. Data are presented as mean±SEM.  
**, p<0.01; *, p<0.05.  
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Pharmacological blockade of mast cells  
 To assess the contribution of central nervous system versus peripheral mast cells to the 
modulation of anxiety-like behavior in the adult mouse, we used disodium cromoglycate 
(cromolyn) to block mast cell degranulation (Theoharides et al., 1980).  Cromolyn does not cross 
the blood brain barrier (Norris, 1996) and therefore we could distinguish the role of central and 
peripheral mast cell populations with intraperitoneal (i.p.) versus intracerebroventricular (i.c.v.) 
injections.  WT mice were tested in a within subject experimental design to compare behavioral 
responses to i.p. and lateral i.c.v. cromolyn injection. 
 Central, but not peripheral, injection of cromolyn into WT mice increased anxiety-like 
behavior in the open field arena (Fig. 4).  I.c.v.-injected animals (n=8) had 58% fewer entries 
into the center square compared to mice injected with saline i.c.v. (n=7) or cromolyn i.p. (n=8) 
[3.3 vs. 8 (saline i.c.v.) and 7.9 (cromolyn i.p.) occurrences, p<0.05].  There was no significant 
difference between mice injected i.p. with cromolyn or saline (p>0.05).   In mice injected with 
i.c.v. cromolyn, there was a suggestive but not significant increase in the latency to enter the 
center of the open field arena (139 s) compared to i.c.v. saline injected (64 s) and also i.p. 
injected animals (p=0.16).  Cromolyn injected i.p. did not significantly affect the latency to enter 
or the total number of entries into the center square compared to i.p. saline injected controls 
(p>0.05). 
 In the elevated plus maze as in the open field arena, i.c.v. but not i.p. injection of 
cromolyn increased anxiety-like behavior (Fig. 5).  When injected i.c.v., cromolyn caused a 79% 
decrease in the number of entries and an 86% decrease in the number of investigations into the 
open arms compared to i.p. cromolyn injected mice (entries: 1.0 vs. 7.5 occurrences, p<.05; 
investigations: 7.9 vs. 37.0 occurrences, p<0.01).  Central cromolyn also increased the latency to 
81 
enter the open arm compared to animals injected i.p. with cromolyn (352 vs. 33 s; p<0.01).  The 
behavior in animals injected with cromolyn peripherally did not differ from that of animals 
injected with saline i.p. (p>0.05).    
 There were no significant effects of cromolyn on defecation.  Neither i.c.v. nor i.p. 
injection of cromolyn caused changes in stress-induced defecation rate during the open field test 
or elevated plus maze.   
 
Figure 5.  Cromolyn effects on elevated plus maze 
behavior. (A) Cromolyn injected i.p. into WT animals had
no significant effects on behavior in the elevated plus 
maze.  There were no differences between saline and 
cromolyn injected animals in number of entries or 
investigations into the open arms or the latency to enter 
an open arm.  (B) Cromolyn injected i.c.v. decreased the 
number of entries into and investigations into open arms.  
The latency to enter an open arm was increased 
compared to saline-injected controls. Data are presented 
as mean±SEM.  **, p<0.01; *, p<0.05.
Figure 4.  Cromolyn effects on open field behavior. (A) 
Cromolyn injected i.p. into WT animals had no significant 
effects on open field behavior.  There were no differences 
between saline and cromolyn injected animals in number of 
entries into the center square or the latency to enter the 
center square.  (B) Cromolyn injected into the lateral 
ventricle resulted in decreased exploratory behavior.  
Compared to saline injected controls, WT animals injected 
with cromolyn i.c.v. had fewer entries into the center 
square and a suggestive, but not significant, decrease in 
the latency to enter the center square. Data are presented 




Fear and depressive-like behaviors in sash-/- mice 
 Sash-/- mice (n=6) had an increased fear 
response to the conditioned stimulus in a classic 
cued-fear paradigm compared to sash+/- mice (n=7; 
Fig 6).  During the testing session (24h after tone-
shock pairs were presented during training) sash-/- 
mice froze 7.2% more than sash+/- mice in response 
to the tones (F1,37=5.62, p<0.05).  Baseline freezing responses for sash-/- mice were not different 
from sash+/- mice (t11=1.25, p>0.05).  Additionally freezing in response to the training shocks 
was not different between genotypes (t11=0.62, p>0.05).  However, the increased freezing in 
sash-/- mice could be due to differences in either learning during training or fear during retrieval. 
















Figure 6. Mast cell effects on cued fear conditioning. The 
percentage of time freezing over the 3 tones was greater in 










 Anhedonia was measured as index of depressive-like behavior by comparing sucrose 
consumption between genotypes (Fig 7A).  On average, sash-/- mice (n=11), consumed over 10% 
less sucrose than sash+/- (n=10) mice (t19=1.90, p=0.07), suggesting an increase in anhedonia.  
There were no differences in the absolute amount of water or sucrose consumption between 
genotypes.   
 Depressive-like behavior was also measured using the tail suspension and forced swim 
tests. In the tail suspension test, there was no difference in the amount of time spent immobile 
between sash+/- (n=6) and sash-/- (n=5) mice (Fig 7B; t9=0.252, p>0.05).  There was also no 
significant difference between sash+/- (n=5) and sash-/- (n=5) mice in the amount of time spent 
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Figure 8. Mast cell effects on circadian rhythmicity. Representative actograms depicting running wheel 
activity for a sash+/- and sash-/- mouse in constant darkness. Activity is denoted by black hash marks and is 







Figure 7. Mast cell effects on depressive-like behavior. (A) Levels of anhedonia are shown in the sucrose preference test for sash+/- and sash-/- m
Individual animals are plotted to reveal large individual variability; red denotes mean ± SEM.  (B) The amount of time spent immobile in the tail suspension 





















































































Arousal phenotype of sash-/- mice compared to sash+/- mice 
 Baseline Behavior  While we saw a mast cell effect on anxiety behavior and other 
measures of emotionality, there were no differences in any of the other arousal behaviors tested 
which encompassed baseline behavior and sensory responsiveness. Sash-/- mice showed no 
differences in the circadian rhythm of  baseline running wheel activity in DD compared to sash+/- 
littermate controls (Fig 8).  There was also no difference in the total amount of baseline 




 Sensory Responsiveness There were no differences between groups in the responses to 
tactile, olfactory, or vestibular stimuli as measured by amount of activity following delivery of 
the stimulus (Fig 9A).  Additionally, there were no differences in the pain threshold as measured 
by tail flick latency following exposure to heat in sash-/- (n=6) compared to sash+/- (n=7) mice 
(F1,11=0.26, p>0.05; Fig 9B).  Both genotypes flicked their tail away from the heating apparatus 














Figure 9. Mast cell effects on sensory responsiveness. (A) There were no significant differences in the arousal responses of sash-/-
mice (white bars) compared to sash+/- littermate (hatched bars).  Vertical activity is shown for in response to stimulation of each modality -
tactile, olfactory and vestibular. Data are shown as mean ± SEM. (B) Pain Threshold.  There were no significant differences between sash-/-
(white bar) and sash+/- littermate controls (hatched bar) in the latency to flick their tail away from a heated coil.  Tail flick latency (ms) is 


























 Lastly, there was no difference in the startle response between sash+/- and sash-/- mice at 
any single stimulus amplitude (Fig 10A).  Over all amplitudes there were main effects of 
genotype (F1,99=13.9, p<0.01) and stimulus intensity (F8,99=9.8, p<0.01).  Pre-pulse inhibition 
was used to test sensorimotor gating. Sash-/- mice (n=6) had larger startle responses (were less 
inhibited) following the lower volume pre-pulses compared to sash+/- mice (n=7; Fig 10B).  Sash-
/- mice were less inhibited by the pre-pulses of 86 (F1,11 =6.35, p<0.05), 88 (F1,11 =4.99, p<0.05), 
90 (F1,11 =6.09, p<0.05), and 92 dB (F1,11 =9.88, p<0.01). There were no significant differences 
in the startle response following the 94, 86 and 98 dB pre-pulses (F1,11<2.33, p>0.05).  Given 
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results from the startle test 
showing a main effect of 
increased startle amplitude in 
sash-/- mice, this PPI results is 















































Figure 10.  Mast cell effects on startle and sensorimotor gating. (A) Startle Reflex.  
There were no significant differences in the startle reflex to auditory tones between sash 
mice (□) and sash+/- littermate controls (♦). The maximum response (volts) is shown as 
mean ± SEM to various startle tones. (B) Pre-pulse inhibition.  Sash-/- mice were less 
inhibited when the pre-pulse was presented at a low volume (≤92dB), compared to sash+/-














































































































 In the present experiments, using a genetic model, we demonstrate that a specific cellular 
element of the hematopoietic system, the mast cell, mediates the expression of cued fear and 
anxiety-like behavior but has no effect on sensory arousal, locomotor responses, circadian 
rhythms or depressive-like behavior. Using a pharmacological manipulation, we show that, in 
part, the effect of mast cells in modulating behavior can be in the adult rather than exclusively 
the result of developmental abnormalities in the mast cell deficient mouse.   Additionally the 
blockade of central, but not peripheral mast cells affects anxiety-like behavior, revealing a 
central nervous system site of action. While there are a multitude of  mast cell mediators and 
triggers of their activation some candidate mast cell constituent(s)  can be identified.   
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  Mast cell-dependent changes in behavior are possibly due to multiple interacting mast 
cell mediators and neural systems. It is not known which of all of the possible mediators are 
contained in brain mast cells, given that mast cells synthesize different mediators based on their 
local microenvironment.  Considering all known mast cell mediators, including 
neurotransmitters, cytokines and lipid derived factors (Marshall, 2004), many have been 
individually implicated in the modulation of behavior.  Histamine is implicated in the regulation 
of the sleep-wake cycle (Brown et al., 2001), as well as other arousal-related systems including 
sex behaviors and anxiety (Donoso and Broitman, 1979; Ikarashi and Yuzurihara, 2002).  Our 
data show that brain histamine levels are decreased in the absence of mast cells (Chapter 2), and 
histamine binding to H1 and H2 receptors is known to impact anxiety (Brown et al., 2001; 
Zarrindast et al., 2008; Zlomuzica et al., 2008).  Another possibility for mast cell influence on 
anxiety-like behavior is through serotonin which functions both as a transmitter affecting many 
systems including aggression, appetite and mood (Lucki, 1998), and also as a trophic factor 
influencing neurogenesis and thereby affecting emotionality and memory (Gould, 1999; Gaspar 
et al., 2003).  Mast cells synthesize, store and secrete mast cells (Metcalfe, 1984; Kushnir-
Sukhov et al., 2007).  Serotonergic signaling within the limbic system has effects on 
emotionality behavior such as anxiety-like behavior (Sudak and Maas, 1964; Gray, 1983).  
Additionally, selective serotonin reuptake inhibitors increase serotonin signaling and decrease 
anxiety (Handley, 1995; Dulawa et al., 2004), therefore a lack of mast cell derived serotonin may 
result in an increase in anxiety-like behaviors.   
 Mast cell derived cytokines present more possibilities for mast cell impact on behavior as 
cytokines have neuromodulatory effects on neuronal systems which regulate behavior.  Tumor 
necrosis factor-α (TNF-α), interleukin-1, and interleukin-6 act on the hypothalamic-pituitary-
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adrenal axis and stress behavior (Dunn, 2000).  TNF-α also plays a role in the regulation of body 
temperature and the sleep-wake cycle (Krueger et al., 2001; Conti et al., 2004).  Lipid-derived 
factors like prostaglandin D2 also have known roles as neuromodulators, contributing to the 
regulation of the sleep, pain and body temperature regulation (Ueno et al., 1982; Ueno et al., 
1983; Mong et al., 2003).   
 Lastly, it is possible that mast cells mediate anxiety-like behavior through impact on the 
hypothalamic pituitary adrenal (HPA) axis.  Increases in HPA activation results in increases in 
anxiety-like behavior and mast cells have known interactions with corticotrophin releasing 
hormone (CRH), a hormone which engages the activation of the HPA axis.  First, mast cells have 
CRH R1 and R2 on their cell surface and CRH application to mast cells causes activation (Cao et 
al., 2005).  Second, mast cells can synthesize and secrete CRH, enabling mast cell to directly 
affect the HPA axis (Kempuraj et al., 2004). Given the large number of mediators, mast cells 
most likely have multi-faceted interactions with brain systems controlling behavior.   
 Since a majority of thalamic mast cells are active in the basal state (Florenzano and 
Bentivoglio, 2000; Wilhelm et al., 2000), factors affecting mast cell numbers in the brain are 
likely to be neurophysiologically important.  Many apparently unrelated manipulations including 
handling, sex and stress increase the numbers of brain mast cells.  An early study by Persinger 
showed that simple gentle handling of rat pups changed numbers of detected mast cells in the 
brain developmentally, most likely representing due to an increase in degranulation in mast cells 
(Persinger, 1980).  Psychological stressors induced through social defeat and isolation stress 
increased the number of mast cells in the brain (Bugajski et al., 1994; Cirulli et al., 1998).  
Lastly, gonadal hormone signals from mating partners cause increases mast cell number and 
activation in the brain (Yang et al., 1999; Wilhelm et al., 2000; Asarian et al., 2002).  
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 The present behavioral results are consistent with previous, highly suggestive evidence of 
associations between mast cells and emotionality.  Food allergies, asthma and irritable bowel 
syndrome (all mast cell mediated pathologies) are commonly linked to trait-anxiety in humans 
but are potentially confounded by the stressful recurrent episodes themselves (Lehrer et al., 
1993; Addolorato et al., 1998).  Induction of an asthmatic or food allergy response in mice, 
causes mast cell dependent increases in anxiety-like behavior and activation of the hypothalamic-
pituitary adrenal axis (Costa-Pinto et al., 2006; Costa-Pinto et al., 2007).  Additionally, patients 
afflicted with systemic mastocytosis, a disease characterized by an increase in the number of 
mast cells (Metcalfe, 2008), report low arousal states, lethargy and induction of coma (Tajima et 
al., 1994; Boncoraglio et al., 2005).  These symptoms are reversed by treatment which included 
histamine antagonists and cromolyn.  Lastly, the incidence of autistic spectrum disorders is 6.75 
times higher in mastocytosis patients or their immediate relatives than in the general population 
(Theoharides et al., 2008), suggesting a genetic link between mast cells and autism in humans. 
 While much of the evidence for immune system effects on brain have come from disease 
states, other evidence, including data presented here, points to the role of neuroimmune 
interactions in normal physiology.  The former line of research shows that dysregulation of the 
immune system can negatively impact brain functioning.  Cytokines released in the periphery 
during an immune response gain access to the brain (Maier, 2003) and modulate many brain 
systems including affect, cognition and pain processing (Maier, 2003; Irwin and Miller, 2007).  
Specifically interferons and interleukins have been causally implicated in mediating depression 
(Raison et al., 2006).  Interestingly, this has led to the immune system becoming a focus of novel 
therapeutic targets for the treatment of neurological disorders including psychiatric diseases (Di 
Filippo et al., 2008; Theoharides et al., 2008).  On the other hand, the present study joins a 
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growing literature investigating the role of immune cells in the healthy brain.  CNS-specific T-
cells contribute to hippocampal neurogenesis in adults with consequences for the formation of 
spatial memories (Ziv et al., 2006).  Also, major histocompatibility complex molecules 
(expressed on dendritic cells, T-cells, microglia and mast cells in the brain) are implicated in 
neuronal synapse development (Huh et al., 2000) and play a role in synaptic plasticity (Oliveira 
et al., 2004).   
 Overall our data provide evidence for an association of brain mast cells impacting 
anxiety-like behavior.  Given that they can change the signaling milieu of the brain (Marshall, 
2004), we suggest that mast cells provide a functional link through which the immune system 
interacts with the brain.  The results provide evidence of the behavioral importance of immune 
cells in the brain. 
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The effect of mast cells on the hypothalamic-pituitary-adrenal axis 
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Abstract 
 Anxiety-like behavior is increased in mice that lack functional brain mast cells. Anxiety-
like behavior is mediated in part, by the hypothalamic pituitary adrenal (HPA) axis, the neural 
system activated following stress.  Corticotrophin releasing hormone (CRH), a peptide 
synthesized to initiate HPA activation, also activates mast cells. Additionally, mast cells can also 
synthesize and release CRH.  The studies in this chapter explore the possibility that the HPA axis 
is differentially regulated in the absence of mast cells, and therefore could provide a link between 
mast cells and anxiety behavior.  However, results show no differences in CRH production or 
overall HPA reactivity as measured by corticosterone between mast cell deficient KitW-sh/W-sh 
mice or controls.   
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 Introduction 
 Mast cell deficient mice have elevated levels of anxiety-like behavior and increased 
stress-induced defecation (Nautiyal et al., 2008). We sought to determine the mechanism(s) of 
mast cell impact on the neural bases underlying these behaviors.  Anxiety-like behavior is 
controlled, in part, by the hypothalamic-pituitary-adrenal (HPA) axis (Schulkin et al., 1998).  A 
stressful or fearful stimulus activates corticotrophin releasing hormone (CRH) production in the 
paraventricular nucleus (PVN) of the hypothalamus. CRH stimulates the release of 
adrenocorticotropic hormone (ACTH) into the blood from the anterior pituitary gland.  ACTH 
stimulates increased synthesis and secretion of glucocorticoids into the blood stream from the 
adrenal gland.  Glucocorticoids, like corticosterone or cortisol, act on internal organs to aid in the 
fight or flight response to the initial stressful or fearful stimulus.  They also gain access to the 
brain and act on neural bases of behavior and cognition to aid in the stimulus response 
(Breedlove et al., 2007).  Increased activation of the HPA axis is linked to increased anxiety 
behavior measured with open field arena and elevated plus maze.  In humans chronically high 
activity is linked to several psychiatric disorders like depression and chronic anxiety disorders 
(McEwen, 2003). 
There is strong evidence to support a hypothesis that mast cells interact with the HPA 
axis via CRH.  Mast cells have the capability to release CRH.  Human mast cells in vitro, derived 
from umbilical cord blood, release both CRH and urocortin (Ucn), an endogenous ligand of CRH 
receptors that is a structurally and functionally similar peptide to CRH (Kempuraj et al., 2004).  
These cells contain both the protein and also mRNA of both CRH and Ucn.  Furthermore, 
stimulation of mast cells with immunoglobulin E (IgE) antibodies causes the release of CRH and 
Ucn from the majority of these cells in vitro.  Studies in vivo illustrate that mast cell-derived 
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CRH has a functional effect on the HPA axis.  Intracerebral injection of Compound 48/80, a mast 
cell secretagogue, causes dose dependent increases in ACTH and cortisol in dogs (Bugajski et 
al., 1997; Matsumoto et al., 2004).  Compound 48/80-induced increases in ACTH and cortisol 
are blocked with prior administration of an anti-CRH antibody (Matsumoto et al., 2004).  These 
results suggest that when stimulated by immune agents, mast cells can release CRH causing 
subsequent activation of the HPA axis, and have potential effects on behavior. 
Interestingly, the interaction between mast cells and CRH seems to be bidirectional.  The 
mechanisms of CRH effects on mast cells have, for the most part, been investigated in peripheral 
tissues like the skin, dura and gut.  Skin mast cells interact with CRH to act as 'central cellular 
switchboards’ of stress induced inflammatory and pruritic skin responses (Arck and Paus, 2006).  
An acute stressor causes increases in skin CRH and activates skin mast cells resulting in 
increased locally vascular permeability to promote inflammation and histamine mediated itching 
(Lytinas et al., 2003).  This response can be mimicked by direct intradermal injection of CRH 
and also by activation of skin mast cells directly with Compound 48/80.   
CRH activation of mast cells in the dura mediates stress induced disruptions in the blood-
brain barrier (BBB) (Esposito et al., 2002) and has clinical relevance in conditions in which 
disruptions of BBB integrity causes worsening of the disease’s brain pathophysiology, like 
multiple sclerosis and metastases of tumors to the brain (Esposito et al., 2001; Theoharides et al., 
2008).  The mast cell derived chemical mediator that is responsible for the breakdown in BBB 
permeability is unknown, however histamine, cytokines and vascular endothelial growth factor 
all increase locally following mast cell CRH receptor stimulation (Theoharides et al., 2008).  
Stress-induced BBB disruption is reduced following administration of the mast cell stabilizer 
cromolyn, which blocks degranulation (Esposito et al., 2001).  Lastly, mast cells in the gut 
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respond to CRH to affect intestinal function and are implicated in stress-related gut dysfunction 
like irritable bowel syndrome (Tache et al., 2009; Ohman and Simren, 2010).  CRH activates 
CRH receptor subtypes R1 (CRHR1) and R2 (CRHR2) on mast cells in the colon (Wallon and 
Soderholm, 2009) to increase colonic motility through serotonin release (Chen et al., 2001).  
Blocking mast cell activation with CRH antagonists prevent stress-induced gastrointestinal 
dysfunction (Larauche et al., 2009).   
 Stress-induced defecation is also centrally regulated by CRH binding of brain CRH R1 
(Martinez et al., 2004; Tache and Bonaz, 2007). Since sash-/- mice had increased levels of stress-
induced defecation in multiple behavioral assays of anxiety-like behavior (Nautiyal et al., 2008), 
we hypothesized that differences in brain CRH may mediate this effect.  To assess brain CRH 
signaling, we measured CRH protein expression, CRH mRNA expression and CRH R1 binding 
in sash-/- mice and their sash+/- littermate controls.  We also assessed plasma corticosterone levels 
to determine if there were any downstream effects of differential CRH signaling.  No differences 




 Mast cell deficient C57BL/6-KitW-sh/W-sh (sash-/-) mice were obtained from Jackson 
Laboratories (B6.Cg-KitW-sh/HNihrJaeBsmJ; Bar Harbor, ME) and bred to establish a colony at 
the Columbia University animal facilities.  Sash-/- mice carry an inversion mutation upstream 
from the c-kit receptor promoter causing reduced expression on stromal cells, and therefore an 
inability for mast cells to differentiate from their myeloid progenitors (Kitamura and Fujita, 
1989; Duttlinger et al., 1993).  This strain has been well characterized and there have been no 
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reports of abnormalities in the number or function of any other immune cell type (Grimbaldeston 
et al., 2005).  Male sash-/- and sash+/- littermates from sash+/- × sash-/- crosses were weaned at 28d 
and  used in all experiments (12-18 wks of age).  Mice were housed in a 12:12 light-dark cycle 
and food and water were available ad libitum.  All animal care and testing were approved by the 
Columbia University Institutional Animal Care and Use Committee.   
 For examination of CRH protein, mice (n=9) were anesthetized with Nembutal and 
injected with colchicine (20 μg in 10 μl saline, Sigma Aldrich, St. Louis, MO) into the lateral 
ventricle (stereotaxic coordinates: bregma+1.0, mid-0.7, skull-3.0).  48 h following injection, 
mice were perfused with 0.9% saline and then 4% paraformaldehyde.  Brains were removed 
from crania, post-fixed overnight, and then transferred to 20% sucrose.  Brains were cut on a 
cryostat into 50 μm sections and every 4th section was processed for CRH immunoreactivity. 
 For examination of CRH mRNA and CRH R binding, mice (n=17) were subjected to one 
of three behavioral conditions: 1. control (no manipulation), 2. 30 minutes of restraint stress 
(moderate stressor), 3. 10 minutes of open field exposure (mild stressor).  Mice were decapitated 
40 minutes following onset of stressor.  Brains were rapidly removed from crania, frozen in dry 
ice and stored at -80 °C.  Brains were cut into 20 μm sections and thaw mounted onto Probe-on-
Plus slides (Fisher Scientific, Waltham, MA).  Slides were stored at -80 °C until processed.  
  
Immunocytochemistry 
 Free floating sections were processed for CRH immunoreactivity as previously described 
(Justice et al., 2008). Briefly, sections were washed with phosphate buffer (PB) with 0.1% triton-
X (PBT), then blocked with normal donkey serum in PBT, before incubation in primary 
antibodies against CRH (Rabbit α-CRH, kindly provided by Dr. Wylie Vale, UCSF) and AVP 
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(Guinea Pig α-AVP, Peninsula, Belmont, CA) for 48 h at 4 °C.  Sections were then washed in 
PBT, and incubated for 2 h in secondary antibodies against rabbit and guinea pig conjugated to 
CY3 and CY2 fluorophores (Jackson Immunoresearch, West Grove, PA).  Finally, sections were 
washed, mounted, dehydrated and then coverslipped.   An antibody adsorption control was also 
run by preincubating the primary antibodies with CRH peptide (CRH r/h, Bachem, Torrance, 
CA), which resulted in no CRH immoreactivity. 
 Images of the staining in the PVN were taken with a Zeiss Axiovert 200 MOT 
fluorescence microscope with Zeiss LSM 510 laser scanning confocal attachment and LSM 3.95 
software (Carl Zeiss, Thornwood, NY).  5 μm optical images were taken throughout all sections 
containing PVN as localized by AVP staining.  Images were reconstructed using the LSM 
software, and the number of individual CRH-positive cells within the PVN were counted by two 
observers blind to the experimental groups.  Three sections containing PVN (200 μm apart) were 
counted bilaterally and averaged for each animal, and this average number of cells per 50 μm 
slice is reported. 
 
In situ hybridization 
 The CRH riboprobe was kindly provided by Dr. Russell Romeo (Barnard College) and 
Dr. Aaron Jasnow (Emory University), and generated as previously reported (Romeo et al., 
2007).  Briefly, a 1.2-kb fragment of the rat CRH cDNA contained in a pBluescript SK vector 
was linearized with Xho I and Sac I to make antisense and sense cRNA probes, respectively. 
Labeled RNA probes were synthesized by transcription of the linearized, gel-purified DNA 
templates using the appropriate T3 and T7 polymerases with 35S-labeled UTP. Full-length probes 
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were separated from labeling reactions and mixed with hybridization buffer for measurement of 
specific activity. 
 Slide-mounted sections were processed as previously described (Romeo et al., 2007).  
Briefly, slide-mounted sections were fixed in 3.7% formaldehyde, then rinsed in phosphate-
buffered saline (PBS), triethanolamine-HCl (TEA), TEA with acetic anhydride and sodium 
chloride citrate (SCC).  Slides were then dehydrated in a series of ethanols (70, 95 and 100%), 
delipidated in chloroform, and rinsed again in 100% ethanol. For pre-hybridization, sections 
were covered in hybridization solution (225 μl/slide) without probe, covered with parafilm and 
placed in a humidity chamber and incubated for 1 h at 55°C. Slides were then washed in 2xSCC 
and again dehydrated (70 and 95% ethanol). For hybridization, sections were covered in 
hybridization buffer (225 μl/slide) with the 35S-labeled antisense or sense ribonucleotide probes 
(approximately 1x106 cpm/slide), covered with parafilm and incubated overnight in a humidity 
chamber at 55 °C. Following hybridization, slides were washed in 2XSCC buffer and incubated 
with RNase A (10 μg/ml) in digestion buffer, and then digestion buffer alone. Slides were then 
washed with 2XSCC and 0.2XSCC, dehydrated again and then air-dried for 24 h.  Slides were 
apposed to Kodak BioMax MR film (Sigma Aldrich) for various exposure times to generate a 
partial exposure-optical density curve.   
 Section images from the developed film were digitized using a light box with flat-field 
correction.  Relative optical densities (RODs) were measured from the autoradiograms using 
computerized image analysis software (MCID Core 7.0, Imaging Research, Inc., St Catherines, 
Ont., Canada). Brain areas analyzed were the PVN, dorsolateral amygdala and dentate gyrus and 
CA1 regions of the hippocampus.  PVN was sampled with a circular tool in the center of the 
anatomical PVN defined by the darkened exposure.  For the amygdala, a circle tool (with a 
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diameter of 20 pixels) was used to sample the center of the dorsolateral region.  A square tool 
(10x10 pixels) was used to sample the dentate gyrus, CA3, and CA1 in the darkest portion of 
these cell layers.  Background measurements were taken from an area adjacent to the target area 
and subtracted from that taken from the target area. Bilateral measurements were made from 
three adjacent sections for each brain area for each animal.  
 
Receptor binding 
 Receptor autoradiography for CRH R1 was carried out using the 125I labeled- Tyr0-
Sauvagine isotope (Perkin Elmer, Boston, MA) and urocortin II (UcnII; Phoenix 
Pharmaceuticals, Burlingame, CA) blockade of CRH R2 as previously described (Saavedra et al., 
2006).  Slide-mounted sections were pre-washed in Tris-HCl, then each section was covered 
with 60μl of incubation buffer (50 mM Tris-HCl, 10 mM MgCl2 , 0.1%Bacitracin, 0.2 nM 125I 
labeled- Tyr0-Sauvagine, 300 nM UcnII) for 90min.  Control slides were incubated with excess 
CRH peptide (2 nM CRH peptide [Bachem, Torrance, CA] and 0.2 nM 125I labeled- Tyr0-
Sauvagine) to assess non-specific binding.  Slides were washed in Tris-HCl with MgCl2, and 
then allowed to air-dry overnight, before exposed to film for 72 h.   
 Images from exposed film were digitized using a light box with flat field correction and 
imported into MCID Core 7.0 Software (Imaging Research, Inc., St Catherines, Ont., Canada). 
Relative optical densities (RODs) were measured from the images using MCID, for the 
following brain areas: lateral dorsal striatum, rostral hippocampus, caudal hippocampus, 
dorsolateral amygdala, medial amygdala and prefornical region of the thalamus.  The ROD of 
control slides were no greater than background.  Five bilateral ROD measurements were taken 
105 
for each brain area for each animal, from which background ROD, as measured in a brain region 
directly outside the brain region of interest, was subtracted.   
 
Corticosterone EIA  
 For assessment of corticosterone levels, mice (n=22) were sacrificed by decapitation 
within 2h following lights on.  Trunk blood was collected into EDTA coated tubes (BD, Franklin 
Lakes, NJ) and was spun down at 4°C at 5000xg for 15 min.  Plasma was collected and stored at 
-80°C until processed.   Plasma corticosterone was assayed using a commercially available EIA 
kit (Cat# 500655, Cayman Chemical, Ann 
Arbor, MI) according to the manufacturer’s 
directions.  The limit of detection of this kit 
is 30 pg/ml and cross reacts less than 10% 
with 11-Dehdyrocorticosterone.  Samples 
were run at a dilution such that they fell 
within the linear portion of the standard 
curve.  If the %CV between duplicate run 
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Figure 1. Mast cell effects on CRH expression. (A) Representative 
5μm optical slices from the PVN of sash+/- and sash-/- mice showing 
CRH (red; target protein) and AVP (green; used for localization of PVN) 
immunoreactivity. (B) Quantification of the number of CRH+ cells in the 



































quantified in the PVN of sash+/- (n=5) and sash-/- (n=4) mice from IHC stained sections (Fig 1A).  
There was no significant effect of genotype on the number of CRH+ cells at baseline state 
(t7=0.79; p>.05; Fig 1B).  PVN was the only region assessed here, as it is the region with the 
largest number of CRH-producing and storing cells.  However, there are other brain regions in 
which CRH protein is found, but no further brain regions were explored due to a lack of 
differences found in the CRH mRNA studies presented next. 
 
 CRH mRNA  
 CRH mRNA was quantified following in situ hybridization in PVN, amygdala and 
hippocampus.  Representative images from radiolabeled sections from sash+/- and sash-/- mice are 
shown (Fig 2A, D, G, J).  Close-ups of regions of interest from those sections are also shown 
(Fig 2B, E, H, K).  Amount of mRNA for each region was quantified by ROD measurement and 
shown by condition and genotype (Fig 2C, F, I, L).  There were no significant effects of 






















































Figure 2.  Mast cell effects on CRH mRNA. Representative images are shown of brain regions analyzed for CRH mRNA 
(A,D,G,J).  Close-ups of regions-of-interest show locations of sampling for ROD measurements (B,E,H,K).  ROD 
quantification is shown for PVN (C), amgdala (F) and hippocampus (I,L) over the 3 conditions run – control (C), open 
field/moderate stress (O), restraint stress (R) for sash+/- and sash-/- mice.   There we no differences between genotype in 



































CRH R1 binding 
 CRH R1 binding was analyzed in the hippocampus, amygdala, and thalamus (Fig 3).  
ROD sampling of brain area included rostral and caudal hippocampus, medial and lateral 
amygdala and the parafascicular nucleus of the thalamus.  All of these regions are known for 
their expression of CRH R1 (Primus et al., 1997) and CRH R1 mRNA (Korosi et al., 2006).  
Quantification revealed no significant differences between genotypes in the receptor distribution 
or quantity in sash+/- and sash-/- mice for any region analyzed including the parafasicular region 
108 
of the thalamus (F2,11=2.94, p>0.05), rostral and caudal hippocampus (F2,10=0.39, p>0.05 and 
F2,11=1.61, p>0.05), medial and dorsolateral amygdala (F2,11=0.35, p>0.05 and F2,11=1.52, 
p>0.05, respectively), or lateral dorsal striatum (F2,9=0.11, p>0.05).  While there were no 
statistically significant differences between genotypes in any of these regions, there was a trend 
in the measurements of the parafasicular nucleus.  Sash-/- mice may have decreased CRH binding 
here compared to sash+/- and sash+/+ mice that was not detected due to small sample size. 
 
Plasma corticosterone 
 We measured basal plasma corticosterone to determine whether anxiety-like behavior 
was mediated by a basal difference in HPA activity between genotypes.  Basal levels were also 
compared to plasma corticosterone following 30 min restraint stress to assess any differences in 
the stress-reactivity of the HPA axis. There were no significant differences in the baseline levels 
of plasma corticosterone measured in sash-/- (n=7) and sash+/- mice (Fig 4; t12=0.05, p>.05).  Both 
genotypes showed a marked increase in plasma corticosterone in response to stress (t12=4.76, 
p<0.01 for sash+/- mice and t12=3.80, p<0.01 for sash-/- mice), but there was no difference 
between genotypes in the stress response (t12=1.18, p>0.05).  This suggests that there is no 











































































Figure 3. Representative sections used for analysis of receptor binding are shown for the 
following regions analyzed – rostral hippocampus (A), caudal hippocampus (C), medial 
amygdala (E), lateral amygdala (G), and parafasicular nucleus of the thalamus (I).  White 
boxes highlight the sampled areas within the region. ROD measurements were quantified as 
a measure of the amount of CRH R1 binding and are shown for each brain region for 
sash+/+, sash+/- and sash-/- mice (B,D,F,H,J). There were no significant differences in CRH 































































Figure 4.  Mast cell effects on baseline plasma 
corticosterone. Plasma corticosterone levels in sash+/- (black 
bars) and sash-/- (white bars) mice are not significantly at 
baseline or following 30 min restraint stress.  Both genotypes 
showed an increase in plasma corticosterone from baseline, 

























































 Despite differences in anxiety-like behavior and stress–induced defecation between 
sash+/- and sash-/- mice reported in Chapter 3, there are no apparent differences in the function of 
the HPA axis.  Namely, there are no differences between genotypes in the amount of CRH 
protein, CRH mRNA, CRH R1 binding, or plasma levels of corticosterone, nor any difference in 
stress reactivity.  Overall, this suggests that the HPA axis, at this level of the system, does not 
mediate mast cell effects on anxiety behavior.  
 These results are surprising given the evidence showing that mast cells interact with CRH 
(Bugajski et al., 1997; Kempuraj et al., 2004; Cao et al., 2005).  However the data presented in 
this chapter show that there is no differential CRH signaling in the brain and no change in HPA 
axis activity as measured by corticosterone levels.  This leaves open the possibility that CRH 
activates mast cells which causes the release of some chemical mediator that modulates anxiety 
behavior through a non-HPA mechanism, namely the sympathetic nervous system (Mason, 
1968).  Catecholamines released by the adrenal gland also regulate anxiety behaviors and stress-
induced physiology.  Although there is no evidence, to my knowledge, that epinephrine interacts 
directly with mast cells, epinephrine is commonly given as a treatment following mast cell-
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dependent hypersensitive reactions to reverse the symptoms associated with acute mast cell 
mediator release (Castells, 2006).   
 Given that mast cell deficient mice have increased anxiety behaviors, it seems that mast 
cells may be acting to dampen the stress response.  Although we see no evidence of a dampened 
stress response as measured by HPA activity seen here, it is possible that other measures of the 
stress responsiveness might have revealed this.  For example, injections of dexamethosone can 
be used to test the response to glucocorticoids (McEwen, 1979).  Perhaps mast cell deficient 
sash-/- mice are more sensitive to circulating levels of glucocorticoids compared to sash+/- mice. It 
is possible that there are deficits in the negative feedback mechanisms engaged by 
glucocorticoids in sash-/- mice, resulting in an increased behavioral response (Meaney et al., 
1993).  
 An alternative hypothesis is that the increased stress-induced defecation in sash-/- mice is 
mediated by peripheral effects of mast cells located in the intestine (Tache and Bonaz, 2007).   
The original hypothesis was based on data showing that blocking mast cell activation leads to 
reduced stress-induced defecation (Chen et al., 2001).  However this was an acute treatment in 
adulthood.  Since sash-/- mice lack mast cells throughout development, it is possible that 
compensatory mechanisms yield a different regulation of gut motility.  In this case, the anxiety 
behaviors would result from a parallel, but distinct mechanism than the increased defecation.   
 Additionally, there is also a possibility that these results represent false negatives in 
genotype differences seen between sash+/- and sash-/- mice.  This is most likely in the CRH 
mRNA and corticosterone measurements.  CRH mRNA is known to increase in regions like the 
PVN and hippocampus following mild to moderate stressors (Hsu et al., 1998; Romeo et al., 
2007).  However, the results from the CRH mRNA study here do not reveal an increase in CRH 
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production following either open field or restraint stress.  This may be due to overexposure of 
film which may have caused the exposures to reach ceiling levels.  On the other hand, 
differences in corticosterone may not have been detected in the two time points measured here.  
The results include data from only baseline states and following 30 min following restraint 
stress.  This study leaves open the possibility for differences between genotype in the recovery 
from stress as seen in previous studies (Markham et al., 2006; Romeo et al., 2007).   
 Overall, the most likely hypothesis for impact of mast cells on the limbic system is 
through the hippocampus.  Cross referencing brain regions involved in the mediation of anxiety 
behavior with the location of mast cells (Fig 5) reveals that the hippocampus is the only limbic 
system region in which mast cells reside (see Chapter 1 and Hendrix et al., 2006).  Mast cells are 
found in large numbers nearby and within the hippocampus through development (Chapter 2).  
In the next chapter, I report findings illustrating mast cell impact on hippocampal physiology and 
function. 
Figure 5: Mast cell location (blue shading) and limbic system 
structures (yellow shading) are shown here on a sagittal mouse 
atlas map. The only overlapping region is the hippocampus 
(green) suggesting a potential locus of mast cell mediation of 
the limbic system.   
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 Brain mast cells are located within and nearby the hippocampus throughout development 
and in adulthood.  Given that they synthesize and store a number of factors that affect adult 
hippocampal neurogenesis - cell proliferation, survival and differentiation were assessed in mast 
cell deficient KitW-sh/W-sh mice and littermate controls. Mast cell deficient mice have 40% 
reduced cell proliferation in the hippocampus, but not the subventricular zone, another region 
where adult neurogenesis exists but no mast cells are found.  The reduction in cell proliferation 
extends to immature and surviving neurons in the hippocampus, however there is no affect of 
mast cells on the percentage of cells surviving or differentiating into neurons.  Using a capillary 
electrophoresis with laser induced native fluorescence instrument, our studies demonstrate that 
mast cells contribute significant amounts of serotonin to the hippocampus. Chronic treatment 
with a selective serotonin reuptake inhibitor which increases serotonin signaling, reversed the 
neurogenesis deficit in mast cell deficient mice.  Given the known role of the hippocampus and 
hippocampal neurogenesis in cognition, mast cell deficient mice were compared to littermates in 
behavioral assays of spatial learning and memory.  Profound deficits were seen in mast cell 
deficient mice in the radial arm maze and Morris water maze.  Some of these deficits could be 
reversed with enriched housing.  These studies show that mast cells have the potential to 
contribute serotonin to the hippocampus throughout development and adulthood.  It is possible 
that a lack of mast cell derived serotonin is affecting hippocampal-dependent behaviors, like 
those presented here and anxiety-like behavior in Chapter 3.  Overall, these results suggest that 
hematopoietic cells contribute to the physiology and function of the hippocampus.   
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Introduction  
 Several lines of research point to the hippocampus as the likely site of mast cell 
mediation of the limbic system.  Mast cells in the mouse are located within and nearby the 
hippocampal formation throughout postnatal development and adulthood (chapter 2).  
Additionally, mast cells synthesize and release mediators with known roles in regulating 
hippocampal signaling and neurogenesis, including serotonin and nerve growth factor among 
others (Gould, 1999; Heldmann et al., 2005; Frielingsdorf et al., 2007).  While the involvement 
of the hippocampus in regulating emotionality behaviors and cognition has been known for 
decades (Olds and Olds, 1969), more recently hippocampal neurogenesis as a specific 
mechanism has drawn attention (Sahay and Hen, 2007).  Given precedence for immune system 
effects on hippocampal physiology and function (Ziv et al., 2006; Yirmiya and Goshen, 2011), 
the location of mast cells in the brain (Chapter 2), and their ability to release hippocampus-active 
factors (Marshall, 2004), we examined mast cell impact on hippocampus and hippocampus-
dependent behaviors.  Our hypothesis was that a lack of mast cells would result in deficits in 
hippocampal signaling and hippocampal-dependent behavior, due to a lack of mast cell-derived 
serotonin in development and adulthood.   
 Mast cells are well known for synthesizing, storing and releasing serotonin (Kushnir-
Sukhov et al., 2007).  Importantly, mast cells are located in large numbers near and within the 
hippocampus during development and adulthood, where serotonin has known roles as a multi-
potential amine.  It acts as a transmitter, neurotrophic factor, chemotactic factor, and a target for 
the treatment of various psychiatric conditions (Gould, 1999).  The most commonly attributed 
source of hippocampal serotonin is from neuronal afferents from the raphe nuclei (Zhou and 
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Azmitia, 1983).  Serotonergic deafferentation of the hippocampus through ablation of 
serotonergic neurons with 5,7-dihydroxytryptamine results in a 60-80% decrease in serotonin as 
measured in the dorsal and ventral hippocampus (Altman et al., 1990).  This suggests that up to 
20-40% of serotonin in the hippocampus is not released by these neuronal afferents and is 
potentially of mast cell origin. Due to the location of mast cells in hippocampus and peri-
hippocampus in adulthood, it is possible that serotonin released from mast cells affects 
hippocampal serotonin signaling.   
 Serotonin acts as a trophic factor that affects neurogenesis and synapse formation during 
development (Gould, 1999; Gaspar et al., 2003).  Depletion of serotonin in adulthood reduces 
cell proliferation (Benninghoff et al., 2010) and depletion of serotonin in development has 
effects on the formation of synapses (Mazer et al., 1997).   Serotonin also plays a role in the 
organization of the developing brains, and is specifically involved in neurite outgrowth and cell 
proliferation and differentiation (Lauder, 1990).  Additionally, disruptions in serotonergic 
signaling in the hippocampus during development result in profound behavioral abnormalities in 
adulthood (Hohmann et al., 2007).  
 Mast cell effects were assessed using a genetic mast cell loss-of-function C57BL/6-KitW-
sh/W-sh (sash-/-) mouse model, which lacks mast cells but has an otherwise normal immune cell 
profile (Kitamura and Fujita, 1989; Grimbaldeston et al., 2005).  Mast cell contributions to the 
hippocampus were measured by comparing hippocampal neurochemistry and hippocampal 
neurogenesis in mast cell deficient mice and littermate controls.  Two growth factors were 
chosen, one that could be directly affected by mast cell activation (NGF) and another which 
could be indirectly affected (BDNF).  Additional analysis of hippocampal neurochemistry 
included serotonin at baseline states and following activation of mast cells in vitro.  Effects of 
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selective serotonin reuptake inhibitor (SSRI) treatment and enriched housing conditions were 
also assessed.  Overall, the results presented here point to a beneficial role for mast cell impact 
on the hippocampus.   
 
Materials and Methods   
Animals 
Mast cell deficient C57BL/6- KitW-sh/W-sh (sash-/-) were used in these studies.  Mice were obtained 
from Jackson Laboratories (B6.Cg-KitW-sh/HNihrJaeBsmJ; Bar Harbor, ME) and bred to establish 
a colony at the Columbia University animal facilities.  As previously described,  sash-/- mice 
completely lack mast cells due to an inversion mutation upstream from the c-kit receptor 
promoter, causing a reduced expression of c-kit receptor in the bone marrow and therefore an 
inability for mast cells to differentiate from their myeloid progenitors (Kitamura and Fujita, 
1989; Chen et al., 2005).  Importantly for studies presented in this chapter exploring 
hippocampal function, sash-/- mice do not have deficits in c-kit receptor expression in the 
hippocampus (see Chapter 2).    
Sash-/- mice received from Jackson were crossed with wild-type C57BL/6 mice (the 
background strain) to generate heterozygote (sash+/-) mice.  An analysis of the number of mast 
cells from mice in litters containing sash+/+, sash+/- and sash-/- mice (generated by sash+/- × sash+/- 
crosses) revealed that sash+/- mice have brain resident mast cells (see Chapter 2).  Therefore, the 
studies reported here used sash+/- littermates as controls for sash-/- mice to allow for control of 
genetic and epigenetic variability.  
Litters were weaned at 28 d and male mice from these litters (at 12-18 wks, except where 
noted for development study) were used.   Following weaning, all mice were housed 2-5/cage in 
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transparent plastic bins (36×20×20 cm) in a 12:12 light-dark cycle at 22±1 °C.  Cages had corn 
cob bedding (Bed-o’cobs, Maumee, OH) and food and water were provided ad libitum.  Animals 
used in the mast cell mapping study and the immunohistochemistry studies were anesthetized 
with pentobarbital (200 mg/kg) and then sacrificed by transcardial perfusion, first with 0.9% 
saline, then with 4% paraformaldehyde.  Brains were removed from crania, postfixed overnight, 
then submerged in sucrose for 48 h. Animals used in assays for hippocampal levels of NGF, 
BDNF and serotonin were sacrificed by decapitation.  Brains were rapidly removed from crania 
and placed in ice cold Hank’s balanced salt solution (HBSS; Invitrogen).  Animal care and 
testing were approved by the Columbia University Institutional Animal Care and Use 
Committee.   
 
Enriched Housing 
In the experiment assessing the effects of enriched housing, mice were randomly assigned to 
enriched or standard housing conditions.  Mice in the enriched housing condition were housed 6-
8 per multi-compartment enriched cage.  Each enriched cage consisted of 3 bins (45×25×25 cm) 
connected by plexiglass tubes (6 cm diameter, 10 cm long; Columbia University Facilities and 
Machine Shop, New York, NY).  Each bin contained one running wheel (3 total; 13 cm 
diameter) and 2 of the following per bin (6 total per enrichment cage): paper nesting material, 
cardboard tube (4 cm diameter, 12 cm long), rodent plexiglass tunnels (5 cm diameter, 9.5 cm 
long, BioServ, Millersville, MD), mouse igloo hut (BioServ, Millersville, MD), mouse shepherd 
shack (SSP, Milford, NJ). Items in the enriched cages were changed every 3-4 days and clean 
objects were replaced in new orientations.   
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BrdU Injections  
5-Bromo-2’-Deoxyuridine (BrdU; Sigma Aldrich, St. Lois, MO) was used to label dividing cells.  
For assessment of cell proliferation and survival in the dentate gyrus at baseline, sash+/- and sash-
/- mice were injected once per day for 3 days with BrdU at a dose of 150 mg/kg (concentration 
7.5mg/ml saline, i.p.) and perfused 24 h following the 3rd injection. For assessment of cell 
survival in dentate gyrus and olfactory bulb, sash-/- and sash+/- mice were injected once per day 
for 3 days with BrdU (150 mg/kg) and perfused 28 days following the 3rd injection.  For 
assessment of cell proliferation in the subventricular zone (SVZ), the SSRI study and the 
enrichment study, mice were injected once with BrdU (150mg/kg) and perfused 24 h later.   
 
Immunohistochemistry 
Brains of animals injected with BrdU were cut into 50 μm coronal sections on a cryostat 
(Microm HM 500M) into phosphate buffer.  Every eighth section of hippocampus and olfactory 
bulb and every fourth section of the subventricular zone (SVZ) were processed by free-floating 
immunohistochemistry as previously described (Meshi et al., 2006).  In brief, sections were 
washed in tris-buffered saline (TBS), denatured in 50% Formamide/2xSSC for 2 h at 60 °C, 
washed in SSC, then in HCl and Boric Acid, then again in TBS.  Sections were incubated in 
primary antibodies for 36 h at 4 °C, against the following antigens: BrdU [AbD Serotec, 
Cat#OBT0030G, Raleigh, NC, 1:200], doublecortin (DCX) [Santa Cruz Biotechnology, 
Cat#SC8066, Santa Cruz, CA, 1:1000], neuronal-specific nucleus protein (NeuN) [Chemicon, 
Cat#MAB377, Billerica, ME, 1:500].  Sections were then washed and incubated in the 
appropriate fluorescent secondary antibodies – donkey anti-rat secondary conjugated to CY3 for 
BrdU, donkey anti-goat conjugated to CY2 for DCX, and donkey anti-mouse conjugated to CY2 
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for NeuN [Jackson Immunoresearch, West Grove, PA, 1:200] for 2 h, then washed, mounted, 
dehydrated and coverslipped.   
  
Analysis of Immunostained sections 
Images of single labeled sections were captured using a Nikon Eclipse E800 light microscope 
(Nikon Co., Tokyo, Japan) equipped with the GFP (480±20 nm) or Texas Red (560±40 nm) 
filters to detect CY2 or CY3 fluorophores, respectively. The microscope is fitted with a Q-
Imaging Retiga EXi, fast 1394 camera (Quantitative Imaging) with QCapture software (version 
2.95.0, Quantitative Imaging, Surrey, BC, Canada).  Images were loaded into Photoshop 7.0 
(Adobe Systems, San Jose, CA) for cell counting.  
 BrdU labeled cells were counted by 2 observers blind to genotype and condition (inter-
rater reliability: R2>0.95).  In the dentate gyrus (DG) and SVZ, BrdU+ cells in every 8th section 
were counted.  For the DG, a BrdU+ cell was counted if it was localized along the subgranular 
layer which was clearly visible in all sections.  For the SVZ, BrdU+ cells located adjacent to the 
lateral ventricle were counted.  In the olfactory bulb, BrdU+ cells were counted in 3 
representative areas (0.1 x 0.1 mm) that were randomly placed in the granule cell layer on every 
8th section.  DCX staining was analyzed by measuring the area of staining using ImageJ 1.31, 
with the threshold of positive staining set using the built-in Otsu method, which divides the pixel 
grey level histograms into two classes that have the least inter-class variance (Otsu, 1979). 
 Double labeling of cells with BrdU and NeuN was assessed by first counting the number 
of BrdU cells as described above in Photoshop.  Then the number of cells labeled with both 
BrdU and NeuN were counted within the population of BrdU+ cells.  Confocal microscopy was 
used confirm double labeled BrdU and NeuN.    Specifically, bilateral hippocampi from one 
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representative section (bregma-2.2) per animal was scanned with a Zeiss Axiovert 200 MOT 
fluorescence microscope (Carl Zeiss, Thornwood, NY, USA) with Zeiss LSM 510 laser scanning 
confocal attachment and LSM 3.95 software (Carl Zeiss).  Each cell within the captured images 
was examined in 2μm optical slices using the LSM 3.95 software for confirmation of double 
labeling.  The percentage of double labeled cells achieved with both methods was not different 
(R2>0.95, p<0.01).   
 The volume of the dentate gyrus was estimated using the Cavalieri method (Gundersen 
and Jensen, 1987) in sash-/- and sash+/- mice.  The two-dimensional area of the dentate gyrus was 
taken by measuring the area of NeuN staining.  The area of staining was measured in every 8th 
section throughout the hippocampus using ImageJ, with threshold set automatically by the Otsu 
method (Otsu, 1979).  The volume of each section was calculated by multiplying the area 
obtained from ImageJ (in μm2) by the thickness of the section plus the distance between each 
section (50+150 μm).  The total volume was calculated by summing this volume across all 
sections. 
 
ELISA measurement of trophic factors 
The hippocampus was dissected out of 600 μm slices cut on the vibratome from fresh brain 
tissue.  Both left and right side was dissected out and pooled.  Hippocampal tissue from 3 slices, 
representing rostral (H1), mid (H2) and caudal (H3) hippocampus, were used.  Tissue was 
homogenized using a hand-held electric homogenizer in lysis buffer [150 mM NaCl, 50 mM Tris 
(pH 7.4), 10% glycerol, 1 mM EDTA (pH 8.0), 1% TritonX-100] with 0.1% protease inhibitor 
cocktail (Sigma—Aldrich, St. Louis, MO). Homogenates were centrifuged at 10,000g for 15 min 
at 4°C, and supernatants were used for enzyme-linked immunosorbent assay (ELISA) using 
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commercially available kits to measure BDNF (Promega BDNF Emax ImmunoAssay System) 
and NGF (Promega NGF Emax ImmunoAssay System) according to manufacturer instructions. 
The total protein concentration in each sample was also measured using the BCA protein assay 
(MicroBCA Protein Assay, Pierce), and the levels of NGF and BDNF were calculated as pg/g 
total protein.   
 
Capillary electrophoresis laser induced native fluorescence 
 Brain slices (300 µm thick) from fresh brains were cut on a vibratome in ice cold Hanks 
Balanced Salt Solution (HBSS). Two slices containing hippocampus were used for analysis, one 
representing rostral hippocampus (bregma – 1.70 mm) and one representing caudal hippocampus 
(bregma - 2.92 mm). Degranulation of mast cells was induced by applying 400 µl of Compound 
48/80 (C48/80; Sigma Aldrich, St. Louis MI) at a concentration of 0.1 mg/ml in HBSS. 
Following a 3 min incubation with C48/80 or the HBSS vehicle, the hippocampus was dissected 
out of the slice, placed into Eppendorf tubes, weighed, and manually homogenized in 20 µl of 
extraction matrix [49.5% LC-MS Chromasolve Methanol (Sigma Aldrich, St. Louis MI), 49.5% 
LC/MS grade water (Thermo Scientific, Waltham, MA), 1% acetic acid (Sigma Aldrich, St. 
Louis MI)] per mg of dissected tissue.  Homogenized tissue was incubated with extraction matrix 
for 90 min at 4°C before centrifugation at 15,000 g for 15 min.  The supernatants were then 
transferred to PCR tubes and frozen at -80 °C until analysis by capillary electrophoresis with 
laser-induced native fluorescence (CE-LINF). 
 Each sample was analyzed in triplicate using a laboratory-built CE-LINF instrument 
equipped with a wavelength-resolved detector similar to that previously described (Fuller et al., 
1998; Squires et al., 2007).  Briefly, 10 nl of the supernatant was hydrodynamically injected into 
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a fused silica capillary and 21 kV applied for separation.  Eluting analytes were excited via 264 
nm radiation from a frequency-doubled argon ion laser.  The native fluorescence was collected 
and the spectrum imaged onto a CCD array where it was recorded at a rate of 2 Hz.   The peaks 
resulting from the elution of serotonin were identified by comparison of both retention time and 
fluorescence characteristics to a standard of serotonin (Sigma Aldrich, St. Louis MO) spiked into 
extraction matrix. For quantification, the total integrated signal was calculated from the 
electropherograms by comparison to a linear working curve derived from 5 serotonin standards 
of known concentration (15-250 nM) and was then normalized to the weight of dissected 
hippocampal tissue. Outlying data points were removed based on the results of the Q-test.  If 
either of the two section of hippocampus were found to be a statistical outlier the corresponding 
data for the remaining section of hippocampus was removed.  Differences in the populations 
were evaluated by the Kruskal-Wallis non-parametric analysis using Origin 8.0 (Kruskal and 
Wallis, 1952).  We also measured Tyr, and tested for the presence of several serotonin-related 
catabolites [HIAA, serotonin sulfate, HITCA, NAS: see (Squires et al., 2007)].  These catabolites 




For analysis of the effects of SSRI treatment on cell proliferation, sash+/- and sash-/- mice were 
given once daily i.p. injections of fluoxetine hydrochloride for 35d at a dose of 10mg/kg/day 
(concentration of 1 mg/ml saline; Biotrend AG, Zurich) or an equivalent volume of saline 
vehicle.  Novelty suppressed feeding and open field behaviors were assessed following 28 d of 




Radial Arm Maze. For assessment of spatial learning and memory, sash+/- and sash-/- mice were 
tested in the radial arm maze.  Animals were weighed once per day and kept on a slightly 
restricted feeding paradigm to maintain their body weight at 80-85% of their free-feeding weight. 
The radial arm maze was made of black plexiglass with 8 arms extending 50 cm from the center, 
with 16cm high walls.  Racks and other behavioral testing equipment in the room served as 
spatial cues.  Mice were tested twice daily in the maze (2 h and 8 h after lights on). Mice were 
placed into the center of the radial arm maze restricted to a plexiglass cylinder for 15 s. The 
cylinder was then lifted and the session began, lasting 10 min or until all rewards were retrieved 
and eaten.  Each session was videotaped and the maze was wiped down with 70% ethanol 
following each animal.  Mice were given three habituation sessions during which pieces of fruit 
loops were scattered throughout the maze and then placed at the end of each arm.  Mice were 
given 20 training trials in which 3 arms (#s 3,6,8) were baited with fruit loop pieces.  Each arm 
entered was noted, as well as latency to enter the first arm and latency to retrieve each arm.  
Other behaviors recorded include grooming, rearing, investigation of potential food location 
(weigh-boat), and scratching/biting weigh-boat.  None of these behaviors were significantly 
different between genotypes and are therefore not reported here.  Following the 20 training 
sessions, a reversal trial was performed in which 3 different arms were baited and the same 
measures recorded.  An entry into an arm was counted as an error if the mouse had already 
entered that arm during the trial (working memory error), or if the arm did not contain a reward 
(reference memory error).       
Morris Water Maze. For further assessment of hippocampal dependent spatial learning, mice 
were tested in the Morris water maze, adapted for mice (Morris, 1984).  A 150 cm diameter 
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round pool was filled with water (25°C, 10 cm deep) and made opaque by the addition of non-
toxic white tempera paint.  Four black and white patterns (small checked, large vertical stripes, 
small horizontal stripes, large circle) on 8½x11” paper were placed on the inside wall of the 
Morris water maze to serve as spatial cues.  Mice were subject to 4 trials daily, for 9 days.  Mice 
were videotaped during each trial (Sony Handycam) and CleverSys software was used for 
analysis of swim path and time spent in each quadrant. 
 Mice were placed in the pool at each of 4 drop points (N, E, S, W) randomized between 
days, but kept consistent for all animals within a given day.  A basic black and white patterned 
cue was placed at each of the 4 drop points above the water line to serve as spatial cues.  A 
plexiglass platform (10x10 cm) was weighted down and placed in the center of a quadrant.  Time 
to reach the platform was recorded for each trial (escape latency) in seconds.  Mice were allowed 
90 s to reach the platform, on which they had to remain for 5 s before being removed by the 
experimenter.  If a mouse did not reach the platform within the 90 s, a latency of 90 s was 
assigned and the mouse was gently guided by the experimenter to bump into and climb onto the 
platform, before being removed from the water.  A visible platform was used on the first day for 
shaping trials.  It was elevated 1cm from the water surface and clearly marked with a flag.  On 
the next 4 days, a platform hidden 1 cm below the water surface was placed in the same location 
within the pool. On the 6th day, a single probe trial was run; the platform was removed from the 
pool and the time spent in that quadrant was measured.  On days 7-9, visible platform trials were 
run to assess non-spatial deficits such as swimming performance or sensory perception.  In these 
trials the platform was elevated 1cm above the water surface and marked with a flag; mice were 
always placed in the pool at the E drop point, and the location of the platform placement was 
varied among the center of each of the quadrants.   
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Statistics 
Two-tailed Student’s t-tests were used to compare hippocampal volume measurements, BrdU+ 
cell counts and DCX staining area between genotypes.  If the test for normality failed, a Mann-
Whitney Rank Sum Test was run.  Two-way ANOVAs were used to assess effects of genotype 
and trial in behavioral experiments, and also effects of genotype and treatment in the SSRI 
experiment. Tukey’s HSD was used for post hoc testing when appropriate.  A two-way repeated 
measure ANOVA was performed on Morris water maze data in the enrichment experiment.  
Specific one-way ANOVAs were performed for pair-wise comparisons when main effects or 
interactions were significant.  
 
Results  
Mast cell location relative to the hippocampus 
 The number of mast cells located within or nearby the hippocampus over six 
developmental ages and in adults were re-analyzed from the study of mast cell distribution 
presented in Chapter 2.  The data show that mast cells are located in large numbers nearby and 
within the hippocampus from PN1 (Fig 1A).  As development progresses, the number of mast 
cells within the hippocampus decreases and reaches the mature adult state at around 2 weeks of 
age.  In contrast, mast cells located nearby the hippocampus are very few in number at PN1 and 
increase throughout development peaking around PN12 and remaining moderately high 
throughout the rest of development into adulthood (Fig 1B).  
 Mast cells are preferentially associated with the hippocampus compared to other brain 
regions in early development (Fig 1C).  During PN1-5, ~25% of all brain mast cells are located 
nearby or within the hippocampus.   This percentage decreases by PN9, and remains at around 
131 
5% through adulthood.  Specifically, mast cells are located near more caudal regions of the 
hippocampus in adulthood (Fig 1D).  The preferential presence of brain mast cells near the 
hippocampus during development suggests that they may be playing a role in the development 
and maturation of hippocampal circuits and plasticity.   
 
Figure 1. Mast cell location in relation to the hippocampus. (A) Mast cells (blue dots) are shown in relation to the 
hippocampus (shaded red) at PN1 (left) and adulthood (right).  (B) The number of hippocampal-associated mast cells 
is shown throughout developmental ages PN1-21 and in adulthood.  Mast cells are classified as being within (in the 
parencyhma) or nearby (in meninges or choroid plexus).  (C) The percent of hippocampal-associated mast cells out of 
the totalnumber of intracranial mast cells is shown throughout development and in adults. (D) Localization of mast 
cells in the mouse brain is plotted on four representative coronal brain atlas maps.  Each dot represents the location of 





















































































































































Cell Proliferation  
 Cell proliferation in the hippocampus was assessed by incorporation of BrdU into 
dividing cells.  There was a 43.5% reduction in the number of proliferating cells in the granule 
cell layer (GCL) of the DG in sash-/- mice compared to sash+/- littermates, over several rostral-
caudal levels (Fig 2A-C).  Counts of the number of BrdU+ cells in the DG revealed decreased 
numbers, in sash-/- mice (n=9) compared to sash+/- controls (n=12) (75.2±15.0 vs. 133.1±14.7; 
t19=2.73, p<0.05; Fig 2C).  There were no significant effects of genotype on cell proliferation in 
the SVZ where sash+/- mice had 356.1±34.0 while sash-/- mice had 371.8±20.6 BrdU+ cells (Fig 











































































Figure 2. Cell proliferation in dentate gyrus and subventricular zone in sash+/- and sash-/- mice. (A) 
Representative photomicrographs show BrdU staining in the dentate gyrus (bregma -1.8).  (B) The number of BrdU+ 
cells is shown across the rostral-caudal extent of the dentate gyrus.  (C) Histogram shows BrdU+ cells summed over 
the rostral-caudal extent of the dentate gyrus. (D) Representative photomicrographs of BrdU staining in the SVZ are 












































































Immature neurons in the dentate gyrus – Doublecortin staining 
 Staining for DCX, a marker of immature neurons, was performed to determine if the 
reduction in cell proliferation extended to neurons (Fig 3A). Consistent with the deficit in cell 
proliferation, sash-/- mice (n=8) had reduced DCX immunoreactivity compared to sash+/- controls 
(n=8), with a total area of staining of 0.08±0.01mm2 in sash-/- mice compared to 0.11±0.01 mm2 
in sash+/- controls (Fig 3B; t14=3.06, p<0.01).  This percent reduction in DCX staining was 
comparable to that seen in cell proliferation between genotypes. 


























Figure 3. Number of immature neurons in dentate gyrus in sash+/- and sash-/- mice. (A) Representative 
photomicrographs of DCX staining of the dentate gyrus are shown. (B) Area of DCX staining in the dentate gyrus 




























Cell Survival and phenotype 
 There was a 26.8% reduction in the number of cells surviving in the GCL of the DG after 
28 days in sash-/- mice (n=9) compared to sash+/- controls (n=8; t15=2.38; p<0.05; Fig 4A).  This 
reduction is likely the result of the decreased number of cells born.  The deficit in sash-/- mice is 
reduced from 43.5% less proliferation to 26.8% less survival (F1,34=4.73, p<0.05),  indicating 
possible compensation in sash-/- mice which allows a higher percentage of surviving cells. 
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 BrdU and NeuN co-localization was examined to determine if differentiation of new cells 
in the dentate gyrus was affected in sash-/- mice (Fig 4B).  In sash-/- mice (n=9), 63.4±2.8% of 
BrdU labeled cells were NeuN positive, compared to 51.9±4.6% in sash+/- mice (n=8; t15=1.76; 
p=0.11).  Although this difference was not statistically significant, this suggestive increase in 
BrdU+NeuN+ cells in sash-/- mice may represent a compensatory increase in neuron fate due to 
the overall reduction in cell proliferation.  There were no significant effects of genotype on 
cell survival in the olfactory bulb (Fig 4C, D).  Sash+/- (n=9) and sash-/- (n=8) mice had similar 
number of BrdU+ cells per 100 micron cube of tissue within the granular cell layer of the 
olfactory bulb, 34.67±1.53 and 34.29±0.98 respectively (t15=0.2, p>0.05).   















































































Figure 4. Survival and differentiation of cells in dentate gyrus and olfactory bulb in sash+/-
and sash-/- mice. (A) Histogram show the number of surviving BrdU+ cells in the dentate gyrus, 
28d after BrdU injection. (B) Histogram shows  the percent of BrdU+ surviving cells that were also 
NeuN+. (C) Representative photomicrographs show BrdU staining in the olfactory bulb. (D) 





























































 The volume of the GCL of the DG in sash-/- mice is reduced by 12.9% compared to 
littermate sash+/- controls. The granule cell layer in sash-/- mice (n=8) was an average of 
0.192±0.005 mm3 compared to that of sash+/- control mice (n=10) at 0.221±0.007 mm3 (t16=3.22; 
p<0.01).  There was no difference in the volume of the CA1-CA3 region of the hippocampus in 
sash-/- mice compared to sash+/- controls, with volumes of 0.49±0.03 and 0.47±0.02 mm3, 
respectively (t16=0.94; p>0.05).  
                                             
Mast cell effects on levels of trophic factors in the hippocampus 
 Levels of NGF in the hippocampus were not significantly different between sash+/- (n=6) 
and sash-/- (n=6) mice at any of the three rostral-caudal levels measured (Fig 5A).  H1 (the most 
rostral) and H3 (the most caudal) levels were slightly, but not significantly elevated in sash-/- 
mice compared to sash+/- mice (t10=1.56, p=0.14 & t10=1.99, p=0.08 respectively).  There was no 
significant difference between sash+/- and sash-/- mice in the levels of NGF protein at the H2 
(mid) level (t10=1.07, p>0.05). Additionally there were no significant effects of genotype on the 
levels of BDNF protein in the hippocampus (Fig 5B).  Levels of BDNF in sash+/- (n=6) mice did 
not differ from sash-/- (n=6) mice in any of the three rostral to caudal levels of the hippocampus 
(H1: t10=0.16; H2: t9=1.30; H3: t9=1.41; for all tests p>0.05).   
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Figure 5. Levels of neurotrophic factors in the hippocampus of sash+/-
and sash-/- mice. Levels of NGF protein in sash+/- and sash-/- mice are 
shown at 3 rostral-caudal levels of the hippocampus – H1 (rostral), H2 (mid) 
and H3 (caudal).  There are no significant differences in the levels of NGF 
between genotypes at any level of the hippocampus. Levels of BDNF protein in 

















































































Mast cell contribution of serotonin to the hippocampus 
 To investigate mast cell contribution of serotonin to the hippocampus, mast cells in brain 
slices were activated by application of C48/80.  The total serotonin content was subsequently 
measured at two rostro-caudal levels of the hippocampus using CE-LINF detection.   The 
instrument built by the Sweedler Laboratory (University of Illinois, Urbana-Champaign) allows 
for the trace analysis of natively fluorescence analytes from very small volume samples, and is 
well suited for characterizing trace-levels of indoles in the hippocampus (Fuller et al., 1998; 
Hatcher et al., 2008).  Analysis of both rostral and caudal regions of the hippocampus in sash+/- 
and sash-/- mice revealed that mast cells contribute significantly to the serotonin content in the 
caudal, but not rostral hippocampus (Fig 6).  
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 In the rostral hippocampus, there were no significant differences between sash+/- (n=4) 
and sash-/- (n=5) mice in baseline levels of serotonin, measured following application of Hank’s 
Balanced Salt Solution (HBSS) control vehicle solution (H1=0.00, p>.05; Fig 6A).  Additionally, 
following application of C48/80 in HBSS, there were no differences in serotonin content in the 
rostral hippocampus between sash+/- (n=7) and sash-/- (n=7) mice (H1=0.10, p>0.05, Fig 6B).   
 In the caudal hippocampus, there were also no significant differences between sash+/- and 
sash-/- mice in baseline levels of serotonin measured in HBSS vehicle condition (H1=0.02, 
p>0.05).  In contrast, following application of C48/80 to slices containing caudal hippocampus, 
serotonin content in sash+/- (n=7) mice was increased compared to sash-/- (n=8) mice (H1=6.48, 
p<0.05; Fig 6B).  Only the sash+/- mice showed increases in the amount of hippocampal 
serotonin compared to the HBSS vehicle condition.  Approximately 50% more serotonin was 
measured in sash+/- mice compared to sash-/- mice in C48/80 stimulated caudal hippocampus.  
 This represents a dynamic mast cell-mediated increase in serotonin in the hippocampus.  
Interestingly this increase corresponds to the larger population of mast cells resident near the 
caudal vs. rostral hippocampus in adulthood (see Fig 1D) and indicates that degranulation of 
mast cells in brain tissue contributes measurable levels of this neurotransmitter to the 
hippocampal milieu.   When measuring serotonin with the CE-LINF instrument, tyrosine was 
also measured but was not expected to change with mast cell activation.  While a small but 
significant difference was observed between sash+/- and sash-/- animals, the difference between 




Figure 6. Effects of mast cell degranulation on hippocampal serotonin content in mast cell deficient sash+/- and sash-/- mice.  The 
effect on Serotonin content in the rostral (blue) and caudal (red) hippocampus is shown following stimulation with (A) HBSS vehicle or (B) 
C48/80. There were no significant differences between genotypes in either rostral or caudal hippocampus following HBSS vehicle stimulation 
or in rostral hippocampal slices stimulated with C48/80.  However sash+/- but not sash-/- mice showed increases in serotonin in the caudal 













SSRI treatment effects on cell proliferation 
 Given the known effects of SSRI treatment on increasing serotonin signaling and 
neurogenesis in mice (Malberg et al., 2000), the effects of fluoxetine treatment in sash-/- mice 
were assessed. Following 35 days of fluoxetine or saline vehicle injections, cell proliferation was 
measured in sash-/- (n=17) and sash+/- (n=16) mice.  The deficit in cell proliferation in sash-/- mice 
(seen in Figure 2), was replicated in saline-treated animals - sash-/- mice had a ~40% reduction in 
the number of BrdU+ cells compared to sash+/- mice (t13=4.05, p<0.01; Fig 7A).  Fluoxetine 
treatment resulted in an increase of BrdU+ cells in both genotypes (F1,29=15.9, p<0.01). 
Fluoxetine increased the number of BrdU+ cells in the dentate gyrus from 62.0±4.4 to 90.2±13.5 
in sash+/- mice (Mann-Whitney, p<0.05) and from 36.4±4.5 to 107.8±17.4 in sash-/- mice 
(t15=3.76, p<0.01). This indicates that sash-/- mice can sustain normal cell proliferation in the DG.  
There was no significant effect of genotype on the number of BrdU+ cells in fluoxetine-treated 
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mice (t16=0.80, p>0.05).  There was a suggestive, but non-significant interaction of genotype and 
treatment (F1,29=2.99; p=0.09).   
 DCX immunoreactivity revealed a similar pattern to the effect of fluoxetine on the 
number BrdU+ cells (Fig 7B).  Fluoxetine treatment increased DCX staining regardless of 
genotype (F1,29=8.43; p<0.01) from 0.10±0.01 to 0.18±0.03 mm2 in sash+/- and from 0.07±0.01 to 
0.19±0.04mm2 in sash-/- mice (t15=2.71, p<0.05).  SSRI treatment increased DCX staining in 
sash-/- mice more than in sash+/- mice resulting in no significant genotype effects following 
treatment (t16=0.41, p>0.05).   
 
Enriched housing effects on cell proliferation 
 Since enriched housing conditions are known to increase hippocampal neurogenesis and 
hippocampal-dependent behaviors (van Praag et al., 1999; Brown et al., 2003), the effects of 
enrichment were also assessed in sash+/- and sash-/- mice (Fig 7C).  There was a main effect 
genotype on cell proliferation (F1,26=4.3, p<0.05).  In standard housing conditions, lower levels 
of cell proliferation were seen in sash-/- mice, as expected.  Standard-housed sash+/- mice (n=7) 
had an average of 78.4±5.2 BrdU+ cells compared to 63.3±3.9 in standard-housed sash-/- mice 
(n=6; t11=2.27, p<0.05).  Enriched housing increased the number of BrdU+ cells in both 
genotypes (F1,26=29.8, p<0.01), increasing the number of BrdU+ cells to 110.6±6.7 in enriched 
sash+/- mice (n=10; t15=3.62, p<0.01), and to 99.6±7.4 in sash-/- mice (n=7; t11=4.34, p<0.01).  
There was no significant difference in the number of BrdU+ cells between genotypes in the 
enriched housing condition (t14=1.07, p>0.05), and no significant interaction of genotype and 
housing condition (F1,25=0.11, p>0.05).  
 Enriched housing also increased DCX staining in both genotypes (Fig 7D; F1,26=24.94, 
p<0.01).  The reduction in DCX staining in sash-/- mice was replicated in standard housing 
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conditions, with sash-/- mice having about 40% less DCX staining (t11=3.15, p<0.01).  Enriched 
housing in sash+/- mice increased DCX staining to 0.22±0.2 mm2 from 0.16±0.02 mm2 in 
standard housed conditions (t15=2.61, p<0.05).  Enrichment also increased DCX staining in sash-
/- mice from standard housing (0.19±0.2 vs. 0.09±0.1mm2; t11=4.60, p<0.01).  There was no 





















































Figure 7. SSRI treatment and enriched housing effects on neurogenesis in sash+/- and sash-/- mice. (A) The number of BrdU+ cells and 
(B) the area of DCX staining is shown in response to saline and SSRI treatment. Different lowercase letters above the histogram bars indicate 
instances of statistically significant differences. (C) The number of BrdU+ cells and (D) the area of DCX staining is shown in response to 



























































Radial Arm Maze 
 Sash-/- mice showed deficits in hippocampal dependent learning and memory in the radial 
arm maze (Fig 8A).  Both sash-/- (n=4) and sash+/- (n=5) controls reduced the number of errors 
made over the 5 training blocks (4 training trials were averaged to make a training block) 
suggesting that mice learned to locate the rewards (Fig 8A; F5,35=12.42, p<0.05).  There were no 
significant differences between genotypes on the number of errors made during the training 
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(F1,35=0.06, p>0.05).  During the last training block, sash+/- mice made on average 4.2±0.5 errors, 
and sash-/- mice made on average 3.9±0.5 errors.  Collapsed across genotypes there was a 
decrease in the amount of time taken to retrieve all rewards over the 5 training blocks 
(F5,35=9.51; p<0.05), however there was no effect of genotype (F1,35=0.49; p>0.05).   
 On the reversal trial, sash+/- mice had an increase in the number of errors compared to the 
last training block indicating that they learned the location of the rewards.  However, the number 
of errors that sash-/- mice made did not increase.  Sash-/- mice made on average 4.3±0.3 errors 
while sash+/- mice made 7.2±1.3 (F1,14=4.31, p=0.057) during the reversal trial.  Interestingly, the 
lack of increase in the number of errors in the sash-/- mice indicates that they may not have 
learned the location of the rewards based on spatial cues.  Rather, their “successful” performance 
with minimal errors may be due to a learned search strategy.  Analysis of the pattern of arm 
entries in sash-/- mice reveals a serial search behavior (Fig 8B).  We define an exact match serial 
search as entering successive arms in a clockwise or counter clockwise fashion during a single 
trial.  Over 21 trials (training+reversal), sash-/- mice carried out an exact match serial search 
30.9% of the time while control mice did so only 1.9% of the time (t7=2.43, p<0.05).  
 
Morris Water Maze 
 Sash-/- mice also showed impaired learning and memory in the Morris water maze test of 
hippocampus dependent spatial learning (Fig 8C).  Compared to sash+/- mice (n=9), sash-/- mice 
(n=8) took longer to reach the hidden platform (Fig 8C; F1,59=5.61, p<0.05).  By the 5th day, 
sash+/- mice reached the platform in 13±5 s while sash-/- mice took 31±6 s (t15=2.04, p=0.059).  
Collapsed across both genotypes, the escape latency decreased over days (main effect of time; 
F4,59=17.05, p<0.01).  There was no significant difference between genotypes in escape latency 
in the visible platform trials indicating competence in motor and sensory systems in sash-/- mice.  
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Performance during the probe trial indicates impairments in spatial learning and memory 
in sash-/- mice. There is a difference between genotypes in the amount of time spent in each 
quadrant (sash+/- vs. sash-/-: t15=2.45, p<0.05; Fig 8D).  Sash+/- mice spent significantly more of 
their time in the target quadrant compared to the other three (42%; F3,32=20.81, p<0.01).  In 
contrast, sash-/- mice spent only 28% of their time in the target quadrant which is the same as the 
amount of time spent in any other quadrant (F3.28=0.94, p>0.05; Fig 8E) indicating a lack of 
learning and/or memory of the location of the platform which is consistent with a reference 
































































































Figure 8. Spatial memory in sash+/- and sash-/- mice in radial arm and Morris water mazes. (A) The number of 
errors over trials in the radial arm maze are shown for the training and reversal trials. (B) The percentage of trials in 
which mice performed a serial search is shown. (C) Escape latency in the Morris water maze is shown over hidden and 
visible platform trials.  (D) Representative samples depicting swim paths during the probe trial of sash+/- and sash-/-
mice are shown.  Dashed lines demarcate quadrants and the grey box indicates the location of the platform during 
training.  (E) Percent of time spent in each quadrant of the pool during the probe trial is shown for sash+/- and sash-/-






















































































Enrichment effects on Morris Water Maze 
 Enriched housing with running wheels, social interaction, nesting areas and toys is known 
to increase performance in hippocampal associated behaviors (van Praag et al., 1999; Brown et 
al., 2003).  The deficit in the performance of sash-/- mice in the Morris water maze was 
ameliorated by enriched housing conditions (Fig 9).  There were effects of genotype (F1,26=7.7, 
p<0.05), housing (F1,26=7.0, p<0.05), and trial (F1,104=115.6,p<0.01) as well as a significant 
interaction of trial x genotype x housing (F4,104=3.1, p<0.05).  Within mice housed in standard 
conditions, sash-/- mice (n=7) performed worse than sash+/- mice (n=6), taking longer to find the 
platform as previously shown in Fig 8.  By day 3, sash-/- mice took significantly longer to reach 
the platform compared to sash+/-, and this deficit extended through days 4 and 5 (F1,11=7.2, 
p<0.05; F1,11=19,5, p<0.01; F1,11=17.6, p<0.01; respectively).  Sash-/- mice that were housed in an 
enriched environment (n=8) improved performance to reach the platform faster than sash-/- mice 
in standard housing.  Specifically, by day 4, enriched sash-/-mice reach the platform 20s faster 
than standard housed sash-/- mice, in 13±3 s (F1,13=6.7, p<0.05).   By day 5, enriched sash-/- mice 
improved to reach the platform in 11±2 s, again significantly faster than standard housed sash-/- 
mice (F1,13=10.5, p<0.01).  There was no significant difference at any time point between 
enriched sash-/- mice and standard-housed sash+/- mice (F1,12<1.8, p>0.05), suggesting that 
enrichment reversed the deficit seen in sash-/- mice.  The performance of enriched sash+/- mice 
(n=9) was improved on only the first day, compared to standard-housed sash+/- mice and all sash-
/- mice.  They reached the platform in an average of 50±4 s compared to standard-housed sash+/- 
mice who took 75±8 s (F1,13=8.7, p<0.05).  There were no other significant effects of enrichment 
on sash+/- mouse performance (F1,13<3.7, p>0.05).  
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Discussion    
 The results indicate that mast cells 
significantly contribute to several aspects 
of hippocampal function. Mast cells are 
immune cells found in the brain in many 
species (Persinger, 1979; Hough, 1988; 
Lambracht-Hall et al., 1990b; Michaloudi 
et al., 2007) a finding confirmed here for 
mouse hippocampus. Compared to their littermates, mast cell deficient sash-/- mice have reduced 
mast cell derived serotonin in the hippocampus, deficits in spatial learning and decreased 
neurogenesis. Cell proliferation, but not survival or differentiation is affected by the absence of 
mast cells in the mouse.  The mast cell contribution to cell proliferation is localized to the 
hippocampus, and does not affect the SVZ, another neurogenic niche which lacks mast cells. 
Taken together, the results indicate that mast cells contribute to hippocampal physiology and 
function in ways previously ascribed only to neurons. 
 Many of the deficits reported here in sash-/- mice, including behavioral deficits in spatial 
learning and reduced neurogenesis, have been associated with altered serotonin signaling in the 
hippocampus (Lucki, 1998; Gould, 1999; Benninghoff et al., 2010). Mast cells synthesize and 
release serotonin in rodents (Ringvall et al., 2008) and humans  (Kushnir-Sukhov et al., 2007). It 
has previously been shown that application of C48/80, a purported mast cell degranulating agent, 
to brain slices facilitates release of serotonin into the thalamus (Lambracht-Hall et al., 1990a; 
Marathias et al., 1991). Our CE-LINF approach is well suited for quantifying 5-HT and other 























Figure 9. Effects of enriched housing on spatial learning and 
memory. Escape latency in the Morris water maze is shown over 
hidden and visible platform trials in both genotypes housed in 














approach, we show that serotonin levels increase in the hippocampus of sash+/- but not sash-/- 
mice following mast cell activation of caudal hippocampal slices; this change is correlated with 
mast cells due to the co-localization of 5-HT and mast cells in the caudal hippocampus (see Fig 
1).  As a control, we examined Tyr levels; its levels in sash+/- and sash-/- do not change with 
stimulation by C48/80.  Overall, our results confirm a significant contribution of mast cells to the 
pool of serotonin in subregions of the hippocampus. 
 Administration of the SSRI fluoxetine, increases hippocampal serotonin signaling  
(Malberg et al., 2000) and cell proliferation by increasing division of early progenitor cells 
(Encinas et al., 2006).  It has been suggested that mast cells mediate SSRI effects on the 
hippocampus given that they express  the serotonin transporter on their cell surface (Vega and 
Rudolph, 2002) and take up serotonin in vitro (Ferjan and Erjavec, 1996).  Since sash-/- mice 
show increased neurogenesis following chronic SSRI treatment, it is clear that neither mast cells 
nor their chemical mediators are necessary for SSRI-induced increases in hippocampal 
neurogenesis.   This result supports the hypothesis that mast cell derived serotonin contributes to 
the maintenance of hippocampal neurogenesis.   
 The increases in cell proliferation seen in sash-/- mice following chronic fluoxetine 
treatment are comparable to that of their sash+/- littermates and C57BL/6 wild-type mice in 
general (Santarelli et al., 2003; Navailles et al., 2008). Thus, the reduction in neurogenesis in 
sash-/- mice is not due to a defect in progenitor cells themselves or in their responses to 
serotonergic signaling.  We note that following SSRI treatment, sash-/- mice show a trend toward 
greater increases in cell proliferation than sash+/- mice, perhaps mediated by an increased 
sensitivity to the elevated serotonin levels. This may result from an increase in 5-HT1A or 5-
HT2C receptor expression, receptors known to subserve serotonin-mediated increases in 
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neurogenesis (Benninghoff et al., 2010).  As previously reported for the C57BL/6 strain 
(Crowley et al., 2005; Sugimoto et al., 2008), we found no effect of SSRI treatment on 
depressive behaviors (data not shown).   
  It has been suggested that neurogenesis is required for the behavioral efficacy of SSRI 
antidepressants (Santarelli et al., 2003). Spatial learning and memory tasks have been linked to 
neurogenesis as well; however the deficits in performance by sash-/- mice on these tasks are more 
profound than previously reported in studies of neurogenesis ablation.  Generally, following 
ablation of adult hippocampal neurogenesis, there is little to no effect on acquisition of 
hippocampal dependent spatial learning and memory tasks such as the Morris water maze, radial 
arm maze and Y-maze (Snyder et al., 2005; Saxe et al., 2006; Saxe et al., 2007; Clark et al., 
2008).  Even in studies where deficits are reported (Zhang et al., 2008), they are much smaller in 
comparison to the behavioral deficits we see in sash-/- mice.  Genetic ablation of neurogenesis 
can produce major deficits in performance on spatial learning and memory tasks, however these 
manipulations arrest cell division throughout the entire brain (Garthe et al., 2009), while the 
effects on neurogenesis reported here are restricted to the hippocampus.  Possibly, the profound 
deficits in the sash-/- mouse deficits in spatial learning and memory revealed here, as well as in 
previously described emotionality behaviors (Nautiyal et al., 2008), result from the absence of 
mast cell mediators, and the consequent reduction in neurogenesis throughout development. This 
contribution of mast cells to development may even extend to pre-natal development, as mast 
cells are known to be localized to the placenta (Purcell and Hanahoe, 1991).  To our knowledge, 
all prior studies have focused on the effects of adult neurogenesis and this is the first examination 
of the effects of reduction of hippocampal neurogenesis starting early in development.   
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 While some studies report that deficits in the Morris water maze and radial arm maze are 
due to increased anxiety (D'Hooge and De Deyn, 2001), this does not seem to be an appropriate 
interpretation of the results presented here.  Given that previous results show increased anxiety-
like behavior in sash-/- mice in the open field and elevated plus maze (see Chapter 3), this was 
an important possibility to explore.  There were no differences between genotypes in anxiety-like 
behavior in the Morris water maze or radial arm maze as measured by thigmotaxis and total 
number of arms entered, respectively.   
 Our results show that enriched housing causes recovery of the neurogenesis deficits seen 
in sash-/- mice.  Interestingly, enriched housing was sufficient to also ameliorate the deficits in 
spatial learning and memory in sash-/- mice.  This is likely the result of enrichment effects on a 
variety of aspects of hippocampal function, and not just hippocampal neurogenesis.  Previous 
studies have shown that neurogenesis is not required for the behavioral effects of enriched 
housing (Meshi et al., 2006).  Enrichment causes increases in a number of trophic factors, 
including increases in the serotonergic precursor, tryptophan (Chaouloff et al., 1989; Olson et al., 
2006).  It is possible that enriched housing in sash-/- mice increases neuronally-derived serotonin 
via the increased tryptophan.  This may compensate for the deficit in mast cells by restoring 
levels of hippocampal serotonin to normal levels present in mast-cell competent mice.  It is also 
possible that enrichment is causing beneficial changes in the hippocampal milieu of sash-/- mice 
that are unrelated to the primary deficits caused by a lack of mast cells.  Given that neural 
systems mediating behavior are redundant, effects on multiple pathways can have similar 
consequences on behavioral output.   
In addition to serotonin, mast cell have the potential to release many other neuro- and 
vaso- active mediators (Marshall, 2004). For example, mast cell derived trophic factors including 
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nerve growth factor, fibroblast growth factor and vascular endothelial growth factor have all 
been implicated in hippocampal neurogenesis and cognition, anxiety or depression behaviors 
(Levi-Montalcini et al., 1996; Jin et al., 2002; Cao et al., 2004; Frielingsdorf et al., 2007; Udo et 
al., 2008; Mudo et al., 2009; Perez et al., 2009).   While we found no effect of mast cell 
deficiency on nerve growth factor and brain derived neurotrophic factor, the effects of other mast 
cell mediators on the hippocampal milieu remains to be assessed.    
 Taken together, the data suggest that mast cells are present in the brain throughout 
development, they contribute serotonin and possibly other mediators to nearby tissue and, based 
on the effects of their lack, they profoundly affect cell survival, neurogenesis, and behavior. 
Overall these data point to a striking instance of an immune system cell contribution to normal 
brain development and extend the existing body of work  showing that such cells and their 
signaling molecules  contribute to normal hippocampal function (Raison et al., 2006; Goshen et 
al., 2008; Koo and Duman, 2008). The consequences of inadequate immune activation during 
development may include an increased prevalence of hippocampus-related behavioral disorders, 
including anxiety and depression reviewed in  (Rook and Lowry, 2008).  
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 The results presented in this thesis suggest that brain mast cells have a functional 
role regulating brain physiology and behavior in the mouse.  Mast cells are present in the 
mouse brain from birth through adulthood and functionally contribute to brain 
neurochemistry (Chapter 2).  Additional data presented in Chapter 2 contribute to the 
development of a mouse model to study the functional role of mast cells in the adult 
mouse brain.  Given that mast cells are recruited to the brain following stressors 
(Bugajski et al., 1994; Cirulli et al., 1998), my hypothesis was that they had some role in 
regulating behavioral responses to stress through interactions with neural systems.  This 
argument is supported by the discovery that mast cell deficient mice have increased 
levels of anxiety-like behavior and stress-induced defecation, presented in Chapter 3 
(Nautiyal et al., 2008).  Given strong evidence showing that mast cells are activated by 
stressors via CRH receptors (Theoharides et al., 1995; Cao et al., 2005), it was surprising 
that no differences in HPA reactivity were seen in mast cell deficient mice, as described 
in Chapter 4.  Instead, the increased stress reactivity and additional cognitive deficits may 
be mediated by mast cell impact on the hippocampus as shown in Chapter 5.  The 
hippocampus is a site of negative feedback to the HPA axis and can also affect anxiety 
behavior via projections to the amygdala.   
 The results presented in this thesis present a novel role for mast cells by showing 
that a lack of mast cells has profound effects on brain neurochemistry, physiology and 
function.  Additional data not included in this dissertation (Nautiyal et al., 2009) shows 
that a lack of mast cells has some small effects on the immune response.  Mast cell 
deficient mice have abnormal thermoregulatory responses to a high dose of 
lipopolysaccharide modeling sepsis.  While the impact of a lack of mast cells on sepsis is 
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expected (Echtenacher et al., 1996; Mallen-St Clair et al., 2004), the data showing that 
mast cells affect brain and behavior is novel.  
 
Serotonergic contribution of mast cells 
 Mast cells contribute serotonin and affect hippocampal physiology and function.  
More specifically, a lack of mast cells causes deficits in hippocampal neurogenesis and 
hippocampal-dependent spatial learning and memory.  One way in which mast cells 
could regulate these functions is through contribution of hippocampal serotonin which 
has effects on learning and memory and emotionality behavior (Olds and Olds, 1969; 
Santarelli et al., 2003; Deltheil et al., 2008).  Results presented in Chapter 5 show that 
mast cell degranulation causes increases in hippocampal serotonin.  Given that 
hippocampal serotonin is also implicated in the regulation of anxiety behavior (Olds and 
Olds, 1969), serotonin is a potential mediator of the mast cell impact on behavior seen in 
Chapter 3.   
Additionally, a recent study in humans suggests that mast cell-derived serotonin 
plays a role in regulating emotionality (Kushnir-Sukhov et al., 2008).  Patients diagnosed 
with mastocytosis, a disease characterized by a profound abnormality and/or increase in 
mast cells in the body, underwent clinical assessment and blood collection for 
measurement of serotonin.  The clinical assessment included a screen for psychiatric 
symptoms including depression, anxiety, emotional instability, and memory loss.   Blood 
serotonin levels were significantly correlated with psychiatric assessment, with low 
serotonin levels predicting more clinical psychiatric symptoms.   The actions of serotonin 
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on these psychiatric symptoms could be mediated through serotonergic signaling in the 
hippocampus. 
 There are a variety of ways in which serotonin can act on the hippocampus in 
order to influence hippocampal physiology and hippocampus dependent behavior (Jacobs 
and Azmitia, 1992).  Serotonin can act as a transmitter in the hippocampus, to impact 
behavior “on-line” (Olds and Olds, 1969; Jacobs and Fornal, 1999) or as a trophic factor 
during development and adulthood (Azmitia and Whitaker-Azmitia, 1991; Gould, 1999).  
It is possible that mast cell-derived serotonin plays a part in all of these mechanisms. 
 
Serotonin as a neurotransmitter  
 It was suggested as far back as the 1960s that serotonin should be considered as a 
major neurotransmitter involved in emotional behavior (Sudak and Maas, 1964).  Since 
then, decades of research clearly show that manipulation of serotonergic transmission 
alters emotional reactivity, specifically indices of anxiety behavior (reviewed in Griebel, 
1995)).  Stimulation of each of the serotonin receptor (5-HT R) subtypes 1A, 2A, 2C and 
3, has been implicated in modulation of anxiety, and increases in serotonin transmission 
decrease anxiety. This is consistent with the data in Chapter 3 which suggests that mast 
cells can mediate behavior in an acute manner.  By blocking degranulation of brain mast 
cells in adulthood, direct effects on anxiety-like behavior were seen.  However, since the 
data presented in Chapter 4 show no significant differences in HPA signaling in mast cell 
deficient mice, it is possible that mast cells affect anxiety-like behavior through 
serotonergic signaling in the hippocampus.    
158 
Serotonin in the hippocampus has roles as a neurotransmitter in regulating the 
response to stressors.  Correlative evidence shows that levels of serotonin in the ventral 
hippocampus increase during exposure to a stressor, suggesting a role in the response to 
stress (Rex et al., 2005).  Increases in firing rate of serotonergic neurons and extracellular 
levels of serotonin at their axon terminals are also correlated with increased anxiety-like  
behavior (Jacobs and Azmitia, 1992).  These associations are well characterized, as 
studies have eliminated many non-stress related hypotheses that could account for the 
correlation, such as general arousal (Jacobs and Azmitia, 1992), motor activity or 
enhanced vigilance (Jacobs and Fornal, 1999).  However, since the mechanisms of stress-
induced increases in serotonergic signaling are unknown, the implication of mast cells as 
a vehicle for these effects is possible. 
Hippocampal serotonin in the context of stress responses has effects on the 
resulting behavioral response by increasing the strength of the hippocampal corticoid 
negative feedback.  The HPA axis receives negative feedback from the hippocampus 
following stimulation of corticosterone receptors like glucocorticoid receptors (GR) and 
mineralcorticoid receptors (MR).    Chronic increases in serotonin causes increases in GR 
and MR mRNA and protein expression in primary hippocampal cell cultures (Lai et al., 
2003). The GR expression is, in part, mediated by 5-HT1A receptor binding and the MR 
expression is blocked by administration of a 5-HT7 receptor antagonist.  In vivo, repeated 
stress results in increased levels of GR in the hippocampus which is reversed by blockade 
of serotonin receptors or deafferentation of hippocampal serotonin (Robertson et al., 
2005).   
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Serotonin as a trophic factor in adulthood  
While the role of hippocampal serotonin signaling in regulating anxiety and 
depression has been known for decades (Olds and Olds, 1969), more recently serotonin’s 
role as a trophic factor for hippocampal neurogenesis (Gould, 1999) has drawn attention 
in the context of anti-depressant treatment (Sahay and Hen, 2007).  SSRIs reduce 
reuptake of serotonin released at nerve terminals by blocking serotonin transporters 
(SERT) on pre-synaptic nerve terminals, resulting in increases in serotonin in the 
synaptic cleft and therefore increased binding to post-synaptic receptors.  While this 
increase in serotonin signaling occurs following acute administration of the drug, 
behavioral efficacy of antidepressant treatment requires chronic treatment.  A recent 
hypothesis explains this temporal discrepancy between neurochemistry and behavioral 
change by attributing changes in behavior to increases in neurogenesis which requires a 
longer time course.  The latency accounts for the time necessary for a newly divided cell 
to mature, migrate and become incorporated into existing hippocampal neural circuits 
(Sahay and Hen, 2008).  The neurogenic hypothesis of depression and anxiety (Jacobs et 
al., 2000) is supported by data showing that serotonin acting antidepressants increase 
hippocampal neurogenesis (Malberg et al., 2000).  Both the number of new cells born and 
the survival rate of the new cells is increased following chronic antidepressant treatment 
(Sahay and Hen, 2007).  These effects are blocked by co-administration of serotonin 
receptor antagonists.  Furthermore evidence shows that increases in neurogenesis are 
necessary for the behavioral effects of antidepressants.  For example, ablation of 
hippocampal progenitor cells by focal x-irradiation blocks the antidepressant and 
anxiolytic effects of SSRIs (Santarelli et al., 2003).  Although these studies have 
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elucidated a link between neurogenesis and depression, they have also prompted the 
search for evidence that hippocampal adult neurogenesis is involved in the etiology of 
depression.  This converse of the neurogenic hypothesis remains contentious, as some 
studies show that depression is not correlated with reduced cell proliferation (Reif et al., 
2006) and others retort that measurement of one stage of neurogenesis is not enough to 
discount the neurogenic hypothesis (Plumpe et al., 2006).   
 Studies assessing adult hippocampal neurogenesis in Chapter 5 led to the 
hypothesis that mast cells were contributing to the maintenance of adult hippocampal 
resulting in deficits in neurogenesis-dependent cognition and affective behavior.  Mast 
cells act as a reservoir of trophic factors in adulthood and functionally contribute 
serotonin and potentially other trophic agents, like nerve growth factor that promote the 
proliferation and survival or neural stem cells in the hippocampus.  Mast cell involvement 
in the regulation of hippocampal neurogenesis is one way in which mast cells affect the 
longer-term regulation of emotionality.  It is possible that during normal physiology, mast 
cell mediators in the brain act as “endogenous SSRI antidepressants” to help to maintain 
normal levels of hippocampal neurogenesis.  In this way a lack of mast cells would lead 
to reduced neurogenesis, potentially mediating the anxious phenotype.  This would result 
in mast cell impact on behavior occurring over the longer term (in the order of weeks) by 
impacting the proliferation of new neurons which aren’t functional until around 28 days 
after their birth.  This delayed efficacy is in contrast to studies presented in Chapter 3, 
which use the pharmacological mast cell loss-of-function model, and suggest that mast 
cells regulate behavior acutely.  It seems plausible that mast cell derived serotonin is 
acting both as a transmitter to fulfill an acute role of mast cells in the brain, as well as a 
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trophic factor to have longer term and possibly even developmental effects on the 
hippocampus.   
 
Serotonin as a trophic factor in development  
Serotonin is a trophic factor important for normal embryonic and postnatal 
development (Gaspar et al., 2003).  Serotonin is present in the brain of neonatal rats, 
rising sharply before birth and steadily thereafter from 1 week of age until adulthood 
(Baker and Quay, 1969).  The pattern in the mouse brain is similar.  This serotonin source 
is attributed to neurons from the raphe that differentiate and begin synthesizing serotonin 
prenatally and send axons to the forebrain (Lauder et al., 1982).  Furthermore, inhibition 
of serotonin in raphe neurons early in development results in delayed cell differentiation 
in the forebrain (Lauder and Krebs, 1978).  In vitro, serotonin promotes synaptogenesis 
and glia proliferation in hippocampus explants (Gromova et al., 1983).  In vivo, serotonin 
depletion at postnatal day three causes large reductions in dendritic spines on granule 
cells in the adult dentate gyrus of the hippocampus (Yan et al., 1997).   
Given the degree of severity of the spatial learning and memory deficits seen in 
the sash-/- mice in Chapter 5, it is plausible that mast cell derived serotonin is impacting 
the development of neural circuits responsible for cognition and affect.  This hypothesis 
of mechanism extends from the fact that the deficits seen in the Morris water maze and 
radial arm maze are larger than expected from a 40% reduction in adult hippocampal 
neurogenesis.  Complete ablation of adult hippocampal neurogenesis does not have such 
profound effects on spatial learning and memory (Snyder et al., 2005; Saxe et al., 2006; 
Clark et al., 2008).  This therefore, led us to consider a developmental model of mast cell 
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impact on hippocampal dependent behavior. This points to the potential unstudied effects 
of a reduction in hippocampal neurogenesis starting at an early time-point in 
development.  No studies to date have investigated the effects of the ablation of 
hippocampal neurogenesis from birth or any developmental age.  Since mast cells are 
located in the brain, near the hippocampus, from birth (see Chapter 2), it is possible that 
mast cells are contributing to the development, maturation and organization of 
hippocampal neural circuits that mediate adult behavior.  
This developmental hypothesis fits with a growing literature describing immune 
cell impact on brain development, especially with regards to the hippocampus.  The 
adaptive immune system is not functional to defend against pathogens until around the 
third week in postnatal mouse development; however, there are a number of immune 
cells and signaling molecules present in the brain before this time (Helmuth, 2000; 
Boulanger and Shatz, 2004).  This and other evidence initially suggested the hypothesis 
that the immune system may be involved in brain development (Huh et al., 2000; Bilbo 
and Schwarz, 2009).  Microglia and dendritic cells both may a play a role in brain 
organization, maturation and plasticity of neural systems (Mikami et al., 2004; Yirmiya 
and Goshen, 2011).  More specifically, there is evidence showing that such immune cells 
as microglia and immune signaling molecules like major histocompatibility complex 
(MHC) and TNF-α play an important role in the development of the hippocampal 
formation (Corriveau et al., 1998; Goddard et al., 2007).  Major histocompatibility 
complex (MHC) class I is highly expressed in the brain peri-natally and been shown to 
regulate hippocampal maturation and plasticity (Huh et al., 2000; Boulanger and Shatz, 
2004).  Resident immune system cells within the hippocampus during development can 
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also shape later adult experience and behavior (Wakselman et al., 2008; Bland et al., 
2010).  For example, early life immune insult results in a hippocampal dependent 
learning impairment following a peripheral immune challenge in adulthood.  This 
neonatal infection is associated with increases in cytokine expression and glial cell 
marker mRNA in the hippocampus and the adulthood learning impairments can be 
blocked by inhibition of IL-1β production during the initial infection (Bilbo et al., 2005).  
Specifically, contextual learning in adulthood is affected following re-infection and is 
associated with decreases in BDNF mRNA and increases in IL-1 β mRNA in the 
hippocampus (Bilbo et al., 2008).  More broadly, there is strong evidence that peri-natal 
exposure to infectious agents affects the adult brain and behavior through cytokines like 
TNF-α, IL-1β and IL-6 (Bilbo and Schwarz, 2009).  There is evidence that early life 
immune activation results in changes in stress reactivity and psychiatric disorders like 
autism and schizophrenia (Rantakallio et al., 1997; Hornig et al., 1999; Shi et al., 2003).   
Additionally, mast cells have the potential to have effects pre-natally.  Although 
mast cells are not seen in the rodent until embryonic day 15, in utero effects are possible 
even earlier due to the mast cell status of the mother.  For example, mast cells are present 
in the placenta and have known effects on the regulation of angiogenesis and blood 
floow.  It is therefore possible that placental mast cell activation can have profound 
effects on the development of brain and behavior. 
 The developmental hypothesis was considered due to a lack of an ability to 
explain the large effects of a lack of mast cells on behavior with either acute or long-term 
impacts during adulthood. However, in lieu of a developmental hypothesis, it is possible 
that mast cell derived serotonin is acting both as a transmitter and as a trophic factor in 
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conjunction during adulthood.  These acute and long-term (but not developmental) effects 
could account for the large deficits in behavior that are not seen with alterations of acute 
or long-term serotonergic signaling independently.    
 
Broader impact and significance 
 The hygiene hypothesis is a theory that some immune activation is needed for 
healthy development.  The hypothesis was developed to explain the increasing prevalence 
of allergies in developed countries (Rook and Brunet, 2005).  Recall that allergies are 
mediated in large part by mast cells.  The theory offers an explanation for increased 
atopic disorders, specifically that they are due to decreased immune activation resulting 
from increased hygiene and sanitation.  As a result, children, especially under the age of 
5, are exposed to fewer antigens than was previously common.  The hygiene hypothesis 
makes the case that this causes a lack of immune activation during development and 
therefore a lack of appropriate levels of immunoregulatory systems that dampen and shut-
off the immune response.  This is required for many immune responses because the 
mechanisms engaged normally persist until an antagonist signal to shut them down is 
received.  Epidemiological studies have provided data to support this hypothesis showing 
that the rates of chronic inflammatory diseases, like Crohn’s disease, are lower in rural 
places where parasitic worms are more common.  The hygiene hypothesis even attempts 
to explain sex differences in the prevalence of asthma, allergy, auto-immune disorders 
(like MS) and even depression (Clough, 2011).  A controversial extension suggests that 
women have higher rates than men of these disorders because girls are watched more 
than young boys and encouraged to remain clean and hygienic while boys ingest more 
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microbes and are less likely to be prevented from “getting dirty” under parental 
supervision.   
Relevant to the work presented here, the hygiene hypothesis has been taken a step 
further to encompass mental health (Rook and Lowry, 2008).  There are suggestions that 
the increase in the number of cases of depression might be causally linked to increases in 
sanitation and hygiene as well.  Recent studies have added to the scope of this hypothesis, 
showing a link between decreased exposure to certain bacteria and increased rates of 
depression. Rook and Lowry note that some cases of depression are comorbid with 
increased inflammatory signals and that treatment with serotonin-selective reuptake 
inhibitors reduces the inflammatory profile.  Therefore they propose that the depression is 
causally linked to the increase in proinflammatory cytokines induced by the failure of 
immune regulation caused by abnormal development of the immune system due to 
decreased exposure to antigens during early development.   
 Even in the absence of an antigen or pathogenic state, immune cells resident in 
the brain play an important and beneficial role in the regulation of brain and behavior.  
The studies presented here on mast cells add to this literature which currently implicate T 
cells, microglia and immune signaling molecules in the regulation of neural systems 
underlying cognition and emotionality behavior (Capuron and Miller, 2011; Yirmiya and 
Goshen, 2011).  For example CNS resident T cells in the brain impact hippocampal 
neurogenesis (Wolf et al., 2009).  A lack of these T cells results in reduced hippocampal 
neurogenesis and consequential deficits in spatial learning and memory as both deficits 
are reversed with reconstitution of CNS specific T cells (Ziv et al., 2006).  Microglia, 
166 
while commonly known for their role as support cells, secrete a host of cytokines that 
have effects on social and emotional behaviors (Dantzer and Kelley, 2007).   
 
Limitations and Future Directions 
 In order to delineate the mechanisms of mast cell impact on the brain and 
behavior, further studies are needed.  First the use of additional models besides a 
organism-wide, non-inducible genetic mast cells knock-out model can strengthen the 
interpretation of the data presented here.  For example, additional pharmacological, 
inducible transgenic mice or site specific knock-down models would add to the argument 
that brain mast cells affect brain and behavior.  Second the use of more causal models can 
help point to the mechanism(s) of the effects described in Chapters 3 and 5 of mast cells 
effects on brain physiology and behavior.  Additionally, further studies will help to target 
the effects of mast cells in the brain specifically.  Given that these mice lack all mast cells 
– peripheral and central – it is possible that some of the effects seen in the brain are due 
to peripheral mast cells releasing chemical mediators into the blood which are then 
gaining access to the brain.  It is possible to follow up the use of this genetic mast cell 
deficient sash mouse model with pharmacological studies in which specific populations 
of mast cells can be inactivated.  One such study was presented in Chapter 3, in which 
wild-type mice were injected with disodium cromoglycate (cromolyn) either 
intraperitoneally (i.p.) or intracerebroventricularly (i.c.v) into the lateral ventricle.  
Cromolyn renders mast cells non-functional by stabilizing the mast cell membrane and 
preventing activation and degranulation.  Since cromolyn does not cross the blood-brain 
barrier, the i.p injection only affects the peripheral population of brain mast cells and the 
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i.c.v. injection dose is too low to have effects from circulation in the blood.  This allows 
the dissociation of the two populations of mast cells and conclusions about brain mast 
cells specifically can be drawn.  However, the use of cromolyn has its disadvantages as 
well.  Cromolyn has been shown to not act specifically on mast cells.  Macrophages and 
natural killer cells are also affected by cromolyn.  Overall, convergent results from the 
two models – genetic and pharmacologic, can strongly suggest conclusions about mast 
cells effects on brain and behavior.   
Future studies can solidify these effects by using other models besides 
constitutive, body-wide, mast cell deficiency.  One potential experimental model is a 
brain mast cell gain-of-function mouse.  Mast cells can be injected directly into the brain 
(i.c.v.), and the resulting the effects on brain physiology and behavior can be measured.  
The mast cells would not likely stay in the brain for an extended period of time, and 
therefore these studies would only address acute affects of brain mast cells. However, 
another loss-of-function model can be used to supplement these data.  By using targeted 
selective ablation of mast cells in the adult brain, tissue specific effects of chronic mast 
cell deficiency can be assessed while the developmental effect of mast cells is left 
unaltered.  Saporin conjugated to IgE antibody injected into the brain (i.c.v.) would bind 
FceRIa, a high affinity IgE receptor expressed on the cell surface of mast cells 
exclusively.  These antibodies crosslink and can then be internalized which would cause 
death of the cell if conjugated to saporin.  Overall, additional models would help 
determine whether the effect of mast cells was central or peripheral, as a transmitter or 
trophic factor, in development or adulthood, or all of the above. 
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Future experiments may also be aimed at investigating the effect of mast cells on 
early pre-natal development.  These effects would initiate from the mother’s mast cells.  
Experiments presented here did not directly address these effects.  Future studies can 
assess this question of maternal mast cell impact on pup development in utero by 
comparing heterozygote offspring from mast cell competent and mast cell deficient dams.  
Follow-up experiments would need to include in vitro fertilization to rule out genetic 
effects from the egg, and cross-fostering to rule out effects of rearing.   
A limitation of the research presented here is that data from only males are 
reported.  While some initial behavioral screens described in Chapter 3 were also run on 
female mice (data not shown), future experiments excluded their use due to large 
variability seen in the behavioral data.  The studies report a novel finding of mast cell 
effects on brain and behavior in males, however it is unknown whether these findings 
would persist across both sexes.  It is important to determine this in future experiments as 
there are known sex differences in emotionality behavior and autoimmune phenomenon 
seen in rodents as well as sex differences in humans in the prevalence of anxiety and 
other mental health disorders as well as mast cell-mediated disorders like asthma and 
allergy (Grossman, 1989; Goldstein, 2006; Bale, 2009; McCombe et al., 2009). 
Sexually dimorphic influences of the immune system on the the brain are seen as 
early as peri-natal development (Amateau and McCarthy, 2004), suggesting that the 
developmental hypothesis of mast cells impact on brain may be subject to differences in 
females.    Additionally, neural systems that are impacted by imflammation, including 




 The immune system is now being targeted for the treatment of many mental 
health disorders, like depression.  This stems largely from the finding that depressed 
patients have a pro-inflammatory phenotype, suggesting that the immune system is 
overactive in depression.  Recently, one of the first causal examples in humans showed 
that cytokines can be responsible for the development of depression.  Administration of 
the cytokine INF-α caused profound depression in nearly all subjects that was alleviated 
following termination of the treatment (Raison et al., 2006).  It is becoming clear that 
neuroimmune interactions must be finely tuned and carefully regulated.  Too much 
immune system impact on the brain can backfire, leading to large amounts of 
inflammation and immune system activation that can act detrimentally on brain and 
behavior.    
 Several lines of evidence, based on humans and rodent subjects link psychiatric 
disorders to mast cells through mast cell mediated disorders like allergy, asthma and 
mastocytosis.  First, epidemiological evidence shows that increases in anxiety and 
depression assessed by DSMIV criteria, correlates with increases in allergy as measured 
by plasma IgE assays (Goodwin et al., 2004).  This is a tonic effect and is not associated 
with acute anxiety associated with allergic attacks.  Furthermore, allergy treatment in this 
population results in alleviation of anxiety and depression (compared to untreated IgE-
positive controls).  Other epidemiological evidence shows that there is a higher 
prevalence of autism in families of patients suffering from mastocytosis (Theoharides et 
al., 2008).  
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 Although these data highlight a potential link between mast and depression, 
anxiety and autism in humans, it is the reverse direction from what you would expect 
given the rodent data presented in this dissertation.  For example, in our results, a lack of 
mast cells causes increases in anxiety, but other studies suggest that great numbers or 
activation of mast cells causes increases in anxiety.  While seemingly inconsistent, this 
inverted U-shaped phenomenon is seen frequently in immune effects on brain, in which 
too much or too little immune activation has negative consequences.  This is seen 
strongly in the case of IL-1 as impaired IL-1 signaling is associated with deficits in 
hippocampal neurogenesis and hippocampal-dependent behavior and cognition (Avital et 
al., 2003),  but increases in hippocampal IL-1 production are also detrimental to 
neurogenesis and stress induced depression onset (Goshen et al., 2008; Koo and Duman, 
2008).  A parallel relationship between anxiety and mast cells may mirror the effects of 
both over and under-expression of IL -1 in the hippocampus.   
   
Conclusion 
 I conclude that mast cells are present in the mouse brain and contribute 
functionally to the regulation of brain and behavior.  As immune cells in the brain, mast 
cells reduce anxiety-like behavior and physiology by contributing serotonin to the 
hippocampus which acts as a transmitter and trophic factor during development and 
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 Mast cells affect the development and maintenance of blood vessels by release of 
pro-angiogenic factors.  This is seen clearly in the vascularization of a solid state tumor 
and fat tissue in addition to blood vessel repair following tissue damage.  Mast cells are 
also located in the brain, but their role in contributing to brain blood vessel formation or 
repair is unknown.  Using a mast cell deficient mouse, the effects of a lack of mast cells 
on brain vasculature were investigated in the adult and developing brain.   
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Introduction 
Mast cells impact blood vessels  by releasing mediators that aid in angiogenesis, 
the formation and repair of blood vessels (Norrby, 2002).  Mast cell involvement in 
angiogenesis has been implicated in the many tissues.  They contribute to vascular repair 
during wound healing in skin (Tonnesen et al., 2000), and are required in fat tissue for the 
vascularization required to support expanding adipocytes in diet-induced obesity (Liu et 
al., 2009).  Mast cells also promote angiogenesis in solid state tumors where 
vascularization is necessary for tumor expansion like in carcinomas of the skin (Martins 
et al., 2010), gut (Ribatti et al., 2010) and oral cavities (Sawatsubashi et al., 2000; Souza 
et al., 2010).  Induction of a pancreatic tumor in genetic and pharmacological models of 
mast cell deficiency resulted in reduced vascularization of the tumor in the absence of 
mast cells (Soucek et al., 2007).  There was a reduction of blood vessels and a lack of 
organized vascularization which functionally resulted in smaller tumors due to hypoxia-
induced cell death.  In a squamous cell carcinoma model, mast cells were also shown to 
affect angiogenesis, purportedly via release of vascular endothelial growth factor 
(VEGF), a well-known pro-angiogenic cytokine released by mast cells (Sawatsubashi et 
al., 2000). 
Mast cells have the potential to release many angiogenic factors in addition to 
VEGF, including tumor necrosis factor (TNF) α and β, fibroblast growth factor (FGF), 
and matrix metalloproteinases (Norrby, 2002).  Mast cell tryptase and chymase were also 
recently shown to have angiogenic functions (Ribatti et al., 2011).  In addition to released 
factors, mast cells can also contribute to vascularization through promotion of VEGF 
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production from non-mast cell sources (Cohen et al., 1996), as well as the recruitment of 
macrophages and leukocytes which also have pro-angiogenic roles (Norrby, 2002).   
Mast cells are located in the brain, where their role in angiogenesis has not been 
investigated (Silver et al., 1996).  Brain mast cells are highly localized near blood vessels 
in the developing rat brain and mast cell infiltration into the brain early in development 
correlates with the largest post-natal expansion of brain vascularization (Michaloudi et 
al., 2003; Khalil et al., 2007).   Brain angiogenesis occurs from the sprouting of branches 
from the original large penetrating blood vessels.  Interestingly, mast cells are frequently 
located near large blood vessels.  Furthermore, in the developing rat, mast cells were 
found preferentially at branch points of blood vessels during a developmental period 
characterized by large expansion of vasculature and an increase in small blood vessels.  
Overall this characterization of the distribution of mast cells in the developing brain 
suggests that mast cells are positioned to have a role in the development of brain blood 
vessels.   
The role of mast cells in developing neurovasculature has not been tested.  Given 
mast cells involvement in angiogenesis and the presence of mast cells in the normal 
brain, their absence could be deleterious to brain development.  Deficiencies in brain 
angiogenesis could prevent adequate blood flow and result in hypoxia-induced cell death 
or retarded neural maturation. Impact on the development or maintenance of neural 
systems would cause effects on brain physiology and behavior.  Therefore the goal of this 
project was to assess the effect of a lack of mast cells on the developing and adult 
vasculature.  We studied the vasculature in brain regions with known mast cell 
populations, in mast cell deficient (sash-/-) mice and their heterozygote (sash+/-) 
181 
littermates.  Developing mice were run in addition to adults to rule out any non-mast cell 
mediated compensatory mechanisms that might have resulted in no differences between 
genotypes in adults.  Developmental ages were chosen with regard to the known 
developmental pattern of brain vascularization (Caley and Maxwell, 1970; Michaloudi et 
al., 2003) and also the developmental distribution of mast cells (Chapter 2).   
 
Materials and Methods 
Animals 
 Mast cell deficient KitW-sh/W-sh (sash-/-) mice on a C57BL/6 background were 
obtained from Jackson Laboratories (B6.Cg-KitW-sh/HNihrJaeBsmJ; Bar Harbor, ME) and 
bred to establish a colony at the Columbia University animal facilities.  As previously 
described (see Chapter 1; Duttlinger et al., 1993), sash-/- mice completely lack mast cells 
due to an inversion mutation upstream from the c-kit receptor promoter, causing a 
reduced expression of c-kit receptor on the bone marrow cells and therefore an inability 
for mast cells to differentiate from their myeloid progenitors (Kitamura and Fujita, 1989; 
Chen et al., 2005).  Heterozygote (sash+/-) mice were bred with sash-/- mice to produce 
litters with sash+/- and sash-/- mice.  Pregnant dams were checked daily for births.  All 
animals were housed in standard lab cages with food and water provided ad libitum in a 
12:12 light–dark cycle.  Experimental procedures were approved by the Institutional 
Animal Care and Use Committee at Columbia University.  
 Sash+/- and sash-/- littermate mice were sacrificed at postnatal days (PN) 6 or 11 
or as adults (PN45-63).  Animals were sacrificed by decapitation and brains were 
immediately removed from the crania, frozen on dry ice and kept at −20  °C.  Brains were 
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cut into 50 μm thick sections on a cryostat (Microm HM 500M, Walldorf) and thaw 
mounted onto FisherPlus slides.  Adult brains were cut into coronal sections throughout 
the diencephalon and olfactory bulbs.  PN6 and 11 brains were cut sagitally through one 
hemisphere of the brain.  Slides were stored at −20 °C until immunohistochemistry was 
performed.   
 
Immunohistochemistry 
       Immunohistochemistry (IHC) was performed on every fourth 50 μm sagittal section 
cut coronally or sagittally.  Purified rat anti-mouse CD31 (MEC13.3, Cat#550274, BD 
Pharmingen, San Diego, CA) is a directed against CD31 or Platelet Endothelial Cell 
Adhesion Molecule (PECAM) which is expressed constitutively on endothelial cell 
surfaces (Albelda et al., 1991), allowing the staining of all blood vessels in the brain.  
IHC was performed as previously described (Forster et al., 2006).  Briefly, slides were 
immersed sequentially in ice-cold methanol, acetone, and 4% paraformaldehyde, then 
washed in 0.1% Triton X-100 in phosphate buffer (0.1% PBT), blocked with normal 
donkey serum (NDS) and incubated in the primary antibody overnight at a 1:200 dilution.  
Slides were then washed in 0.1% PBT, incubated in CY3 conjugated donkey anti-rat 
secondary antibody (1:200 dilution; Jackson ImmunoResearch Laboratories, West Grove, 
PA) for 2 h and then washed with PB.  Slides were then incubated with 4’,6-Diamidino-
2-Phenylindole (DAPI, Cat#D-9542, Sigma Aldrich, St. Louis, MO) at a 1 μg/ml 
concentration for 30 min to label nuclei, then washed in PB again, dehydrated, and 




 CD31 staining was visualized on a fluorescent microscope (Nikon Eclipse E800) 
equipped with a Texas Red filter cube (560±40 nm excitation spectrum) to detect the 
CY3 fluorophores and UV filter (~360 nm excitation spectrum here) to detect DAPI. 
Images were captured with a Q-Imaging Retiga EXi, fast 1394 camera (Quantitative 
Imaging) and QCapture software (version 2.95.0, Quantitative Imaging, Surrey, BC, 
Canada) and loaded into ImageJ software for analysis of blood vessel density and size or 
Photoshop for analysis of branch points (Fig 1).  In the developmental study, three 
regions of the hippocampus (lateral, dorsal and ventral), the caudo-lateral region of the 
thalamus (an area which included the lateral geniculate), the olfactory bulb and the cortex 
(primary motor area) were analyzed for blood vessel density, branching and size.  In the 
adult study, two regions of the thalamus (rostral dorsomedial and caudo-lateral which 
included the lateral geniculate), the olfactory bulb and cortex (primary motor area) were 
analyzed for blood vessel density and size.  Regions of interest were localized using 
DAPI stain. 
 Blood vessel area density The area of CD31 staining was determined in sections 
using the built-in default thresholding tool in ImageJ.  Images from 3 sections for each 
brain region were averaged to obtain a single value for each brain region per animal.  
Values for animals were averaged by group (genotype for adults, genotype x age for 
development).  Student’s t-test (for adults) or two-way ANOVAs (for development) were 
used to test significant differences between groups. 
 Blood vessel diameter The diameter of all blood vessels was sampled in a 
randomly chosen 504 x 638 μm area within 3 sections per animal using ImageJ.  Blood 
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vessels were classified by their diameter into small (d < 4 μm), medium (4 ≤ d < 7 μm) 
and large (d ≥ 7 μm).  Distributions of blood vessels between groups were compared 
using Chi-square tests and repeated measures ANOVAs with post hoc Tukey HSD tests. 
 Blood vessel branch points The number of branch points of blood vessels were 
counted in a randomly chosen 508 x 373 μm area within 3 sections per animal using in 
Photoshop.  Every bifurcating vessel in the sample space was counted and averaged 
across sections for a given animal.  ANOVAs were used to test significant differences 
between groups (genotype x age).  
CD31 DAPI CD31
DAPI
Fig 1.  Blood vessel staining in the brain. Vasculature is shown by staining of endothelial cells with CD31/PECAM (left) in the 
dorsal hippocampus of a sash-/- mouse, delineated with DAPI nuclear stain (middle).  Composite of CD31 and DAPI stain is also 
shown (right). Mag bar, 100μm.  
Results 
Adults 
 Blood vessel density  There were no significant differences between genotypes in 
the area of CD31 staining (labeled blood vessels) in the olfactory bulb, cortex or thalamic 
regions (t7<0.99, p>0.05; Fig 2).   
 Blood vessel size There was an effect of genotype on the distribution of blood 
vessel size in the thalamus (χ2=8.8, p<0.05; Fig 3), but not in any other brain region 
analyzed (χ 2<5.0, p>0.05).  There was a smaller percentage of small blood vessels in the 






























Fig 2.  Vasculature in the adult mouse brain. Vasculature is quantified by total area of 














respectively).  There were also corresponding increases in the percentages of both 
medium and large blood vessels in sash-/- mice.  This represents a significant interaction 
of genotype and blood vessel size (F1,15=3.9, p<0.05).  There were no significant effects 
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Fig 3.  Blood vessel size in the adult mouse brain. The distribution of blood vessel size is shown for sash+/- and 
sash-/- mice in the dorsomedial thalamus, a region in which genotype differences were observed (top).  Binned into 
categories of small, medium and large blood vessels, it is clear that sash+/- mice have more small blood vessels 
than sash-/- mice (top right).  The distribution of blood vessel size is also shown for the cortex of sash+/- and sash-/-











































 Blood vessel density  There were no significant differences in the total amount of 
vasculature between sash-/- or littermate sash+/- mice in any brain region measured (Table 
1).  There were also no main effects of age (PN 6 vs. PN 11) on vasculature.  There was, 
however, an interaction effect seen in the cortex (F1,29=9.4, p<0.01) as sash+/- mice had an 












Table 1. Vasculature in the developing sash+/- and sash-/- mouse brains. Vasculature is quantified by total area of endothelial 
cells staining for sash+/- and sash-/- mice in various mast cell-rich regions of the brain at PN6 and PN11. Data is presented as 


























Figure 4.  Vasculature in the developing cortex of sash+/- and sash-/-mice.  The interaction 














 Branch points  There was a significant increase in the number of branch points 
observed from PN6 to PN11 in all mice (Fig 5), regardless of genotype, in all brain areas 
except the olfactory bulb (F1,27=0.2, p>0.05).  This included the lateral (F1,28=8.4, 
p<0.01), ventromedial (F1,23=4.6, p<0.05) and ventral hippocampus (F1,31=18.2, p<0.01), 
thalamus (F1,30=12.2, p<0.01) and cortex (F1,30=9.6, p<0.01).  This indicated that brain 
vasculature was undergoing branching during this period in development.   
 There was a significant effect of genotype on the lateral hippocampus and cortex.  
Sash-/- mice had decreased number of branch points in these areas compared to sash+/- 
mice (F1,28=6.1, p<0.05 and F1,30=4.2, p<0.05 for lateral hippocampus and cortex 
respectively). Overall, there were no significant interaction effects, suggesting that the 










































































Figure 5. Brain blood vessel branch points during development of sash+/- and sash-/- mice.  The number of blood 
vessel branch points are shown for both genotypes at PN6 and PN11 in 6 brain regions in which mast cells are located 









































































 Blood vessel size There was an effect of age, but not of genotype on the size of 
blood vessels in the brain during development (Fig 6).  There was an overall effect of age 
on the number and size of blood vessels in all brain regions measured (F1,32>5.1, p<0.05 
and F15,480>7.2, p<0.01).  Specifically there were more small blood vessels at PN11 than 
at PN6.  This effect was most pronounced in blood vessels with diameters 3-5μm, and 
was present in both sash+/- and sash-/- mice.  In all areas except the cortex, there were no 
effects of genotype on the size of blood vessels (F1,32<0.3, p>0.05).  In the cortex there 
was an interaction of genotype and age on the distribution of blood vessel sizes 
(F15,480=3.3, p<0.01; Fig 6).  Specifically, the number of small blood vessels did not 
change in sash+/- mice from age PN6 to PN11.  However in sash-/- mice, the number of 
small blood vessels (3-5 μm diameter) in sash-/- mice was smaller than that in sash+/- 
mice.  Their numbers increased to sash+/- levels by PN11.  
Figure 6. Brain blood vessel size during development of sash+/- and sash-/- mice.  The 
Thalamus




























distribution of blood vessel size is shown for both genotypes at PN6 and PN11 in the thalamus (top) 





























 The data presented here show that angiogenesis is not drastically altered in 
development or in adulthood due to a lack of mast cells.  In adults there is no effect of 
genotype on total area staining of CD31.  There was also no effect of genotype on the 
distribution of blood vessel size in adults, except in the dorsomedial thalamus where there 
were fewer small blood vessels in adult sash-/- mice compared to sash+/- mice.  During 
development, there were also minimal effects of genotype on vasculature.  However, 
there was an effect of mast cell deficiency in the cortex of sash-/- mice, across all 
measures.  Specifically, in contrast to sash+/- mice, they had less CD31 staining, fewer 
branch points, and a delayed increase in small blood vessels.  These developmental 
differences in sash-/- mouse cortex may extend, in part, until adulthood as adult sash-/- 
mice have slightly, but not significantly (p=0.11), less CD31 staining compared to adult 
sash+/- mice.  Lastly, there were also significantly fewer branch points in the lateral 
hippocampus of sash-/- mice during development at both PN6 and PN11.  The deficits 
seen in the cortex and hippocampus sash-/- mice during development are not present in 
adult sash-/- mice.  This likely represents redundant mechanisms in place for the 
vascularization of the brain.  Although there are no differences seen in adulthood, 
however, this does not mean that the developmental delays in angiogenesis in sash-/- mice 
do not translate into long-lasting deficits in the brain.  It is possible that the deficits seen 
in lateral hippocampus during development might translate to abnormal maturation of 
hippocampal neural circuits and resulting hippocampal function.    
 It is clear from the data presented on blood vessel branch points and size that the 
developmental time investigated here represents a period of vascular expansion in the 
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mouse brain.  This time period was characterized by an increase in branch points and 
small blood vessels in most areas measured.  Given that mast cells are located in the brain 
within and nearby the analyzed regions (see Chapter 2), the present data suggest that 
either mast cells do not affect the angiogenesis of non-cortical areas, or mast cells are 
impacting angiogenesis at a different time point in development.  Previous studies 
demonstrate that mast cells are preferentially located near large blood vessels in the rat 
(Khalil et al., 2007).  This suggests that perhaps mast cells are influencing angiogenesis 
at an earlier stage in development characterized by large blood vessels branching off into 
medium size blood vessels, rather than a period in development when medium sized 
blood vessels are becoming even smaller (3-5 μm) blood vessels.  However given that we 
report deficits in adult sash-/- mouse thalamic vasculature, it is possible that mast cells are 
affecting a later stage in development.   
 Many studies use models of mast cell deficiency to implicate direct mast cell 
involvement in the formation of new blood vessels (Michaloudi et al., 2003; Soucek et 
al., 2007).  However, one of the primary roles of mast cells in the periphery is the 
recruitment of other immune cell types, many of which have their own known role in 
angiogenesis.  Therefore reduced angiogenesis in animals models with mast cell loss-of-
function may be due to the lack of angiogenic contribution of the mast cell-recruited cell 
types.  In the brain, however, mast cells have less of a role in cell recruitment since the 
blood brain barrier regulates cell trafficking. Therefore the negative effects presented 
here may represent a potential lack of direct mast cell involvement in angiogenesis more 
generally, rather than specifically a lack of involvement in the formation of brain blood 
vessels.   
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 Lastly, given the importance of the normal and complex maturation of the brain to 
the survival of an organism, it is possible that there are many redundant mechanisms to 
ensure the development and maintenance of brain vasculature.  Nevertheless, future 
studies should investigate the role of brain mast cells in the repair of brain blood vessels 
following ischemia or stroke – pathologies in which mast cells are recruited to the 
damaged brain region.   
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